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Abstract 
Abstract 
Enantiomerically pure chiral amines are important intermediates in the fine chemical, 
pharmaceutical and agrochemical industries. The aim of this work was to investigate 
novel methods to deracemise a wide range of chiral amines. An important aspect of 
this work consisted of identifying variant enzymes, with activity towards novel amine 
substrates, which could be developed as suitable biocatalysts for deracemisation. 
The deracemisation process relies on the combination of iterative cycles of 
enantioselective oxidation of a racemic amine (to an achiral imine intermediate) 
using an amine oxidase and non-specific chemical reduction. Previous work had lead 
to the identification of a monoamine oxidase MAO-N variant from Aspergillus niger 
(Asn336Ser) which exhibited a ca. 47 fold improvement of kcat towards (5)-a-
methylbenzylamine compared with the wild type. The MAO-N variant had been used 
in the deracemisation of rac a-methylbenzylamine to give (R)-a-methylbenzylamine 
in 77% yield and 93% e.e. 
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______________ 	 hydrolysis 
) - Cr'  
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Reducing agent 
In this work the MAO-N N336S variant was initially screened for activity towards a 
panel of amine substrates and was shown to have a broad substrate specificity and 
high enantioselectivity towards the (5)-enantiomer. Further directed evolution of 
MAO-N N336S enzyme towards a secondary amine identified a new variant (1246M 
N336S). This variant had a 6.6 fold improvement in kcat towards the target substrate 
with maintenance of the (S)-enantioselectivity. This variant was used for the 
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preparative deracemisation of secondary cyclic amines in either whole cell (expressed 
in recombinant E. coli) or immobilised formulation. 
The MAO-N 1246M N336S variant underwent further directed evolution by 
randomising amino acid residues identified as potentially important by a homology 
model. The homology model was based on an alignment of the MAO-N sequence 
with MAO-B, the human form of the enzyme. Directed evolution identified a 1246M 
N336S M348K T384N D385S variant with a 19.3 fold improvement in kcat compared 
with the parent and 1354 fold improvement compared to wild type for the (5)-
enantiomer of the target substrate. The E-factor remained high (I 10) which is 
expected to translate to an excellent e.e. for the deracemisation of this substrate. 
Reducing agents were examined to identify those that showed the fastest rate of 
imine reduction. The fastest reducing agents were used in deracemisation reactions. 
The evolved MAO-N 1246M N336S M348K enzyme was used in the preparative 
deracemisation of secondary amines in high yield and enantiomeric excess. 
Preparative deracemisations were performed with purified enzyme immobilised on 
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acetyl CoA acetyl coenzyme A 
AGAO Arthrobacter globforms amine oxidase 
BASPHOS 2,5-bis (oxymethyl)-substituted bis (phospholanes) 
BINAP 2,2' -bis (diphenyiphosphino)- 1,1' -binaphthyl 
BLAST basic local alignment search tool 
BSA bovine serum albumin 
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FDA Food and Drug Administration 
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GFP green fluorescent protein 
HAT hydrogen atom transfer 
HIV human immunodeficiency virus 
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IPTG isopropyIthio--D-ga1actoside 
ITCHY incremental truncation for the creation of hybrid enzymes 
kDa kilodalton 
U kilojoule 
L path length 
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Abbreviations 
MAO-A type A monoamine oxidase from homo sapiens 
MAO-B type B monoamine oxidase from homo sapiens 
MAO-N monoamine oxidase from Aspergillus niger 
mbar millibar 
MDQ 1 -methyldihydroisoquinoline 
MTQ 1 -methyltetrahydroisoquinoline 
Ni-NTA nickel-nitrilotri acetic acid 
OD Optical density 
PAO polyamine oxidase 
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PET polyethyleneimine 
PMHS polymethyihydrosiloxane 
PMSF phenylmethylsulfonyl fluoride 
R gas constant 
rac racemic 
RACHITT random chimeragenesis on transient templates 
RNA ribonucleic acid 
SDM site directed mutagenesis 
SDS sodium dodecylsulfate 
SDS PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
SET single electron transfer 
StEP staggered extension process 
TAE tris acetate EDTA 
TBME tert-butyl methyl ether 
TPQ topaquinone 
Tris tris(hydroxymethyl)aminomethane 
tRNA transfer ribonucleic acid 
U units 
v/v volume by volume 
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Abbreviations 
w/v weight by volume 
(XD optical rotation 
c molar extinction coefficient 
AG change in free energy 
AGt change in free energy (transition state) 
AH change in enthalpy 
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Introduction 
1.1. Synthesis of optically active chiral amines 
Chirality is a key issue concerning the production of fine chemicals and in recent years 
the desire to achieve the efficient synthesis of chiral compounds has increased following 
the release of the FDA's guidelines'. In 1992 the FDA and European Committee for 
Proprietary Medicinal Products required manufacturers to research and characterise each 
enantiomer in all chiral drugs proposed to be marketed as a mixture. Worldwide sales of 
chiral drugs in single enantiomer dosage continue to grow at more than 11.4% annually 
with the market estimated to be worth $14.94 billion by the end of 20092.  The same 
survey showed this growth would be realised by a 36% rise in chemocatalysis and 22% 
in biocatalysis, whilst traditional technology would drop to 41%. To access chirality in 
industrial transformations several options are available. Enantiopure precursors can be 
used from the natural 'chiral pool', asymmetric synthesis can be used or a kinetic 
resolution method maybe undertaken. 
Amines constitute an important class of functional group present in many biologically 
active chiral molecules. Several strategies exist for the preparation of optically active 
chiral amines which are classified into two main groups 3 . Asymmetric synthesis is the 
first of these routes. Typically, a prochiral substrate undergoes an asymmetric chemical 
change to the chiral amine product. This can be achieved by a reductive amination, 
transamination or a transfer hydrogenation. Secondly a physical separation may be 
possible where no chemical modification to the substrate is undertaken. Traditional 
physical separation techniques (distillation, chromotagraphy and crystallisation) cannot 
be used to separate enantiomers because they have identical physical properties. But if a 
chiral additive is introduced separation is possible if it can interact with the substrate, 
this effectively converts it from an enantiomeric to a diastereomeric mixture. Owing to 
the fact that diastereomers are not chemically equivalent, physical separation becomes 
possible. 
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1.1.1. 1,2-Addition to carbon-nitrogen double bonds 
1,2-Addition of nucleophiles to a C=N imino group in an asymmetric fashion provides a 
route to enantiomerically enriched amines 4 . The analogous reaction with the keto, rather 
than imino functionality has been much more widely investigated 5 . Imino groups 
encounter some general problems that make 1,2-additions more challenging than with 
the equivalent keto group; the imino group is less electrophilic, can tautomerise to the 
enanime and can undergo reductive coupling, hampering 1,2-addition reactions. 
However, activation of the imino group and selective reagents can be used to help reduce 
some of these difficulties 4 . Achieving asymmetric synthesis of amines is possible by 
introducing chirality either into the carbonyl or amine part of the imino substrate, in the 
nucleophilic reagent or in the external chiral ligands. 1,2-addition reactions to yield 
chiral amines are not limited to imino functionality, 1,2-additions to hydrazones gives 
hydrazines, addition to oxime ethers or nitrones leads to hydroxylamines 4 . Hydrazines 
and hydroxylamines can then be converted to the corresponding optically active amine 
by reductive cleavage. Oxime ethers are the least useful electrophilic C=N bond 
component for 1,2-additions because they are less electrophilic and usually comprise of 
E/Z mixtures which can interfere with the design of the asymmetric process. In the case 
of aldehyde hydrazones they generally are obtained as E isomers6 . 
Condensation of commercially available enantiopure amines to a carbonyl compound 
can be used to prepare N-alkyllarylamines. In the case where the amine possesses a 
second heteroatom, the transition states are energetically strengthened by chelation and 
this improves diastereoselectivities. Condensation of S-valinol-1 to an aldehyde gave 
non-enolisable arylamines which were subsequently treated with a metal aryllbenzyl 
reagent to give the diastereomeric amine-3 with d.e.s >98%. The auxiliary group could 
be subsequently removed to give the enantiomenc enriched amine. A transition state was 
proposed with the alkoxy group from the f3-amine alcohol coordinating with the metal 
2 
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and therefore directing nucleophilic attack at the si-face of the imine-2. Changing the 
chiral auxiliary to S-alaninol lowered the selectivity from S-valinol-1, showing the 
importance of the more bulky isopropyl group 7 . 









RH 	 RR' 
2 3 
Lo-1  ' I R" J
R = Ph, 4-MeOPh, 2- and 3-thienyl, 2-furyl; R' = BnMgCI 
R = R' = Ph, 4-MeOPh, 4-MePh, 4-CIPh, R = Bn; M = Li 
Figure 1.1.1.1. Diastereoselective synthesis of amines-3 using 3-amino alcohols as an 
auxiliary. 
Synthetic applications of radical addition to C=N bonds can give several potential 
products including unsymmetrical ketones, quaternary C-C bonds and chiral a-branched 
amines  8.  Malonate-derived oxime ethers-4 (as shown in figure 1.1.1.2) gave high 
diastereoselectivity in the hydroxylamine-5 product (d.r. > 40:1) for ethyl radical 
addition reactions. The chiral camphorsultam part of the oxime substrate was not the 
major stereocontrolling element because the oxime ether analogue with no chirality at 
the a-amide carbon (substrate-5a in figure 1.1.1.2) showed little stereocontrol 9 . 
3 
R'. 


















Substrate R R' Yield d.r. 
5a Hydrogen Ethyl 84% (1.1:1) 
5b Benzyl Ethyl 99% (>40:1) 
Sc p-Nitrobenzyl Ethyl 72% (>40:1) 
5d Propargyl Ethyl 43% (>40:1) 
Figure 1.1.1.2. Ethyl radical addition to camphorsultam oxime ether substrates. 
More recently, the radical addition to chiral hydrazones has allowed chiral acyclic 
amino-alcohols to be accessed. This offers a complementary route from the ionic method 
described earlier (figure 1.1.1.1). Bromomethyl or vinyl radical precursors tethered via a 
temporary silicon connection underwent tin mediated 5-exo radical cyclisation of a-
hydroxyhydrazones. Oxidative removal of the tether provided anti-2-hydrazino 1,3 -diols 
in good yield' 0 . The Beckwith-Houk model" predicts enhancement of 
diastereoselectivity based upon increasing substituent steric demand in 4-substituted 5-
hexenyl radical cyclisations. On the assumption that this 5-exo radical cyclisation 
undergoes a similar transition state, A-values were calculated and appeared to correlate 
well with the experimentally observed anti:syn ratio. The A-value is a measure of the 





RJL. 	Bu3SnH (1.4 equiv) 	
NJHNPh2 
H AIBN (Ca. 10 mol %) R.-N1 	
KF, KHCO3 , H202 	FJHNPh2 
0, 111~1 
	PhH (0.02M) 80°C 	O-Si 	
THF, MeOH (1:1) 	
R 
/\ 	 I 
OH OH 
6 7 8 
Product ratio A value 
Substrate R Yield 
(anti:syn) (kcal/mol) 
8a Methyl 76% 79:21 1.6 
8b i-Butyl 68% 85:15 1.8 
8c i-Propyl 80% 96:4 2.2 
8d Phenyl 57% >98:2 2.9 
Figure 1.1.1.3. Diastereo selective addition of hydroxymethyl using a silicon tether 
approach for addition of functionalised radicals to a-hydroxyhydrazones. 
The ketene-imine cyclocondensation of the Staudinger reaction is one approach that can 
be used to prepare 3-lactams. Most stereoselective versions use a chiral amine or ketene 
auxiliary 12 , the first example of a catalytic asymmetric Staudinger reaction was reported 
by Lectka in 2000' s . The Staudinger reaction consists of a chiral nucleophile catalyst 
which activates a ketene towards cycloaddition with an electron deficient imine; the 
product -lactams isolated had high e.e.s but only moderate yields. More recently the use 
of planar chiral nucleophiles as catalysts in the asymmetric Staudinger reaction' 4 were 
effective at catalysing the cycloaddition reaction of symmetric and unsymmetric 
disubstituted ketenes-9 with a wide range of tosylimines-10 (figure 1.1.1.4). Carrying out 
the reaction at ambient temperature afforded 13-lactam-11 products in high e.e.s (81-
98%) with good yields (76-98%). 
Introduction 
Me Fe Me lOmol% 
9 	.-Ts 	 M e 	M e 	 o 	Ts 
	
+ N 	 Me
RAR 	
1- ~
R"'H 	 PhMe, R.T. R" 
9 10 11 
R = R' = cyclohexyl; R" = Ph, (E)-PhCH=CH 2 or c-C6H 11 
R= Ph; R' = i-Bu; R" = Ph or (E)-PhCH=CH 2 
R= Ph; R' = Et; R" = 2-furyl or c-C3H 5 
Figure 1.1.1.4. The catalytic asymmetric Staudinger reaction for the preparation of 
enantiomerically enriched -lactams by'a cycloaddition of a ketene with a tosylimine. 
Although, not a 1,2-addition to a C=N bond, enantioselective hydroamination of alkenes 
is another synthetic method for the preparation of chiral amines. Hydroaminations are 
catalysed by transition metal and alkali metals'. 5 . The potential of enantio selective 
hydroamination of alkenes has been discussed by Roesky and Muller 16 . The 
enantioselective addition of aniline-12 to vinylarenes-13 using palladium catalysts has 
been carried out at 25°C yielding product-14 in 81% yield and 81% e.e. 17 . The attractive 
feature of the Staudinger reaction and the hydroamination of alkenes is that achiral 
inexpensive substrates are converted into a chiral amine product at without the need for 
significant heating. Generally the other asymmetric 1,2 C=N bond additions rely on 
chirality being present in the starting substrates. 
I. 
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Me S NHPh 
NH2 
+ 	 10% [((R)-binap)Pd(OS0 2CF3 )2 ] 
25°C, 72 h 	 LJ 
CF3 	 CF3 
12 	 13 	 (S)-14 
Figure 1.1.1.5. Reaction of aniline-12 with p-trifluoromethylstyrene-13 catalysed by 
[((R)-binap)-Pd(OS0 2CF3)2] 
1.1.2. Asymmetric reduction of imines 
Imine reductions to the corresponding amine are well documented. Catalytic transfer 
hydrogenation offers an attractive alternative to hydrogen gas in reductions with the 
hydrogen source coming from a cheap source such as formate salts 18 , propanol' 9 or 
indoline20 . The synthesis of chiral non-racemic secondary amines by imine reduction is 
divided into three main areas: (i) enantioselective hydride reduction, (ii) enantioselective 
hydrogenation and (iii) enantioselective transfer hydrogenation. 
Much of the emphasis in research in asymmetric transfer hydrogenation is based on 
ketone reduction2 ' and has provided the basis to examine the imine reduction. Noyori, et 
a122 used a ruthenium based catalyst to asymmetrically reduce a cyclic imine-15 using a 
formic acid - triethylamine mixture. The rate and enantioselectivity of the reaction are 
delicately influenced by the chiral ligand. The highest efficiency obtained not only relies 
on the chirality of the N-to sylated 1 ,2-diamine but also the presence of polar functional 
groups, as well as the alkyl substituents on the p-cymene ligand. The NI-12 and ArS02 
groups play important roles for the high reactivity. The catalyst can be fine-tuned to a 
particular imine substrate by modification of 1 6-arene ligand substitution. An interesting 
aspect of this catalyst is that under specific conditions the CN/CO chemo selectivity 
for reduction is in favour of the imine. This ligand was also shown to reduce a variety of 
acetophenone derivatives in excellent yields and e.e. 23 . The Noyori catalyst-17 has been 
7 
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shown to be effective for the enantioselective hydrogenation of imines containing a fully 
substituted nitrogen group along with aniline and bromophenyl ortho-substituted 
imines24 . The main limitation of this method is the sensitivity of the catalyst to product 
inhibition. 
MeO - 	 MeO 	- 
Chiral Ru catalyst 
MeO 
	




R = Me, Ph or 3,4(MeO) 2 C6H3(CH2) [where x = 0, 1 or 2] 
ArSO2 
Ph, 
'1—N /==i Rn 
I RU 
N 	'Cl 17 H 
Figure 1.1.2.1. Noyori' s ruthenium based catalyst for the asymmetric reduction of a 
prochiral imine-15 
Labelling studies with deuterated propan-2-ol indicated that propan-2-ol could not be 
used as a hydrogen source for this particular catalytic system. However, Bäckvall had 
earlier reported the ruthenium-catalysed transfer hydrogenation of imines 25 by propan-2- 
ol in the presence of base (potassium carbonate). The advantage of formic acid is that it 
allows the reduction to be done under essentially irreversible conditions, as carbon 
'dioxide is released as the by-product. 
Two routes have described the mechanism for transfer hydrogenation: (i) direct hydrogen 
transfer and (ii) hydridic route. The direct hydrogen transfer process involves a six-
membered cyclic transition state in which both hydrogen donor and hydrogen acceptor 
are held in close proximity to the metal centre. 
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L, I L 
O..M..N 
R' __J- 	 -R 
Figure 1.1.2.2. Proposed transfer hydrogenation mechanism - direct hydrogen transfer 
The hydridic route proceeds in a stepwise manner by formation of a metal hydride by 
lose of acetone from propanol hydrogen source. The metal hydride then undergoes 
hydride transfer with the hydrogen acceptor. 
NR" 
[L;Ll 	IL L 	AR '  rL Li R  
T1 '' H ] 	 H'NR" 
[ a ]co2 	 [R 
Figure 1.1.2.3. Proposed transfer hydrogenation mechanism in the hydridic route 
The first example of optically active hydride , reagents for asymmetric reduction was 
reported in 1951 where lithium aluminium hydride was modified with stoichiometric 
amount of (+)-camphor. Some of the most successful and general catalysts for hydride 
reduction are based on the oxazaborolidine structure, developed by Corey 26 following 
initial work by Itsuno27 . Itsuno's chiral borane-22 was prepared by combining borane 
and a chiral amino alcohol. Successive additions of substrate realised a more effective 
semicatalytic process 28 . Boim revealed that the absolute configuration of the reduced 
products was determined not only by the catalyst but also the geometric structure of the 
substrates. Namely the E-isomer gave the S-enantiomer and the Z-isomer gave the R-
enantiomer29 . Although the mechanism of the asymmetric induction is unclear, it is 
probably due to differences in steric bulk of the approaching substrate. 
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N_OMe 10 Mol % of catalyst NH2 
II 
Ph BH 3-SMe2 Ph 
50% e.e. 




MeO ..N 10 Mol % of catalyst NH2 
II 	
BH3-SMe2 Ph - Ph- 
55% e.e. 
20 (R)-21 
Figure 1.1.2.4. Oxazaborolidine catalysts used in the asymmetric reduction of ketones 
and imines. 
+ - \ 
K Ph 
./  
H3B'B ° 25 
OBn N 	F1 	 NH2 
II 	 V 
PhMe 	BH3-THF 	Ph 
1J 
23 (S)-24 
90% e.e. (25 mol%) 
52% e.e. (10 mol%) 
Figure 1.1.2.5. Oxazaborolidine catalysts used in the asymmetric reduction in the 
synthesis of alpha-methylbenzylamine. 
The enantioselective preparation of chiral molecules is most commonly performed with 
chiral metal complexes 30 . The main advantage of this approach is that stereochemical 
information of a single chiral ligand can catalytically relay the enantioselection to many 
thousands of molecules effectively amplifying the chiral information. The origin of the 
enantioselection from the chiral ligand has been shown in the transition state 31 . Metal 
complexes also allow both enantiomeric forms of the product to be obtained, provided 
both chiral ligands are available. BINAP and DuPHOS ligands are capable of 
hydrogenating ketones in extremely high e.e., but the major drawback is the requirement 
10 
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for an adjacent heteroatom. A version of DuPHOS called BASPHOS, bearing water 
solublising hydroxyl groups, has been shown to hydrogenate 2-acetamido acrylic acid 
and its methyl ester under aqueous conditions with excellent e.e.s. 32 . Metals other than 
Noyori's Ru (II) have also been used to asymmetrically reduce prochiral ketones these 
catalysts are also late transition metal complexes Rh (I) and Ir (I). Other factors that can 
influence the catalytic reduction include co-catalysts and solvent. The nature of the imine 
substrate is important as the enantiomeric excess achieved asymmetrically in the 
reduction of cyclic imines is insensitive to changes in hydrogen pressure, whilst the e.e. 
of acyclic imines is affected by the hydrogen pressure 33 . The cause of this effect is likely 
to be the mixture of anti- and syn-isomér of the C=N bond which interconverts during 
the course of the reaction. 
Polymethyihydrosiloxane (PMHS) is another interesting alternative to hydrogen because 
it is inexpensive, non-toxic and stable to air and moisture 34. A high throughput screen 
has allowed the rapid identification of new catalysts for the enantio selective reduction of 
imines using PMHS as a reducing agent 35 . Reactions were performed in a 96-well 
microtitre plate which allowed multiple reaction conditions to be evaluated in parallel. 
The crude reaction mixtures were analysed by GC (conversion) and HPLC 
(enantioselectivity). New catalysts were identified for the reduction of imine-26 into 
amine (R)-27 using PMHS as the reducing agent. Chiral induction was possible using 
combination of catalysts such as Sn(OT0 2, Zn(OTI)2, In(OTf) 3 and Cd(CHB)2 with 
chiral ligands-28, -29, -30, -31 and -32. A selection of some of the conditions identified 
is shown in table 1.1.2.1. 
Catalyst 2 mol% 
	
Ph 'N 	Chiral ligand 2 mol% 	Ph 	NH 
II 
PhMe PMHS (1 eq) MeOH 	Ph Me 
26 	 (R)-27 
Figure 1.1.2.6. Asymmetric reduction screening of imines with PMHS. 
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Catalyst Ligand Conversion e.e. 
Zn(OT02 No ligand 87% 0% 
OH 
Zn(OTf)2 28 >99% 30% (R)-27 OH 
L) 
C~OH 
In(OT03 29 	OH 56% 29% (R)-27 
Br 
Sn(OTf)2 30 J 85% 60% (R) -27 
Br 
Br 








 50% 36% (R)-27 
OH 
Table 1.1.2.1. Yield and enantioselectivities of the reduction of N-
Benzylphenylethylimine (immol) with PMHS (1.2 equivalents), 2 mol% catalyst and 2 
mol% ligand in MeOH (reproduced from T. Ireland et a135). 
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Most of the reported methods for imine reductions are carried out in organic solvents 
under anhydrous conditions because imines tend to be unstable in the presence of water. 
Subsequently there is little mention in the literature of imine reductions being carried out 
under mild aqueous conditions that would be compatible with an enzymatic step such as 
would be required in the deracemisation strategy used in this project. Water is not an 
ideal solvent to perform imine reductions as they can be hydrolysed to the 
ketone/aldehyde. Also, water is rarely used in reductions because of the chemical 
incompatibility with most reducing agents. There has been some work in this area to 
address these problems. Imino-acids have been reduced under mild aqueous conditions 
and neutral pH 36  sodium borohydride, ammonia-borane, ammonium formate with a 10% 
PdJC catalyst, with ammonia-borane being the most effective. Zinc powder has been 
used to reduce imines in water at room temperature using 5% sodium hydroxide 37 . 
1.1.3. Enantioselective reductive aminations 
Being able to achieve an enantioselective reductive amination of an amine and a 
prochiral ketone is an attractive route to obtaining chiral amines. There is no need to 
isolated and purify the imine intermediate. There is less attention on enantioselective 
approaches to accessing these chiral amine products from non-chiral starting materials. 
One of the first examples of an asymmetric reductive amination was reported by Blaser 
et al.38 in which a chiral amine grass herbicide was prepared in 78% e.e. from 
methoxyacetone and 2-methyl-5-ethylaniline. More recently Ir-f-Binaphane catalyst has 
been used to achieve highly enantioselective reductive aminations of a variety of simple 







1.2 eq p-anisidine 
H2 (l000psi) 
Ir-chiral ligand 







Figure 1.1.3.1. Asymmetric reductive amination of an aryl ketone with p-anisidine with 
(S,5)-f-binaphane chiral ligand-35. 
An enantioselective hydrogen transfer reductive amination reaction was screened against 
a variety of catalyst types which avoided the use of hydrogen gas 40 . [Rh(C 5Me5 )C12] 2 
was the only catalyst that demonstrated acceptable activity in the presence of ammonia 
and isopropyl alcohol in the reductive amination of acetophenone-36 (figure 1.1.3.2). 
Further investigation of Rh, Jr and Ru complexes using ammonium formate showed that 
Rh and Jr gave poor enantioselectivies compared to Ru. Addition of ammonia was found 
to slow the reaction but improve enantioselectivities. A series of ketones were examined 
under the optimised conditions and amines were obtained in good yields with high 
enantio selectivities (86-98% e.e.). The 2-octanone enantioselective hydrogen transfer 
reductive amination under these conditions showed full consumption of the starting 
material but only a trace amount of 2-octylamine was detected. Removing ammonia 
from the reaction did however give the desired product in 44% yield and 24% e.e. 
14 
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HCOONH4 	 NH2 	 OH 
	
NHCHO 
Ph Me 	catalyst 
	






Figure 1.1.3.2. The reductive amination of acetophenone-36 in the screening of catalytic 
reaction conditions to affect the asymmetric hydrogen transfer reductive amination to cx-
methylbenzylamine-24. 
Alternatively a chiral amine can be obtained with a reductive amination by the addition 
of a prochiral ketone to a chiral amine. There are several cheap chiral amines 
commercially available as both enantiomers which can be used as chiral auxiliaries and 
this is an attractive route to producing chiral amines. (+) and (-)-norephedrine-40 have 
been used as chiral auxiliaries in the preparation of enantiomerically enriched amines 
from a selection of different ketones-39 4 ' (figure 1.1.3.3). Enantiomerically pure chiral 
benzocyclic amines were obtained by asymmetric transamination of the corresponding 
prochiral ketone 42.  In this case (R) and (5)-phenylethylamine-24 was used as the chiral 




RARI *) 	 RXC 
R = Me; R'= Ph 
R=Ph; R'= Et 	 [H] 
R = p-Methyl-phenyl; R'= Me 
R = p-OMethoxy-phenyl; R'= Me 
R = R' = a-tetralone 
OH 
R NH2 	[0] 	
R 
43 	 R' 	42 
Figure 1.1.3.3. Asymmetric synthesis of amines by the reductive amination of ketones 




Enzymes are protein catalysts that are capable of accelerating reactions under mild 
conditions. Biocatalysis encompasses catalysis by bacteria, fungi, other microbes or their 
true catalytic components - enzymes. Biocatalysis is becoming an ever increasingly 
important tool in the industrial synthesis of bulk chemicals, pharmaceutical and 
agrochemical intermediates and food ingredients 43 . High enantioselectivities are one of 
the attractive features associated with biocatalysis. There is much work currently 
underway to exploit the potential this approach has to offer 44 . Recent scientific 
breakthroughs in genomics, directed enzyme evolution and exploitation of biodiversity 
provide exciting opportunities to utilise biocatalysts in many more industrial processes. 
The need to find 'greener' routes for producing fine chemicals has become more 
important in recent years; biocatalysis offers an environmentally friendly alternative to 
synthetic chemistry. Enzymes are proteins and hence are biodegradable, their 
immobilisation onto inert supports pose little to no environmental hazard. They generate 
fewer waste disposal problems and their mild operating conditions require a lower 
energy input. The lower energy usage saves on cost and the reduction of the energy input 
lowers emissions of greenhouse gases. 
1.2.1. Kinetic resolutions 
A process where enantiomers are separated is called a resolution. The first resolution 
was reported by Pasteur in 1848 when he completed the manual resolution of tartrate 45 . 
A kinetic resolution is the process where one enantiomer is more readily transformed 
into product than its mirror image (figure 1.2.1,1). The enantioselection is based on the 
difference of reactions rates (kR and ks) during the transformation by a chiral catalyst to 
16 
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PR and Ps. Recovery of the product PR and the unreacted enantiomer Ss in a non-racemic 
form constitutes a kinetic resolution. 
SR 	
kR 	 PR 
Ss .---------  - -------- 	PS 
kR, ks = rate constants 
SR, Ss = substrate enantiomers 
R ,  Ps = product enantomers 
kR>ks preferably irreversible 
Figure 1.2.1.1. The principle of a classical kinetic resolution. 
One of the most common biocatalytic methods to achieve kinetic resolutions is with the 
class of enzymes called lipases. They are available in bulk quantities from microbial 
sources and many are commercially available. Their role in nature is in fat cleavage, so it 
is not surprising that they have been found to be particularly useful for the resolution of 
esters bearing a chiral alcohol, since their natural glyceride substrates bear a chiral 
alcohol fragment. General guidelines have been suggested concerning lipase specificity 
and enantioselectivity 46 . In addition, the stereo chemical preference of the most 
commonly used lipases (e.g. from Pseudomonas and Candida species) for esters of 
secondary alcohols follow an empirical model generally referred to as 'Kazlauskas 
rule' 47 . 
Figure 1.2.1.2. The preferred substrate enantiomer for lipase specificity according to 
'Kazlauskas rule'. 
Performing lipase catalysed kinetic resolutions is often easier than chemical resolutions, 
which normally require a stoichiometric amount of a covalently bound chiral auxiliary. 
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Lipases have high stability towards organic solvents, which makes them useful in the 
reverse as well as the forward acylation. 1,1 '-Binapthylamine derivatives are useful 
chiral ligands of various asymmetric reactions, 2,2'-diamino-1,l '-binaphthyl has been 
used as the starting material for the synthesis of BINAP which is a chiral ligand used in 
the asymmetric hydrogenation of ketones 48 . The lipase catalysed acylation was recently 
reported using LIP-300 (Pseudomonas aeruginosa immobilised on Hyflo Super-Ce!) and 
LPL-311 (P. aeruginosa) on Toyonite 200-M for the optical resolution of 1,1'-
binapthylamine derivatives-44 49 . The amidation was sensitive to the length of the alkyl 
chain between the binapthyl ring and amino group and improved enantioselectivities 





Acyl donor, isopropyl ether 	 NAR + w 





R = CH 3 , CH 2CH 3, CH 2CH2CH 3 or CF3 
Figure 1.2.1.3. Lipase catalysed amidation of 1,1 '-binapthylamine derivatives. 
The reverse of a lipase catalysed acylation is the hydrolysis reaction. Kinetic resolutions 
have been achieved with Candida antartica B lipase (CAL-B) in the hydrolysis of a-
hydroxy esters 50 (figure 1.2.1.4). Interestingly, during this study it was found that the 
enantioselectivity (E-value) varied significantly depending on the immobilisation 
support used. The enzyme immobilised on cyanogen bromide functionalised resin 
(CNBr-activated Sepharose 4BCL) gave an E-value of 7.4 whilst the PET 
(Polyethyleneimine) derivative yielded E-value of 67 in the hydrolysis of a-hydroxy-
phenylacetic acid methyl ester-47 under similar conditions. The enantioselectivity 
dropped for the PET immobilised CAL-B on reducing the temperature, but the 
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enantioselectivity increased for other derivatives. The difference in performance between 
the different derivatives of immobilised CAL-B supported the hypothesis the lipase 
exists in different structural forms during catalysis. It was suggested that the active site 
of the lipase is secluded from the reaction medium by a helical oligopeptide lid. This lid 
can exist either in the closed (inactive) or open (active) form and the interaction between 
the lipase and the immobilisation support controls the lipase activity causing the varying 
results amongst different supports. 




JCO2H 	+ 	JCO2R 
47 
(R)-48 	 (S)-49 
R = H; R'= Me 
R = CO(CH 2 ) 2CH 3 ; R'= H 
Figure 1.2.1.4. CAL-13 catalysed hydrolysis of an a-hydroxy ester and an a-acyl acid. 
The drawback of a kinetic resolution is that there is a limited 50% yield; close reaction 
monitoring is required because the process has to be stopped at or near 50% conversion 
and the product needs to be separated from unreacted substrate. These difficulties can be 
largely circumvented by a deracemisation. The theoretical yield is now 100% with no 
requirement for a separation step and monitoring can be simplified because the reaction 
can be left to run to completion. 
1.2.2. Dynamic kinetic resolution (DKR) 
If a second step is introduced into a kinetic resolution, allowing the two enantiomers to 
be interconverted,a DKR is possible (figure 1.2.2.1). 
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SR 	 kR 
SR, Ss = substrate enantiomers 
11 racemisation 	 PR ,  Ps = product enantiomers 
ks 	
kRks preferably irreversible 
SS 	 - 	PS 
kR, k5 = rate constants 
Figure 1.2.2.1. Reaction scheme of a dynamic kinetic resolution (DKR). 
To avoid the necessity to undertake a stepwise racemisation and kinetic resolution 
iterations, an in situ racemisation is required. The choice of racemisation strategy falls 
into two classes; chemo-catalytic and bio-catalytic. The easiest and most widely used 
method for in situ racemisation involves acid/base catalysed enolisation, which is usually 
used for racemising the cc-position of a carbonyl. For chemically more stable chiral 
centres, such as sec-alcohols or sec-amines, direct chemical racemisation is more 
difficult. Instead chemically labile derivatives of sec-alcohols can be prepared such as 
cyanohydrins, hemiacetals, hemiaminals and hemithioacetals 51 . Alternatively stable sec-
alcohols and amines can be racemised by an oxidation and reduction sequence with a 
transition metal catalyst such as Ru, Rh, Ir, Al, or Pd 52 . Bäckvall and co-workers have 
developed a system based on the use ofp-chloroacetate as the acyl donor and ruthenium 
as the catalyst to allow the DKR of secondary alcohols. The acyl donor is compatible 
with the metal catalyst and no external base was required in the racemisation 53 . Candida 
antartica lipase B (CAL-B) transesterification with p-chloroacetate combined with the 
ruthenium catalysed racemisation gave (R)-acylated secondary alcohols-51 in 72-98% 
yield and >99% e.e. (figure 1.2.2.2). 
CAL-B 
OH 	.p-CI-C6 H4-OAc (3 equiv) 	 OAc 
Ru-catalyst (2 mol%) 
50 	 toluene (0.25 M) 	 (R)-51 
R = aryl or alkyl 	 78-92% yield 
>99% e.e. 
Figure 1.2.2.2. The DKR.of secondary alcohols-50 combining a metal catalysed 
racemisation step (chemocatalysis) and an enantioselective acylation step (biocatalysis). 
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The challenge of achieving in situ racemisations for DKRs with compounds possessing a 
stable chiral centre may be overcome by performing a stereoinversion. The 
stereoinversion relies on one enantiomer being chemically converted to an achiral 
intermediate. The achiral intermediate is subsequently chemically converted to the 
opposite enantiomer with a second step. In order to achieve the transformation of a 
racemate into a single stereoisomer, at least one step in the stereoinversion must be 
irreversible to compensate for the energetically disfavoured process. In the example 
shown in figure 1.2.2.3, one enantiomer of a secondary alcohol is selectively oxidised to 
the corresponding ketone whilst the other remains untouched. The achiral ketone is 
reduced in a subsequent step with an enzyme displaying the opposite stereochemical 
preference 54 . 
Dehydrogenase 	 Redox-enzyme 
OH 	(reversible) 0 	(irreversible) 	OH 
	





52 	 53 	 54 
NAD(P) + NAD(P)H 	Cofactor-H2 	Cofactor 
4 	 I 
- - - - - 
 
Internal cofactor-recycling 
Figure 1.2.2.3. Stereoinversion of sec-alcohols via oxidation-reduction steps. 
1.2.3. Deracemisation 
A deracemisation constitutes any process during which a racemate is converted into a 
non-racemic product in 100% theoretical yield without intermediate separation of 
materials. According to this definition dynamic kinetic resolution (DKR), dynamic 
thermodynamic resolution, stereoinversion and enantioconvergent transformations of a 
racemate are all classified as deracemisation processes. [Examples of DKR and 
stereoinversion deracemisations are discussed in section 1.2.2]. 
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An enantioconvergent transformation is where enantiomers are converted into the same 
product enantiomer by two independent pathways. One enantiomer is reacted giving 
product with retention of configuration and the opposite enantiomer is reacted with 
inversion of configuration to its counterpart product. An enantioconvergent process can 
be illustrated with epoxide hydrolase 55 . Epoxide hydrolysis takes place via attack of a 
nucleophile to either carbon atom of the oxirane ring of the (S)-enantiomer of (rac)-
epoxide-55 with the structure of substrate and the epoxide hydrolase specificity 
determining the regioselectivity of attack. 
[0H] 
O 	+ O 
R 	 R 	
[OH] 
(mc)-epoxide-55 
Retention 	 ol HO 
	
+ 	HO. 
R 	 'R 
Epoxide hydrolase 	
(R)-ep6xide-56 	(S)-diol-57 
HO O1\+  
HO 
Inversion 	 R 	 R 
(R)-epoxide-58 	(R)-diol-59 
Figure 1.2.3.1. Enzymatic hydrolysis of epoxide-55 in the enantioconvergent of (5')-
diols. 
If the (5)-enantiomer-55 is preferentially hydrolysed from the racemate with retention of 
configuration, kinetic resolution gives the (5)-diol-57 and the unreacted (R)-epoxide-56. 
The (R)-diol-59 can be prepared by hydrolysis of the (5)-epoxide-55 by inversion of 
configuration. Use of the appropriate epoxide hydrolase allows the enantioconvergent 
hydrolysis of epoxides, for example racemic styrene oxide-66 has been deracemised by 









0 idehydroIase Beauveria bassiana 
(R)-66 
Figure 1.2.3.2. The deracemisation of (rac)-styrene oxide-66 through an 
enantioconvergent conversion of (rac)-epoxide with two epoxide hydrolases exhibiting 
different regioselectivities. 
Furthermore, the enantioconvergent synthesis of diols from chiral epoxides is possible 
with a single biocatalyst. Epoxide hydrolase from Novacardia species hydrolyses both 
enantiomers of cis-2,3-disubstituted epoxyalkanes-68 and -6957  . Enantioconvergance is 
possible because hydrolysis is performed at the (5)-configured oxirane carbon with 
inversion of configuration yielding the (2R, 3R)-diol-70 as the product. 
0 
68 
[OH-] 	 Nocardia species 
Epoxide hydrolase 
+ 	 Inversion at S-centre 
L 
"R 







Figure 1.2.3.3. Enantioconvergent synthesis of (2R, 3R)-disubstituted diols from 
epoxyalkanes with Nocardia species epoxide hydrolase. 
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A cyclic oxidation and reduction sequence can allow the deracemisation of sec-alcohols 
and sec-amines 58 . This process relies on the enantioselective oxidation of the substrate 
(figure 1.2.3.4 kR >>ks). One enantiomer of the starting racemate is oxidised to the 
achiral intermediate, either a ketone or imine. The oxidised product is then converted 
back to the alcohol or amine by a chemical reduction in a non-selective manner. 
kred 
R 	kR 
+ 	Oxidation I p 	kR>>ks 
ks 
kred 
Figure 1.2.3.4. Deracemisation by a cyclic oxidation and reduction sequence. 
Hafner and Weliner have reported the generation of L-alanine and L-Ieucine from the 
corresponding D-enantiomers with the use of porcine kidney D-amino acid oxidase and 
sodium borohydride 59 . Subsequently Soda et al extended this method for the 
deracemisation of DL-proline 6° and DL-pipecolic acid 6 ' also using D-amino acid oxidase 
and sodium borohydride. After 4 oxidation and reduction cycles the e.e. of L-amino acid 
will be over >93% from a starting racemate assuming a completely enantioselective 
oxidation and non selective chemical reduction. 
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40 ru 30 20 10 0 
number of cycles 
Figure 1.2.3.5. Progression of the deracemisation of racemic amino acid with D-amino 
oxidase. 
More recently the deracemisation of amino acids using amino acid oxidase combined 
with a chemical reducing agent was extended to include cyclic and acyclic substrates, the 
preparation of 2H-labelled L-amino acids and the use of sodium cyanoborohydride in 
place of sodium borohydride62 . By switching the reducing agent from sodium 
borohydride to sodium cyanoborohydride the imino acid intermediate accumulated, 
indicating that the reduction had become the rate limiting step since some hydrolysis of 
the imine to the corresponding keto acid was observed. It was also found that fewer 
equivalents of sodium cyanoborohydride were required than sodium borohydride 
because borohydride was less stable than cyanoborohydnde under the aqueous 
conditions of the deracemisation. The use of catalytic transfer hydrogenation has also 
shown to be effective as the reducing agent in the deracemisation of amino acids with L-
amino acid oxidase giving (D)-amino acids-71 36. Extension of the deracemisation 
approach of a-amino acids has been used in the stereoinversion of 13-  and 7-substituted 


















Figure 1.2.3.6. Deracernisation of (DL)-amino acids-71 to (D)-amino acids-71 using (L)
amino acid oxidase combined with a chemical reducing agent. 
The concept of deracemisation by an oxidation and reduction sequence has recently been 
applied to amines. The concept has been successfully been validated with the 
deracemisation of a-methylbenzylamine-24 in 77% yield and 93% e.e. 64 . Although this 
result did suffer from a loss of yield primarily as a result of intermediate imine 
hydrolysis it showed in principle that amines can be deracemised in a similar fashion as 
has been used previously with amino acids. 
1.2.4. Biocatalytic routes to optically active amines 
The objective of the work undertaken in this project was to develop a method for the 
efficient synthesis of optically active amines. There are several existing biocatalytic 
routes by which optically active amines can be prepared. The aim here is to highlight and 
provide some examples of different routes by which optically active amines can be 
prepared using a biocatalytic approach. The application of these routes for the 
preparation of chiral amines at industrial scale is also discussed. 
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Unlike the enzyme catalysed acylation of alcohols the corresponding acylation of amines 
is less explored. In 1993 BASF undertook an extensive screening of lipase catalysed 
acylations of amines. It was found that 1-phenylethylamine-24 could be acylated with 
Burkholderiaplantarii lipase with esters of methoxyacetic acid-74 giving optically pure 
(S)-amine-24 and (R)-amide-75 at 52% conversion  65 . After separation by distillation, the 
(R)-amine was released by basic hydrolysis of the amide without racemisation, in 
quantitative yield. The attractive feature of this process was the broad substrate tolerance 
of the catalyst and a wide variety of amines have been resolved, in some cases on a 
multiton scale 66, recycling of the undesired enantiomer by racemisation and recovery of 
the acylating agent help to lower the cost of the industrial process. Reetz has reported the 
use of an in situ racemisation step in the enantio selective acylation of 1-
phenylethylamine using palladium on carbon at 50-55°C67 . This enabled a DKR to take 
place giving the (R)-amide in 64% yield and 99% e.e. 
0 
NH2 	 NH2 
0 	Lipase _______ 	+ 	 + ROH 
+ 	 _______ 
(rac)-24 	 74 	 (S)-24 	C[*~(R)-75 
Figure 1.2.4.1. The lipase catalysed resolution of racemic 1-phenylethylamine-24 with 
methoxyacetic acid esters-74 and a lipase. 
There are few reported methods for the lipase mediated enantioselective acylation of 
secondary amines and the resolutions that are reported tend to suffer from poor yields or 
poor enantioselectivities. The secondary amine 1 -methyltetrahydroisoquinoline (MTQ)-
76 is a building block of YH1885-79,  a potential treatment for GERD (gastro-
oesophageal reflux disease) and duodenal ulcers  68 . Accessing both enantiomers was 
required for the development of the drug and the kinetic resolution was achieved with 
substituted phenyl allyl carbonates-77 in the enantioselective acylation of (rac)-MTQ-77 
with Candida rugosa lipase69 . 
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0 	Candida rugosa lipase 
NH 
+ R OAO 	toluene, 0.05% water 
(rac)-76 	 77 
R = 3-MeO or 2-Me 




ri " ~___ ~] 
(R)-78 E 	0  
Figure 1.2.4.2. The lipase catalysed kinetic resolution of (rac)-MTQ-76 with a 
phenylallyl carbonate acyl donor-77. MTQ is a building block (shown in red) in the 
potential drug YH1 885-79 (GSK). 
Transaminases have also been used in the production of optically active amines. In this 
process, a carbonyl compound such as a ketone or an a-keto acid is converted into an 
amine. The enantioselective transfer is dependent on the transaminase cofactor pyridoxal 
phosphate. The chemical reaction is normally performed in a two-phase system to shift 
the equilibrium in favour of the amine product. Celgene have developed both (S)- and 
(R)-selective transaminases enabling both enantiomers to be accessed  70 . The reaction can 
be carried out either as a synthesis or as a kinetic resolution. In the synthetic procedure 
isopropyl amine provides an amino group which is transferred to a prochiral ketone 
enantioselectively to give the optically active amine product. The kinetic resolution is 
essentially the synthesis in reverse, where the racemic amine substrate is 
enantioselectively converted to the ketone. The amino group is transferred to a low 
molecular weight aldehyde such as propionaldehyde. If ct-ketoacids are used in place of 
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Figure 1.2.4.3. Route A is the synthesis procedure for the transamination of a prochiral 
ketone-80 using a (5)-transaminase and isopropylamine. Route B is the kinetic resolution 
procedure of a (rac)-amine-84 to the (R)-amine-86 (Celgene). 
Optically active amines can also be accessed by exploiting a class of enzymes known as 
amidases. Compared to the lipases however, these enzymes are less commercially 
available but many are found in nature and can be isolated as a microbial culture. 
Growing micro-organisms in simple growth media containing an amide as the sole 
carbon and/or nitrogen source for growth selects for amidase active micro-organisms 
over the remainder of the population. Following successive subculturing, the microbial 
population becomes enriched in micro-organisms possessing the desired arnidase 
activity. Using this approach with N-acetyl-2-butylamine as the amide substrate 
approximately 60 organisms, predominately Arthrobacter species, were isolated  3 . A 
freeze dried microbial sample (BH2-N 1) was shown to exhibit (5)-selective arnidase 
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activity in the hydrolysis of racemic amide substrates. (IS, 2R)-N-acetyl-1-aminoindanol-
89 has been accessed by the amidase approach and this is a key intermediate of the HIV 
protease inhibitor Indinavir-92 (Crixivan, Merck). This amino alcohol is also a useful 
ligand in asymmetric catalysis (C. H. Senanayke, AldrichimicaActa (1998) j, 3-15). 
NHAc 	 NH2 
C~>— 
 OR BH2-N 1 	
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Figure 1.2.4.4. The kinetic resolution of N-acetyl-1-aminoindanol by BH2-Ni amidase. 
The (1 S,2R)-enantiomer of 1 -aminoindanol (shown in red) is a key intermediate in 
Indinavir-92 (Crixivan, Merck). 
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1.3. Amine oxidases 
Amine oxidases catalyse the oxidation of amines to ketones/aldehyde, ammonia and 
hydrogen peroxide through an imine intermediate (figure 1.3.1). They are classified into 
two groups according to which cofactor they possess and are widely distributed in 
nature. Type I are copper dependent and require 2,4,5-trihydroxyphenylalanine quinine 
(TPQ) as a cofactor, whereas type II are flavin dependent primarily comprising 
monoamine oxidases (MAO). In lower eukaryotes amine oxidases appear to have a clear 
role in providing the organism with an assimilable form of nitrogen. In humans, they 
play an important role in catalysing the oxidative deamination of neurotransmitters and 
inhibitors of MAO have been used clinically as antidepressants 71  and in the treatment of 
Parkinson's disease 72 . 
enzyme 	 + 	H20 
RCH2NH2 + 	+ 02 	 RCHNH2 RCHO + NH3 
H202 
Figure 1.3.1. Reaction scheme of amine oxidation catalysed by amine oxidases. 
1.3.1. Flavin containing amine oxidases 
MAO was first discovered in 1928 by its ability to catalyse the oxidative dearnination of 
tyramine73 and is found in a number of different tissue types 74 . MAO plays an important 
role in regulating levels of neurotransmitters in particular dopamine-95, serotonin-96, 
adrenalin-93 and noradrenalin-94. Hence much of the published literature in this area is 
associated with the potential use of MAO inhibitors as antidepressants because of the 
relationship of neurotransmitter levels to various psychiatric and neurological disorders. 
The utility of MAO inhibitors was discovered serendipitously when patients treated for 
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tuberculosis with isoniazid showed signs of an improvement in mood; isoniazid-99 was 
subsequently found to work by inhibiting MA0 75 . The two different types of MAO in 
humans, i.e. type A (MAO-A) and type B (MAO-B) were first discovered 





R 	 H 
R = OH and R'= Me - Epinephrine (Adrenalin)-93 	 Serotonin-96 
R = OH and R'= H - Norepinephrine (Noradrenalin)-94 
R = H and R'= H - Dopamine-95 
Me 	 CI 	 Me 	 0NHNH2 
Ph 	 K 
U 
N 
Deprenyl-97 	 Clorgyline-98 	 Isoniazid-99 
Figure 1.3.1.1. Chemical structures of neurotransmitters and MAO inhibitors. 
cDNA cloning of MAO-A and MAO-13 from human liver elucidated their amino acid 
sequences77 . MAO-A and MAO-13 showed high amino acid sequence identity (70%) and 
subunit molecular weights of 59.7 kDa and 58 kDa repectively. Both contained the 
pentapeptide Ser-Gly-Gly-Cys-Tyr which covalently binds the FAD cofactor 78 . FAD is 
bound by Cys-406 in MAO-A and Cys-397 in MAO-B, one cofactor for each subunit of 
the symmetrical dimer. 
MAO-A and MAO-13 are integral proteins of the outer membrane of mitochondria, 
which has made their crystallisation difficult. The high affinity of MAO-B for the outer 
mitochondrial membrane is demonstrated by the need for digestion of phospholipids for 
its efficient detergent extraction during enzyme isolation. Studies of MAO-B have been 
assisted more recently by the development of a high level expression system in Pichia 
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pastoris, which allowed larger quantities of purified enzyme to be prepared'. Owing to 
the difficulty in preparing soluble, functional membrane proteins, the three-dimensional 
structure of MAO-B has only recently been solved 80 . The crystal structure of MAO-B is 
complemented by the publication of the crystal structure of polyamine oxidase (PAO) 81 . 
PAO is another type II amine oxidase; it has a non-covalently bound FAD cofactor and 
is involved in the catabolism of polyamines such as spermine and spermidine. 
Polyamines are essential for cell growth and differentiation and their metabolism is the 
subject of research into antiproliferative drugs 82.  PAO and MAO-B share -20% amino 
acid sequence identity and comparisons of the two proposed structures of MAO-B and 
PAO revealed structural similarity 80 . The MAO-B crystal structure has also provided a 
more accurate template to model the structure of MAO-A 83 . The structure was solved by 
single crystal isomorphous replacement. The results show the sites that are important for 
its binding to the outer mitochondrial membrane and reveal the architecture of the 
catalytic site. 
N 	N 
Figure 1.3.1.2. A cartoon representation of the proposed crystal structure of the MAO-B 




The crystal structure showed the enzyme to be dimeric with the C-terminus anchored to 
the outer mitochondrial membrane. The proposed structure is likely to be the quaternary 
structure in vivo, as the dimer was observed in both the orthorhombic and triclinic forms. 
Pargyline, an analogue of the MAO-B inhibitor deprenyl-97, binds covalently to the N5 
of flavin on the re-face in a solvent inaccessible environment. The substrate binding is a 
shallow cavity of volume 420A 3 , which is lined by a number of aromatic and aliphatic 
amino acid residues providing a highly hydrophobic environment. Adjacent to the 
substrate cavity is a separate smaller cavity lined with further aromatic and hydrophobic 
residues called the 'entrance cavity'. The recognition site for the substrate amino group 
is an aromatic cage formed by Tyr 398 and Tyr 435 in MAO-B where their aromatic 
rings are slightly turned towards the flavin 80 . It has been shown that point mutations in 
MAO-B of either the aromatic cage tyrosines to serine resulted in inactivation, but point 
mutations to phenylalanine retained activity with an increase in KM85 . Point mutation of 
the tyrosines to phenylalanine removed the hydroxyl group and the mutation to serine 
represents the removal of the aromatic part of the side chain. 
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Figure 1.3.1.3. A schematic representation of the pargyline suicide inhibitor covalently 
attached to FAD and bound at the MAO-B active site  84.  Conserved residues in MAO-A 
are indicated with an asterisk and for the none conserved amino acids, the MAO-A 
amino acids are shown in brackets. Aromatic residues are in ellipsoidal frames and other 
residues in rectangular boxes. 
The entrance cavity is shielded from the surface of the protein by a 13 amino acid long 
loop which is thought to regulate admission into the active site of MAO-B. It has been 
hypothesised that initial movement of the loop 'gated switch' facilitates binding of the 
substrate into the entrance cavity. This is followed by a transient movement of 4 residues 
which separate the entrance and substrate cavities allowing diffusion of the substrate into 
the substrate cavity 84 . 
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1 ,4-diphenyl-2-butene was serendipitously discovered as a competitive inhibitor of 
MAO-B86 (K1 z 351.iM). The novel aspect of this inhibitor compared to other inhibitors 
studied in the crystallisation of MAO-B is that it has two phenyl rings, meaning that one 
ring can be bound in the entrance cavity whilst the other is bound in the substrate cavity. 
Comparison of other inhibitors with 1 ,4-diphenyl-2-butene bound in the crystal structure 
of MAO-:B show that the Ile-199 side chain exists in a different rotamer conformation 87 . 
The substrate binding site faces the membrane surface and the gated switch loop is partly 
embedded in the membrane 88.  In addition to the membrane-loop interaction, the 
membrane may increase the local substrate concentration by a favourable electrostatic 
attraction between the cationic amine and the anionic phosphate of the phospholipids 
head group. This may suggest a multifunctional role of the membrane in controlling 
MAO-B catalysis. 
In both PAO and MAO-B crystal structures the normally planar FAD ring is bent around 
the N5-N1O axis. In PAO Lys-300 is hydrogen bonded to a water molecule which itself 
is hydrogen bonded to the N5-atom of FAD. Binding studies have shown that this 
residue participates in catalysis by compensating for the change in FAD protonation state 
during catalysis 89. This interaction is conserved in MAO-B where Lys-296 undertakes 
the same role, it is also seen in (L)-amino acid oxidase and sarcosine oxidase 90 . In both 
PAO and MAO-B two aromatic amino acids form an aromatic sandwich about 8A apart, 
perpendicular in orientation to FAD on the re-side 80. Structural models of substrates 
bound in the active site of MAO-B and PAO suggested that the aromatic sandwich and 
flavin combine in amino recognition of the substrate. Circular dichroism (CD) spectra of 
MAO-A indicate that on binding a large inhibitor spectral changes occur that is 
consistent with alteration of the environment of tyrosine and tryptophan residues 91 . The 
presumption is that the perturbations of aromatic residues on binding the inhibitor are 




Schilling 92  identified a novel type H amine oxidase enzyme (MAO-N) which oxidised 
mono-amine substrates compared to the previously reported di- or polyamines 93 . This 
enzyme was discovered from butylamine-induced cultures of Aspergillus niger and has 
subsequently been purified to homogeneity using a recombinant MAO-N expressed in E 
coli94 . The recombinant enzyme was shown to have a higher turnover of some aliphatic 
and aromatic amines than the mammalian enzyme. However, the major difference 
between MAO-N and the human MAO enzymes is that the FAD cofactor is non-
covalently bound in MAO-N, as the penta-peptide present in MAO-A and MAO-B to 
which FAD is attached is missing in MAO-N. The non-covalent FAD attachment offers 
the opportunity to gain information on FAD-inhibitor adducts and their mechanism of 
action without the need for proteolytic digestion and purification. 
1.3.3. Mechanism of FAD oxidation in MAO 
There are three principal steps in the catalytic cycle of MAO catalysed oxidation of an 
amine substrate with the FAD cofactor (figure 1.3.3.1). The first of these steps is the 
oxidation of the substrate with concurrent reduction of FAD to FADH 2 . Second, is the 
deamination of the imine intermediate by water giving the corresponding ketone or 
aldehyde and ammonia (strictly this step is not enzyme catalysed but occurs 
spontaneously in water). Third, is the reoxidation of FADH 2 to FAD by molecular 




RCH2 NH2 	+ E-FAD 	 RCH=NH 	+ 	E-FADH2 
Deamination 
RCH=NH 	+ 	H20 	 RCHO 	+ 	NH3 
FAD reoxidation 
E-FADH 2 	+ 	02 	 E-FAD 	+ 	H202 
Figure 1.3.3.1. The principal steps in the catalytic cycle of amine oxidation catalysed by 
MAO. 
Three different pathways have been proposed to describe the precise mechanism of FAD 
reduction and amine oxidation: (1) single electron transfer (SET) pathway, (2) hydrogen 
atom transfer (HAT) pathway and (3) nucleophilic (polar) pathway. The SET pathway is 
the generally accepted version for MAO catalysed cc-carbon oxidation of amines 
according to studies on mechanism-based inactivators 95 . N-cyclopropylamines 
inactivators initially formed an amine radical cation which is proposed to undergo rapid 
ring opening to form a highly reactive primary carbon centered radical. The carbon 
centred radical is thought to be responsible for inactivation of the enzyme. The use of 
14C labe1ledN-cyclopropylamine showed the compound attaches to MAO in a 1:1 
stoichiometric ratio at the flavin or at an active site cysteine residue 96 . 
The nature of the substrate has been shown to be important in the reoxidation of 
FADH297 . It has been shown with stopped flow spectroscopy that a binary or ternary 
complex is present in the catalytic cycle. The ternary complex consisting of reduced 
enzyme, oxygen and product or in the presence of benzylamine and 1 -methyl-4-phenyl-
1,2,3,6-tetrahydropyridine the ternary complex comprised of reduced enzyme, oxygen 
and substrate 98 . There is recent spectroscopic evidence that a stable tyrosyl radical is 
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present in the partially reduced MAO-A' 81 . It is thought that radical forms following 
single electron donation to FAD from the substrate and that the tyrosyl radical is in 
equilibrium with the FAD flavosemiquinone. This evidence further supports the single 
electron transfer mechanism for FAD catalysed oxidations. 
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Figure 1.3.3.2. The proposed SET mechanism for amine oxidation catalysed by a FAD 
dependent MAO enzyme. 
Debate had arisen concerning the deamination step, whether the actual product released 
from the active site of MAO is the imine intermediate or if imine hydrolysis occurs in 
the reduced enzyme-product complex 99" 00 . Direct evidence for the release of imine from 
the MAO catalysed oxidation was shown with N-methylbenzylamine. The amine was 
oxidised in 1% v/v water in benzene and oxidised products were examined by capillary 





1.3.4. Synthetic potential of amine oxidases 
Owing to the synthetic potential of amine oxidases' °2" °3 and that many potential 
substrates have poor solubility in aqueous medium, investigations into the tolerance of 
amine oxidases in non-aqueous medium have been performe& 04 ' 105 . It was demonstrated 
that amine oxidases can tolerate high contents of organic solvents; in biphasic systems 
the enzyme was found to be located in the aqueous phase which avoids unfavourable 
direct contact with the nonaqueous environment. MAO-13 is capable of catalysis in 
organic solvents containing low concentrations of water although it was unclear whether 
this is because catalysis is occurring in aqueous globules or dispersed in the organic 
solvent. Water miscible solvents tended to give very low or no conversion of amine 
substrate and this is thought to have arisen by loss of essential enzyme hydration by 
water stripping 106 . 
1.3.5. Copper dependent type I amine oxidases 
Copper containing amine oxidases (CuAO) contain a covalently bound cofactor 2,4,5-
trihydroxyphenylalanine quinine (TPQ) cofactor which is derived from the modification 
of an endogenous tyrosine residue' 07 . CuAOs contain a copper ion in the active site 
which is involved in the biogenesis of TPQ and in the catalytic cycle of the oxidation of 
amines. Despite the functional differences of CuAOs in different organisms they all 
share a common chemical pathway in the catalytic mechanism. The catalytic cycle 
requires three steps (figure 1.3.5.1); firstly the biogenesis of TPQ, secondly the oxidation 
of amine substrate to generate the reduced state of TPQ and thirdly the reduction of 
oxygen by the reduced TPQ to complete the catalytic cycle. 
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Biogenesis 	EflZapo + 202 + Cu (II) 	 Enz-TPQ0 + H202 
Reductive half reaction 
Catalysis EflZ-TPQ 0 + RCH2NH3 	 N. EflZTPQredNH3 + RCHO 
Oxidative half reaction 
Catalysis Enz-TPQ Ied-NH3 + 02 + H20 	 1.- Enz-TPQ0 + H202 + NH4 
Figure 1.3.5.1. The reactions catalysed by CuAO; biogenesis of the enzyme-TPQ (Enz-
TPQ) from the tyrosine precursor. The catalytic cycle is comprised of the reductive and 
oxidative half reactions. 
TPQ formation is a self processing event synthesised with a single turnover using copper 
and oxygen. To probe the mechanism of TPQ formation, CuAO has been prepared in the 
absence of copper' 08 but the apo-enzyme has high affinity for zinc in the absence of 
copper and proved extremely difficult to remove. Experimental evidence for the 
proposed TPQ biogenesis is based on Hansenula polymorpha amine oxidase (HPAO) 
solution studies' 09  and x-ray crystallographic data of Arthrobacter globforms amine 
oxidase (AGAO)' '°. Crystals of holo-AGAO are pink (?,,,,ax = 480nm) due to the 
presence of the oxidised form of TPQ, in contrast apo-AGAO crystals are colourless. 
This different in spectral properties gives a handle to monitor the progress of TPQ 
biogenesis. The proposed reaction mechanism for the biogenesis of TPQ from tyrosine" 
is outlined in figure 1.3.5.2. The rate determining step in this pathway is the first step in 
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Figure 1.3.5.2. The proposed mechanism for 2,4,5-trihydroxyphenylalanine quinone 
(TPQ) biogenesis in CuAOs. 
The first step in the reductive half reaction for CuAO catalysed oxidation of amines is 
nucleophilic attack of the amine onto TPQ. This results in the formation of an imine 
intermediate. The next step is abstraction of a proton by an active site base (a conserved 
aspartic acid) to give a carbanionic species which rapidly rearranges to give the imine. 
The aldehyde product is released by hydrolysis of the imine resulting in the TPQ being 
left in its reduced aminoquinol state, with the amine nitrogen replacing the oxygen at C5 
of the cofactor. The TPQ ring has been reduced by two electrons and the chromophoric 
spectrum associated because the cofactor is now an aminoquinol. This intermediate has 
been trapped and a 2.4A resolution of the crystal structure of this intermediate confirmed 
the existence of the reduced TPQ species. The enzyme crystals were prepared by 
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bleaching the CuAO anaerobically and reducing it with 0-phenylethylamine". This 
completes the reductive half reaction. To complete the full catalytic cycle in CuAO, TPQ 
needs to be returned back to its resting state by the oxidative half reaction. 
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Figure 1.3.5.3. The proposed catalytic cycle of CuAO for the oxidative deamination of 
benzylamine to benzaldhyde. 
The oxidative half reaction is less well understood than the reductive half reaction. 
Several studies have put forward the hypothesis that copper does not change oxidation 
state during the oxidative half reaction. A kinetic study with HPAO in which copper was 
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replaced with cobalt, gave a very similar keat  with molecular oxygen even though cobalt 
is unlikely to participate in this redox reaction 113 It has been proposed that molecular 
oxygen does not react with Cu (I) but instead binds in the active site and accepts the first 




1.4 Directed Evolution 
Enzymes that are used in synthetic chemistry as biocatalysts have evolved over millions 
of years to be efficient and selective catalysts for the chemical reactions taking place in 
living systems. Potential industrial applications for these catalysts involve substrates, 
organic solvents and other reaction conditions that are not encountered in nature. 
Directed evolution can be used to change the properties of these natural catalysts to suit 
the needs of the industrial application. 
Directed evolution can be considered as the laboratory equivalent of 'survival of the 
fittest', the Darwinian evolution of biological macromolecules. It comprises mutation of 
the gene encoding the potential enzyme accompanied by selection on the basis of the 
desired functional changes. It has emerged as a powerful strategy for improving the 
characteristics of enzymes to a desired goal. Although directed evolution is a relatively 
new concept with regards to improving biocatalysts in laboratories the manipulation of 
biological characteristics by humans has been used for many centuries. For instance, the 
common black and white Friesian breed of cattle was generated by selective breeding 
over many centuries for efficient milk production. 
There are two crucial aspects to achieving the directed evolution of a biocatalyst - 
mutation and selection. They are combined to give rise to an improved variant and each 
will be discussed here in turn. The first step in directed evolution is the generation of 
genetic diversity and strategies for introducing mutations to give rise to libraries of 
variant enzymes (1.4.1). Second is the screening of these libraries to identify a variant or 
variants with the desired characteristic (1.4.2). After an improved variant is found it can 
be subjected to the directed evolution process again to either further improve the variant 
or select for another desired function. This concept of directed evolution comprising of 
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Figure 1.4.1. A schematic representation of directed evolution using genetic 
diversification of a target gene followed by cloning and screening to identify improved 
variant(s). 
1.4.1. Generation of variant libraries 
Many different methods have been developed to generate large libraries consisting of 
hundreds of thousands, billions or even larger numbers of variant proteins. New 
approaches continue to be developed to generate more comprehensive and less biased 
variant libraries. Bias can arise from the uneven representation of particular amino acids 
in a randomised site in a protein sequence. In contrast to rational design, which generally 
concentrates on a small number of variants, evolutionary methods for the directed 
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evolution approach for protein engineering rely on the generation of vast molecular 
diversity by random mutagenesis and recombination. Rational protein design consists of 
making mutations to a protein that are anticipated to alter the property of the enzyme 
based on an understanding of the structure of the enzyme. The attractive feature of 
directed evolution is that there is no requirement for previous knowledge of the structure 
or function of the biocatalyst or when mutations are difficult to predict from the known 
protein structure 115 
One route in which genetic diversity can be produced is from the error prone polymerase 
chain reaction (epPCR). epPCR was developed by a modification of the standard PCR 
procedure to decrease the fidelity of the PCR reaction. It is a random mutagenesis 
technique for generating amino acid substitutions in proteins by introducing mutations 
into a gene during a PCR. Mutations are deliberately introduced by the error prone DNA 
polymerases and/or reaction conditions. The mutated PCR products are then cloned into 
an expression vector and the resulting library can be screened for the desired change in 
the function of the protein. Increasing the concentration of magnesium or manganese 
chloride or by unbalancing the concentration of the four dNTPs leads to lower fidelity in 
the PCR" 6 The presence of Mn2 along with an over representation of dGTP and dTTP 
in the amplification reaction leads to error rates of 1 to 1 Ont/kb in the final library 117 
Commercial kits based on epPCR technologies are available from Clontech (Diversify 
PCR random mutagenesis kit) and Stratagene (GeneMorph system) which detail 
instructions of mutagenesis rate required. The ease by which mutations can be generated 
by epPCR and the control of the mutation rate makes this method appealing as a tool in 
directed evolution, but a drawback with this approach is the problem of mutational bias. 
Transitions (purine to purine or pyrimidine to pyrimidine) mutations are more common 
than transversion (purine to pyrimidine or pyrimidine to purine) and as epPCR only 
introduces single nucleotide mutations, this can lead to a bias in the amino acid that the 
mutant DNA encodes. This arises from the degeneracy of the genetic code. For example, 
single point mutations in a valine codon can encode phenylalanine, leucine, isoleucine, 
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alanine, aspartate or glycine. To access the codons for the other amino acids, either two 
point mutations (C, S, P, H, R, N, T, M, E, Y) or even three (Q, W, K) are required. The 
result of this codon bias is that specific amino acid changes are more likely to occur than 
others while some are not represented at all in a library constructed by epPCR. The third 
source of bias. is caused by the amplification nature of the PCR. If a mutation is 
introduced after the first cycle of the PCR then this will be present in 25% of the product 
daughter molecules. The mutated daughter molecules are amplified during the remaining 
PCR cycles and therefore any molecule that is copied early in the amplification process 
will be over represented in the final library compared with a mutation that is introduced 
towards the end of the PCR. This problem can be reduced by a combination of multiple 
reactions and reducing the number of amplification cycles. Another encumbrance with 
epPCR is the DNA products need to be cloned into a vector prior to screening. 
Stratagene has developed a highly efficient, rapid and reproducible method for 
introducing random mutations into a cloned gene' 18 . This method involves propagating 
the cloned gene in an E. coli strain called XL1-red which is deficient in three of the 
primary DNA repair pathways in E.coli, namely mutS, mutD and muff. DNA polymerase 
is efficient in correcting many errors made during DNA replication, however a 
significant number of errors remain uncorrected after replication has been completed. 
The mismatch repair pathway is another system of repair after DNA replication. MutS is 
one of the genes responsible for correcting mismatched DNA base-pairs; its role is to 
recognise a base pair mismatch and to recruit other proteins involved in the mismatch 
repair pathway. DNA polymerase III has a subunit 8, which is responsible for proof-
reading (3'-5' exonuclease activity) this subunit is encoded by the mutD gene. The role 
of 8-oxodGTPase (the gene product of muff) is to clean the cellular pool of dNTPs 
preventing the incorporation of 8-oxodGTP into DNA"'. The advantage of using XL1 - 
red for random mutagenesis is that the mutation rate can be carefully controlled and 
there is no cloning involved. The main disadvantage is that the XL1-red strain of E. coli 
is its genetic instability resulting in damage to the'bacterial DNA. Other potential 
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problems can arise from introduction of mutations elsewhere because of the 
indiscriminate nature of the mutagenesis. Mutations on the plasmid outside the gene can 
also affect the screening because if they occur at a promoter region it may influence the 
recruitment of the RNA polymerase and therefore the expression of the recombinant 
protein. This leads to expression variants which can either increase or decrease the 
amount of protein produced. 
Rather than introducing random mutations along a section DNA, another approach is to 
target specific positions in the target gene. These techniques are based on the 
incorporation of synthetic DNA within the coding sequence. The synthetic DNA can be 
designed to be randomised at particular positions, which can then be incorporated into 
the target gene. This strategy comprises of two components, firstly the preparation of the 
randomised DNA and secondly incorporating this DNA into the gene. Oligonucleotide 
based mutagenesis is reliant on the chemistry of DNA synthesis. The synthesis of 
oligonucleotides is a well established technique 120  and libraries of synthetic 
oligonucleotides can be prepared by mixing any combination of the four bases at the 
required position to generate diversity. Bias problems can occur with this approach if the 
mixtures of reagents do not react to the same degree giving rise to the greater 
incorporation of one reagent over another. Another bias problem is the triplet nature of 
the genetic code. To randomise a codon to all of the possible 20 amino acids, a mixture 
of four bases is required at the first and second positions of the codon. Also there are six 
times as many codons represented by serine than tryptophan or methionine in the genetic 
code which further skews the bias towards particular well represented amino acids. The 
solution to this problem is to simply synthesise the DNA separately for each mutation, 
but this approach is only appropriate for limited small libraries, i.e. one codon. It is not 
necessary to fully randomise all three bases of a codon to represent all twenty amino 
acids. If an NNS codon is prepared (where N is any of the four DNA bases and S is 
either C or G) each amino acid is represented at least once, whilst reducing the number 
of stop codons. The other benefit with the NNS codon approach is that it decreases the 
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number of variants to be screened at the randomised position. Alternatively, trinucleotide 
phosphoramidites can be used so that 20 codons (one to represent each amino acid) are 
introduced into the oligonucleotide. Trinucleotide phosphoramidites are not 
straightforward to synthesis and this adds to the cost of preparing oligonucleotides by 
this route 121 . 
The MAX system relies on the annealing of oligonucleotides to specific regions of a 
gene, with a completely randomised codon (NNN) at the desired target 122  (figure 
1.4.1.1). If all 20 amino acids are required then the 20 primers for each position are 
synthesised, one codon for each amino acid. These primers are annealed to the template 
according to their adjacent complementary sequence. The ligated primers are converted 
to dsDNA ready to be incorporated into the full gene. The advantage of this is that the 
attractive features of the trinucleotide phosphoramidite approach can be used without the 
significant costs: Although a relatively large number of primers are required, the 
maximum number of primers required to randomise each amino acid is 20 and the 
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Figure 1.4.1.1. MAX method of library generation. The template contains the NNN sites 
(where N is G, C, T or A) selected to be randomised. A selection of primers for each 
position is added to represent each amino acid once (denoted as MAX). Primers are 
annealed, ligated and finally converted into dsDNA ready to be incorporated back into 
the gene. 
Incorporation of the randomised oligonucleotide into the gene is necessary to prepare the 
library of variants. The basic requirement for a successful cloning of the mutated DNA 
into the gene is that a low level of wild type sequence is present in the cloned library. A 
high incidence of wild type in the cloned DNA library would suggest either the cloning 
or mutagenesis was unsuccessful. A range of straightforward techniques are available for 
incorporating DNA into full length genes such as the PCR-based techniques overlap 
extension and megaprimer protocols' 23" 24 . 
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Natural evolution exploits recombination to bring together advantageous mutations and 
separate out deleterious mutations. DNA shuffling was the first laboratory recombination 
technique that was used for directed evolution' 25" 26 . DNA shuffling allows the 
recombination of a collection of genes containing different point mutations or a pool of 
genes with sequence similarity from different sources. In DNA shuffling, the genes are 
digested with DNase to give gene fragments which can then be shuffled. The number of 
crossover points can be controlled by selecting the degree to which the genes are 
digested. The mixtures of DNA fragments are then subjected to repeated cycles of 
melting, annealing and extension. The product DNA is PCR amplified to generate 
adequate quantities of DNA for transformation to allow screening. More recently the 
DNA shuffling method has progressed with a number of other similar techniques 
emerging based on linking gene fragments together' 7 a few examples of which are 
discussed below. 	 - 
One such approach is the staggered extension process (StEP) which also relies on 
repeated cycles of melting, annealing and extension to build up the full length 	17 . In 
StEP fragments of the gene are added to a growing strand of DNA. This is made possible 
by preventing the growing strand completing the gene extension, by use of a very short 
extension time in the PCR. Partial elongation of the gene results, which is then melted 
and re-annealed to a different template leading to a crossover. Balancing the yield and 
recombination can be challenging in StEP. If the extension step is too long, full length 
template is produced and if extension times are too short the yield of mutated DNA can 
be reduced" 7 . 
Random chimeragenesis on transient templates (RACHITT) is a further variation of 
DNA shuffling ' 28 . The fragments in this case are brought together to form one product 
strand. The fragments are then reassembled by annealing together on a parental strand, 
mismatched sections are removed, the fragments extended and ligated to give full length 
recombined genes. Large numbers of crossovers are possible with this method. The 
52 
Introduction 
drawbacks with the RACHITT technique is that the overlapping regions between 
fragments need to be removed by exonuclease digestion and the RACHITT method is 
limited to incorporation of sequence elements that are similar to the template. The 
principles of DNA shuffling, StEP and RACHITT are shown in figure 1.4.1.2. 
- - - - digestion 	 digestion 	- - - 
annealing 
	 annealing 
extension 	 strand extension 








Figure 1.4.1.2. Gene recombination methods for creating mutant libraries of genes. All 
originate from a selection of parental genes. 
It is more challenging to generate recombination events when the sequence homology 
between genes selected to be recombined is low. DNA shuffling techniques suffer from 
the inherent necessity that they require strand extension and annealing to a template. 
Incremental truncation for the creation of hybrid enzymes (ITCHY) was developed for 
shuffling parental genes with low sequence homology 129  It is based on the direct 
ligation of libraries of fragments generated by the truncation of two DNA template 
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sequences. One fragment is digested with exonuclease ifi and Si nuclease from the 5'-
end of the gene and are ligated to fragments of a second template that have been digested 
from the 3'-end. The ligation is introduced at arbitrary sites and because the two ends 
required no template, there is no requirement for any homology. The initial ITCHY 
method was further developed to the thio-ITCHY, where the phosphates of the DNA are 
replaced with phosphothioate bonds. This was necessary as the exonuclease digestion to 
prepare the truncated templates was difficult to control and optimise. Incorporation of 
random exonuclease resistant phosphorothioate linkages into the DNA determine the 
length of the truncated fragments to be ligated 130  The other benefit with the thio-
ITCHY method is that this method has been developed to remove the inherent problem 
of out-of-frame shifts ligation products. 
One of the crucial issues with recombination events in shuffling DNA fragments 
between genes is deciding on the location of the crossover site. Arnold and coworkers 
have reported the approach of using crossover points that have minimal interaction with 
the rest of the protein' 31 . By scanning the known three dimensional structure of a protein 
for local networks of interactions, favourable recombination points between proteins that 
minimise the disruption of favourable steric and electrostatic interactions can be located. 
In one example the resultant libraries of -1actamase variants were shown to contain a 
higher proportion of functional proteins than by using random crossover points' 32 . 
1.4.2. Screening methods 
To determine whether each individual candidate has the desired property of the target 
biocatalyst, the DNA library is assayed using biochemical or biophysical methods; this 
process constitutes a screen. There are three main types of a selection in a screen, a life 
or death selection, a colorimetric/fluorometric screen or a microbial screen. A life or 
death selection has the advantage compared to the other screens that only those variants 
showing the desired enzyme function are represented since those variants not meeting 
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the selection requirements are not viable. The disadvantage with a life or death selection 
is that this often requires 'knock-out' strains of the host organism to be engineered 
which adds to the effort and time for the screen. A colorimetric screen has the advantage 
that the host organism requires no genetic engineering, each variant is assayed for 
activity based on the detection of a chemical response arising from a hit variant. A 
microbial screen is where each variant is analytically examined requiring detection of 
product by HPLC, GC, capillary electrophoresis, mass spectrometry, NMR or other 
analytical techniques. The throughput of the microbial screen is normally the lowest of 
the three selection strategies since each member needs to be individually analytically 
examined. This often needs expensive instrumentation and involves at least some degree 
of human handling, both of which limit the throughput of the screen. The advantage with 
a microbial screen is that should a colorimetric/fluorimetric or life and death selection 
not be possible a microbial selection is normally possible. 
The potential number of candidates that can be generated in a variant DNA library can 
be vast, so it is imperative that the highest throughput screen as possible be employed. 
Often the screen is the limiting factor in assessing the number of library members of a 
variant library. A high quality screen should be flexible and versatile so that 
experimental conditions of the screen can be changed to allow selection of variants with 
the desired improvements. Typically, improvements which may be observed are for 
example, activity of variants in a non-natural environment or improvement of activity to 
novel substrates. It is preferable for screening to be carried out in parallel and within a 
short time frame to accelerate the throughput of the screen and thus enable greater 
numbers of variants to be assessed. Some of the different approaches used in screening 
are discussed below. 
Most high throughput assays are based on chromogenic and fluorogenic substrates or 
sensors. For example, umbelliferone-104 is a fluorogenic phenol and is strongly 
fluorescent due to the blue emission of the phenolate anion. The pK a of umbelliferone is 
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low (pKa —7) and so the substrate fluoresces in buffer at pH 6.5 or lower, although esters 
and ethers of umbelliferone are not fluorescent. This has been used to assay lipase and 
esterases to detect ester hydrolysis by release of umbelliferone' 33" 34" 35 (figure 1.4.2.1). 
The same concept of release of a chromogenic product by ester hydrolysis is used with p-
nitrophenol rather than umbelliferone, where rather than releasing a fluorogenic 
substrate, a yellow chromogenic product is released. 
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Figure 1.4.2.1. Umbelliferone-104 can be used to monitor enzyme activities by 3-
elimination of the enzymatic product. The diol product-102 generated by enzymatic 
cleavage of the ester-101 is oxidised to an aldehyde-103 by godium periodate which 
eliminates to give the fluorescent product. 
Fluorescein and 4-nitrobenzofurazane derivatives are other fluorogenic labels that can be 
used to monitor rates of enzyme mediated reactions. Fluorescein fluorescence 
autoquenches between different substrate molecules when they are fixed in close 
proximity. This feature was employed to follow the proteolysis of fluorescein 




































fluorescein from casein"'. For 4-nitrobenzofurazane the nature of the substituent 
strongly influences the fluorescent properties of the chromophore. Amide hydrolysis by 
acylases has been monitored with 7-chloro-4-nitrobenzofurazane- 107 137 . Alternatively, 
7-hydrazino-4-nitrobenzofiirazane-1 11 allowed the monitoring of acetaldehyde-110 
release from a vinyl ester-109 by hydrolysis with lipases 138 (figure 1.4.2.2). 
Figure 1.4.2.2. Fluorescent 4-nitrobenzofurazane derivative assays for the detection of 
the production of amines and aldehydes. 
In addition to colorimetric screening a new digital imaging spectrophotometer called 
Kcat Technology (KAIROS Scientific Inc.) has been developed. Kcat Technology allows 
the high throughput solid phase assay of microbial libraries expressing variant enzymes 
undergoing directed evolution (figure 1.4.2.3). Each microcolony is analysed 
simultaneously at a single pixel resolution (75p.mlpixel). This allows nearly confluent 
plates with microcolonies densities of 500 colonies/cm 2 to be screened. The benefit of 
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rank in order the relative performance of hits identified in the screen, which is not facile 
with a regular plate based screen. 
'/. Kalios Scientific Inc - Abq REM Experiment - Absorption soul 	 WI1 
File Edit View Acquire Analysis Tools Window Help ..fl 
Figure 1.4.2.3. The graphical interface of the Kcat instrument with an enlarged plate 
based assay. Pixels with microcolonies responding in the assay are further categorised by 
their catalytic velocity 139 . 
Isotopic labels have also been used to determine enantioselectivity of nitrilase 
enzymes 140 (figure 1.4.2.4). The reaction of ' 5N-labelled 3-hydroxyglutaronitrile-1 13 
pseudo-prochiral enantiomers can be used to assay the enantioselectivity of nitrilases 
using mass spectrometry. Isotopically labelled pseudo racemic substrates have also been 


















Figure 1.4.2.4. Determination of the enantioselectivity of nitrilase enzymes using 
isotopically labelled pseudo-enantiomers of a prochiral substrate. 
Although many of these fluorogenic and chromogenic screens are amenable to 
automation and can be performed in parallel on microtitre or agar plates, these screening 
technologies are only able to screen a limited number of mutants, typically not exceeding 
several hundred thousand. Sophisticated approaches to analyse protein-ligand 
interactions have become available, in particular fluorescence activated cell sorting 
(FACS). Using flow cytometly, much larger libraries of variant enzymes can be screened 
(up to 109 variants) to detect expression levels, stability, ligand binding and catalysis 143. 
Flow cytometry is a means of measuring certain physical and chemical characteristics of 
cells or particles by optical density or fluorescence as they travel in suspension one by 
one past a sensing point. As well as measuring optical properties, it is possible to 
measure physical characteristics such as cell size, shape and internal complexity. If a cell 
of interest is detected, the cytometer waits until the cell has travelled to a point in the 
flow where it has become a droplet and the instrument then charges the stream. The 
sorted cell droplet now carries a charge that is different to the rest of the stream and this 
either reflected or attracted to the correct holder by an electrical field. Using this 
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approach FACS is capable of sorting at a rate of 30,000 cells per second so is a 
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Figure 1.4.2.5. The FACS principle for sorting cells in 	 144  
The use of GFP (green fluorescent protein) is another popular way of monitoring enzyme 
activity by FACS. Schultz and co-workers have described the application of GFP and 
FACS to identify the introduction of unnatural amino acids into proteins ' 45 . This work 
evolved aminoacyl-tRNA synthetase to accept unnatural amino acids to charge tRNA 
molecules to translate the unnatural amino acids into proteins. FACS was used to screen 
synthetase variants to identify variants that were able to accommodate p-
isopropyiphenylalanine, p-aminophenylalanine, p-carboxylphenylalanine or 0-
allyltyrosine from a mutant library of 10 9 clones. The screen relied on the ability of the 
synthetase to incorporate an unnatural amino acid at a stop codon during the translation 
of GFP. 
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To discover a GAT enzyme a search of Bacillus species incubated with glyphosate and 
acetyl CoA was performed ' 46 . The acetylation of glyphosate was measured by mass 
spectrometry. Bacillus lichenformis was identified as the optimal strain which 
accumulated the greatest reproducible levels of N-acetylglyphosate. The gene 
responsible for the acetylation was isolated by assaying recombinant genomic DNA 
fragments and the active fragments contained a 438 base pair open reading frame that 
had similarity with other N-acetyltransferase enzymes. Three parental  GAT enzymes 
were identified by BLAST search and analysis.. The ability of each to acetylate 
glyphosate was found to be in range k cat of 1.0 to 1.7 min -1 with a KM of 1.2 to 1.8mM at 
pH 6.8 and 21CC. The average enzyme efficiency (k çat/KM) was 0.81 min'mM' which 
was too inefficient to be used as a GAT enzyme to protect transgenic crops from 
glyphosate; however it provided a starting point for directed evolution by gene shuffling. 
The gat coding regions were PCR amplified, fragmented and reassembled in a 
primerless PCR reaction 147 . Shuffled variants were assayed and those that accumulated 
more N-acetylglyphosate than the parental controls had their genes shuffled again in 
iteration. Several GAT enzymes from the third iteration showed -100 fold improvement 
in kcat/Ki compared with the parent enzymes. This was sufficient to allow the 
recombinant E. coli to grow in 5mM glyphosate. However, this improvement was still 
insufficient to enable transgenic plants to grow in the presence of glyphosate. Further 
rounds of gene shuffling resulted in continual imprOvements in k cat but the KM failed to 
decrease below 0.5mM. An epPCR approach to create variant libraries was used to find a 
variant with a lower KM without success. To solve this problem a dual method was 
engaged. Firstly, a functional prescreen was used which allowed the screening of 10 6 
variants (compared with 5000 using the mass spectrometry screen) eliminating all but 
those containing highly active variants. The prescreen was based on a life or death 
selection, recombinant E. coli expressing GAT variants were treated with glyphosate and 
only those that survived were further assayed. Secondly, the genetic diversification in the 
further iterations of DNA shuffling was increased by using the natural genetic variability 
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In concluding there are various screening technologies available that can be used in a 
screen. Each method has benefits and drawbacks and the most appropriate method 
should be selected individually for each case to best suit the conditions of the screen. 
Furthermore it is imperative that the method chosen is high throughput and is sensitive 
enough to monitor the production of product or products to maximise the numbers of 
candidates that can be examined. 
1.4.3. Progress in directed evolution 
Directed evolution has emerged as an efficient way to develop new biocatalysts. A few 
examples are discussed below which demonstrate the application of directed evolution in 
discovering and enhancing biocatalyst,s. 
Glyphosate-115 (Monsanto's Roundup®) is a herbicide which inhibits the enzyme 
enolpyruvylshikimate-3-phosphate synthase (EPSPS). This enzyme is important because 
it is involved in the biosynthesis of aromatic acids making glyphosate a potent herbicide. 
Plants can gain tolerance towards herbicides by metabolic detoxification through 
chemically modifying the plant toxin. Glyphosate tolerance crops have been engineered 
to withstand glyphosate treatment, but the glyphosate remains in the plant where it can 
interfere with reproductive development and can lower crop yield. If glypho sate is N-
acetylated, the N-acetylglyphosate-116 is not herbicidal and is not an effective inhibitor 
of EPSPS. If a glyphosate N-acetyltransferase (GAT) enzyme could be found it could 
provide a route to detoxification of glyphosate, which would allow spraying during 
reproductive development and give more robust tolerance (figure 1.4.3.1). 
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Figure 1.4.3.1. The N-acetylation of glyphosate-1 15 with a GAT enzyme. 
roil 
Introduction 
in related hypothetical proteins. Synthetic libraries from predicted B. subtilis and B. 
cereus sequences, based on the best GAT variant of the 41h  generation, were incorporated 
as templates to increase diversity. The resultant fifth iterative library produced a variant 
with a KM of 0.05mM. The rounds of iterations were continued until after the eleventh 
round where the most efficient GAT variant was discovered. The improved GAT variant 
was found to have a k of4l6min' and a KM of 0.05mM for the N-acetylation of 
glyphosate, which is nearly a 10,000 fold improvement in kcat/KM over the parental GAT 
enzymes. This variant was 76-79% identical to the original native GAT enzymes and 
was introduced into tobacco plants. Treatment with a 6X glyphosate spray demonstrated 
that the plant suffered no adverse symptoms compared to the control plants (figure 
1.4.3.2). 
!T 
Figure 1.4.3.2. Transgenic maize expressing GAT146.  (A) The control maize 
(untransformed) 10 days after spraying with glyphosate spray. (B to D) Plants on the 
right are shown 10 days after glyphosate treatment, the plants are on the left are 
untreated (B) Transformed maize expressing a fifth iteration gat variant were tolerant to 
a 4X dose but suffered a setback in growth. (C) Transformed maize expressing a seventh 
iteration gal variant showed no symptoms or growth setback at up to 4X glyphosate 
compared to unsprayed controls. (D) Transformed maize expressing tenth and eleventh 
iteration gal variants had tolerance up to 6X glyphosate with no visual damage or growth 
damage. 
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Furthermore, there are numerous examples of lipases being used to control the 
enantioselectivity of the hydrolysis of esters. The lipase catalysed hydrolysis of racemic 
p-nitrophenol esters has been used as a model reaction to evolve Pseudomonas 
aeruginosa lipase to enhance the enantioselectivity of a hydrolytic kinetic resolution 148 . 
The choice of the p-nitrophenol ester substrate allowed the direct monitoring of the ester 
hydrolysis by the production of the yellow p-nitrophenol product (figure 1.4.3.3). 
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RLOcNO2 	
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Figure 1.4.3.3. The lipase catalysed hydrolysis of ap-nitrophenol ester-117 to give the 
acid- 118 and the yellow p-nitrophenolate anion- 119. 
The wild type enzyme had a poor E-value of 1.1 and this proved a good starting point for 
improvement through a directed evolution process. epPCR was employed to generate 
variants to be screened at a mutation rate averaging one amino acid substitution per 
enzyme molecule. After the first round, the most enantioselective variant was isolated 
and the corresponding gene used as a template in the next round of epPCR. After four 
cycles of mutagenesis and screening the selectivity factor in the hydrolytic kinetic 
resolution of the p-nitrophenol chiral ester increased from E = 1.1 to E = 11.3 in favour 
of the (S)-enantiomer. An E-factor of 11.3 was obtained as a result of four amino acid 
changes, but the epPCR method to identify these four residues was not optimised. This 
assumption is reasonable because the size of the screen was smaller (2000-3000 variants 
in each round) than the theoretical number of variants (see section 1.4.1 for discussion 
on epPCR bias). It was assumed that these sites were 'hot spots' therefore saturation 
mutagenesis was undertaken at these points. This led to a new variant 149  with an E-value 
of 20 and by a further round of epPCR a significantly improved variant was identified 
that had an E-factor of 25. 
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DNA shuffling was considered to further evolve the optimized lipase variant but it was 
decided that a higher gene diversification was required. epPCR was repeated on the wild 
type gene but at three times the previous mutation rate, which gave two new variants 
with E-factors of 3 and 6.5 after one cycle' 50 . These two variants, along with the 
optimized variant resulting from the low mutation rate epPCR, were subjected to DNA 
shuffling giving rise to a yet further increase in E to 32. By using extended combinatorial 
multiple-cassette mutagenesis the variants isolated from the high frequency epPCR were 
fragmented. To the mixture of these fragments was added a mutagenic oligocassette 
which allowed two 'hot spots' to be randomized and incorporated into the product gene 
variants (figure 1.4.3.4). The optimized variant generated by this method exhibited an E-
value of>51. 
I 	 X 	XI 	 iyxI 
iY 	 Y 	
Improved variant (E>51) 
Reassembly 
Fragment 	 + 
= NNN for shot spot codon 
I 	x 	xIIxI 
I 	1 I 	
FYI 
Figure 1.4.3.4. Extended combinatorial multiple cassette mutagenesis in the evolution of 
an (S)-selective lipase. The mutagenic oligocassette is shown in pink with the two 
hotspots denoted by Z, both being randomized by NNN incorporation. 
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Using the high mutation frequency the (5)-selective lipase was converted to an (R)-
selective lipase with an E-value of 2.0. Further epPCR rounds of directed evolution gave 
E = 7.0 and then by subsequent DNA shuffling gave E = 30 for (R)-enantiomer 
hydrolysis 151 . The (R)-selective variant had eleven amino acid substitutions in different 
positions to the (5)-selective variants. The ability of directed evolution to increase and 
also reverse enantioselectivity of Pseudomonas aeruginosa lipase was obtained without 
prior knowledge of the 3D structure of the enzyme and its mechanism. 
Detailed molecular modeling has subsequently been undertaken to rationalise what has 
caused these changes in catalysis by the lipas& 52 . The modeling concluded that the rise 
in enantioselectivity was caused by a disruption of the hydrogen bonding network arising 
from the mutations which allows histidine 83 to adopt different conformers. Changes in 
histidine 83 conformations affect the enantioselectivity during catalysis since it is 
involved in the proton shuttle of the catalytic triad of this serine esterase. It was shown 
that the side chain movement of histidine 83 provided additional stabilization of the 
oxyanion hole for the (5)-ester by a new hydrogen bond. In contrast, the (R)-ester doesn't 
have this stabilization, it has a steric repulsion which further helps to increase the 
enantioselectivity for the (5)-selective variants. 
In conclusion, these two examples demonstrate that directed evolution can be used to 
engineer transgenic crops to self-protect against a potent herbicide by enzymatic 
degradation of the toxin. The wild type enzyme alone was insufficient to fulfill this task 
without substantial improvements (10,000 fold compared to wild type) of the parent 
gene by directed evolution. Lipases have been evolved by directed evolution to increase 
enantioselectivity of ester hydrolysis. Combinations of epPCR and DNA shuffling were 
used to invert the enantioselectivity allowing either enantiomer of an ester to be 
selectively hydrolysed. There appears not to be a single preferred method by which 
genetic diversification is best prepared. In practice, it is seen that the preferred choice of 
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variant library preparation is case specific, with the optimal methods often combining 
several approaches such as epPCR, gene shuffling and saturation mutagenesis. 
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1.5. Summary and aims 
The number of different approaches for the preparation of optically active amines has 
increased in recent years. Chiral amine functionality is important in many fine chemical 
intermediates, therefore there is much commercial and academic interest in discovering 
novel routes to provide cheaper and more efficient routes. A biocatalytic approach offers 
many attractive features to achieve this goal. 
The project outlined here is based upon work initially reported for the deracemisation of 
cyclic amino acids60 . Prior to undertaking the work described here, progress had been 
made in applying a similar principle for the deracemisation of chiral amines. The 
previous studies selected MAO-N as the parent gene in the search for an enantioselective 
amine oxidase. A variant MAO-N enzyme (N336S) was discovered by directed 
evolution that had improved activity towards a-methylbenzylamine' 53 . It was shown to 
have high (5)-enantioselectivity and has been employed in the deracemisation of (rac)-a-
methylbenzylamine achieving high e.e. and moderate/good yields 154 . 
The goal in this project was firstly to establish a method for the purification of 
recombinant MAO-N expressed in E. coli. Once MAO-N had been purified and isolated, 
the next task was to screen the improved MAO-N N336S M348K variant against a 
variety of amines to evaluate the feasibility of using this enzyme as a biocatalyst for the 
deracemisation of other chiral amines. The MAO-N was passed through a further round 
of directed evolution, this time screening for activity towards a secondary amine, in an 
attempt to increase the range of substrates that the amine deracemisation principle can be 
applied to. The ultimate aim being to obtain a 'toolbox' selection of MAO-N 
biocatalysts that could be chosen depending on the type of substrate to be deracemised 
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(e.g. primary, secondary or tertiary amine) and which enantiomer was required (either 
(R) or (S)). 
A second MAO-N variant was identified which incorporated a mutation in the protein 
sequence that introduced secondary amine activity. The mutated site was randomised 
and then screened again against secondary amines to select for the optimal amino acid 
residue. Subsequently, further saturation mutagenesis of other residues in MAO-N which 
appeared to perform specific contacts with the substrate at the active site was 
undertaken. The postulation of the specific contacts between the substrate and the 
enzyme was based upon a homology model. The MAO-N sequence was aligned with 
MAO-B and employing the published three dimensional crystal structure of MAO-B 
with an inhibitor bound at the active site 84  gave the basis of the homology model. The 
variant libraries generated by saturation mutagenesis were screened using a solid phase 
assay to identify variants that had improved secondary amine oxidation rates. 
A range of reducing agents was screened for their performance in the reduction of 
imines, which allowed them to be categorized into those that should perform more 
efficiently under deracemisation conditions. The reducing agent screening was critically 
important to highlight those that efficiently reduced imines under aqueous buffer 
conditions thereby maximising the efficiency of the deracemisation cycle and 
minimising loss of substrate by imine hydrolysis. Finally, optimised MAO-N 
biocatalysts and the more efficient reducing agents were combined to investigate the 
viability of the preparative deracemisations of chiral amines using both whole cell 
recombinant E. coli expressing MAO-N and purified MAO-N immobilised on resin. 
During the results and discussion section each MAO-N variant is referred to by number. 
The assigned numbers for each variant have the mutations incorporated as indicated in 
table 1.5.1. 
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MAO-N variant Mutations incorporated 
I N336SM348K 
1246M N336S M348K 
1246M N336S M348K T384S D385N 
I 1246M N336S M348K T384N D385S 
Table 1.5.1. The number assigned with each MAO-N variant and the mutated residues of 
the variant. 
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Results and Discussion 
2.1. Purification and stability studies 
2.1.1. Ion exchange purification 
Separation of crude protein mixtures in ion exchange chromatography depends upon the 
reversible adsorption of charged solute molecules to immobilised ion exchange groups 
of a resin that have an opposite charge. Most ion exchange experiments are performed in 
five main stages as shown in figure 2.1.1.1. There are two methods of ion exchange, 
either anion where the medium is positively charged or by cation exchange where the 
medium is negatively charged. The protein is then eluted by application of a salt gradient 
(3.2.1). Substances are separated based on their charge, charge density and the 
distribution of charge on the surface of the substance. The interaction of protein and ion 
exchanger can be varied according to the conditions used during the purification in 
particular the ionic strength and pH are particularly important. 
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Figure 2.1.1.1. The principle of salt gradient elution in ion exchange chromatography for 
the purification of proteins. The example shown here is anion exchange chromatography 
step 1 = equilibration, Step 2 = sample application and wash, step 3 = gradient elution 
(protein with -1 net charge), step 4 = gradient elution (protein with -2 net charge), step 5 
= gradient elution (protein with -3 net charge) and step 6 = regeneration (illustration 
taken from Amersham biosciences). 
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The first step is the loading of the crude mixture onto the column; the desired protein is 
bound to the pre-equilibrated resin. Desorption then can proceed, this elutes substances 
that have a lower strength of attraction to the resin. This is normally achieved by raising 
the ionic strength which disrupts the ionic interaction between resin and substrate. After 
all substances have been desorbed, the resin is regenerated ready for re-use. 
Purification of recombinant MAO-N L variant by the modification of the reported 
method 94  using Resource Q resin rather than with another ion exchange resin (DEAE-
sepharose) gave better resolution of proteins 153 . Resource Q chromatography gave 
MAO-N protein of approximately 75% purity as determined by SDS-PAGE ' 53 . Resource 
Q is an anion exchange purification technique, so the buffer pH should be higher than 
the protein's p1 to allow the ionic interaction between the protein (net negative charge) 
and exchanger (net positive charge). Cell free extract (CFE) 50ml was adsorbed onto a 
HiLoad 26/10 50m1 Q Sepharose column and a linear salt gradient 0-1.0 M over 20 
column volumes was applied. All fractions were assayed (3.1.1) and MAO-N activity 
was found in three fractions (35-37) corresponding to 238-277mM sodium chloride 
(3.2.1). The efficiency of the purification was measured by the total activity recovered in 
the purified protein relative to the activity measured in the CFE. 
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Figure 2.1.1.2. Separation of eluted fractions obtained by Resource Q chromatography in 
a SDS polyacrylamide gel followed by Coomassie blue staining. Lane 1, Molecular 
weight protein markers (NEB); lane 2 and 3, cell pellet before sonication; lane 4, CFE; 
lane 5, fraction 35; lane 6, fraction 36 and lane 7, fraction 37. 
2.1.2. Affinity Purification 
Affinity chromatography separates proteins on the basis of a reversible interaction 
between a protein (and group of proteins) and a specific ligand coupled to a 
chromatography matrix. The His-tag is a commonly used tag to facilitate the purification 
of recombinant proteins. A chelating matrix with Ni 2 metal ions selectively binds 
proteins if complex forming amino acid residues, in particular histidine, are exposed on 
the protein surface. Application of an increasing imidazole gradient causes proteins that 
are bound non-specifically to be eluted. 
Owing to the pET- 1 6b recombinant expression system that was used in the expression of 
recombinant MAO-N protein, an N-terminal histidine peptide (His) 6  tag was attached. 
This allowed purification of the protein to >95% purity. Optimisation of the affinity 
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purification protocol to determine the maximum imidazole concentration required for 
the MAO-N to remain bound on the resin was determined to be 60mM. This was used in 
the wash step to remove weakly associated proteins from the host organism that were 
non-His tagged proteins. The same investigation was used to determine the minimum 
concentration of imidazole required to elute the His-tagged MAO-N protein, this was 
found to be 200mM imidazole (3.2.2). 
- 	 -. 	 .. 	
'kDa 
1 2 	3 	4 	5 	6 	7 
175 
83 





Figure 2.1.2.1 Analysis of eluted fractions of nickel affinity chromatography purified 
protein samples by SDS polyacrylamide gel electrophoresis followed by staining with 
Coomassie blue staining (3.2.5). Lanes 1 and 7, molecular weight protein markers 
(NEB); lanes 2, 3 and 4, fractions from eluted nickel affinity chromatography; lanes 5 
and 6, CFE. 
Typically, storage of the purified protein overnight led to protein precipitation and 
complete loss of soluble protein as determined by the Bradford assay (3.2.6). 
Furthermore, agitation of the stored protein sample caused flakes of protein to be visible 
indicating the loss of soluble protein. Attempts to improve the purified protein stability 
were tried. It was suggested that the instability of the purified protein may be caused by 
the high concentration of imidazole required to elute the protein in the affinity 
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purification technique (elution buffer 200mM imidazole, Tris-HC1 pH 7.8, 300mM 
NaCl, 1 mlvi DTT and 0.1 mM PMSF). To investigate if this was the case a purified 
sample of protein was exchanged into the same buffer used for MAO-N purification by 
nickel affinity chromatography lacking imidazole. A freshly purified protein sample was 
applied to a Vivaspin centrifugal filter and spun to concentrate the sample (method 
followed was according to manufacturer's guidelines). The concentrated protein sample 
was then diluted in buffer used to purify the protein, lacking imidazole (25 mlvi Tns-HC1 
pH 7.8, 300mM NaCl, 1 mM DTT and 0.1 mM PMSF). The reconstituted protein 
sample was passed through several repetitions of concentration and dilution to exchange 
the buffer into 25 mlvi Tris-HC1 pH 7.8, 300mM NaCl, 1 mM DTT and 0.1 MM PMSF. 
However, the serial concentration and dilution of the sample led to the protein being 
absorbed onto the spin-column membrane. Overnight dialysis was attempted instead. 
Dialysis into the same purification buffer, lacking imidazole, did not prevent loss of 
activity. Storage at 4°C, -20°C and -80°C led to a loss of MAO-N activity, these storage 
conditions did not alleviate the stability problem so a more rigorous investigate of 
protein storage conditions was required (2.1.4). 
2.1.3. Activity profile during MAO-N purification 
The activity profile of MAO-N through the two purification methods, ion exchange and 
nickel affinity chromatography, is summarised in table 2.1.3.1. It showed that the ion 
exchange method gave an overall better yield of purified MAO-N activity with 88% 
recovery from CFE compared with 21% for the nickel affinity method. The differences 
in specific activity of the CFE arise from the fact that the two purifications were 
performed on different batches of cells and were caused by differences in the expression 
level of recombinant MAO-N during the fermentation. The specific activity of the 
purified protein was significantly higher for the ion exchanged purified protein than for 
the nickel affinity purified protein. Normally, the specific activity would rise from the 
CFE to the purified protein, but the opposite occurs for the nickel affinity purified 
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MAO-N protein. This results from the instability of the purified MAO-N protein by the 
nickel affinity procedure [this problem is addressed later (2.1.4)]. 
Total activity 
Total activity Specific Specific activity 
Purification of purified 
of CFE 
protein 
activity of of purified 
method 
(OD/sec) CFE (Umg') protein (Umg') 
(OD/sec) 
Resource Q 
(Ion 1676 1476 0.36 0.81 
exchange) 
Ni-NTA 
(Nickel 5407.5 1112 0.20 0.062 
affinity) 
Table 2.1.3.1. Activity profile during MAO-N I purification; comparison of ion-
exchange and affinity chromatography methods [1 U = 1 tmol/min]. 
The positive ion mode electrospray mass spectrum of MAO-N wild type was recorded 
showing clearly the presence of FAD with M+H = 786 and M+Na = 808 (see 
appendices). The sample was also analysed by LCMS and showed a charge envelope 
characteristic of a peptide (3.2.7). MaxEnt transformation of the charge envelope gave 
several mass peaks in the 51-6lkDa region. The molecular weight of MAO-N wild type 
was calculated to be 55581.313a (monoisotopic mass) in addition to this was the histidine 
tag which increased the molecular weight to 5693 5.3Da. There was no mass peak 
corresponding to either of these exact masses (see appendices) although the mass peaks 
did occur within 5% of the calculated mass of MAO-N wild type. 
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The UV-visible spectrum of MAO-N wild type was recorded to identify the presence of 
FAD cofactor in the purified protein sample (3.2.8). Two maximums were observed in 
the spectrum at 361m and 458nrn. This is consistent with reported UV-visible spectrum 
of MAO-N94 and the based on the absorbance at 458nm (abs = 0.468 units) it was 
possible to calculated the FAD content in the protein sample. The FAD content was 
determined to be 0.04372mM based on the reported extinction coefficient 94  458nm 
0.7mM 1 cm' which gave the concentration of holo-enzyme of MAO-N wild type to be 
2.4mgmr'. The protein concentration measured by absorbance at 458nm (2.4mgmi 1 ) 
matched well with the protein concentration measured by the Bradford assay (3.2.6) 
(2. 5mgmi'). 
2.1.4. Stability of MAO-N upon storage 
MAO-N was purified to homogeneity with nickel affinity chromatography as judged by 
SDS PAGE analysis. The benefit of this single step affinity purification to give pure 
protein was considered to be an improvement over the previously described Resource Q 
Sepharose purification 94. However, the problem of loss of activity during storage needed 
to be addressed to make this technique a viable route for the preparation of MAO-N as a 
biocatalyst in a deracemisation. To examine this, purified protein was stored in different 
buffers at different temperatures, 4°C, -20°C or -80°C. The purified protein was buffer 
exchanged into the desired buffer by PD 10 desalting immediately after affinity 
purification (3.2.3). At various time intervals (24 hours, 48 hours, 72 hours, 168 hours 
and 6 weeks) the samples were thawed on ice and the activity of MAO-N was measured 
against amylamine (amine 1) (using the protocol as described in 3.1.1). The CFE was 
also assayed to test its stability upon storage to determine whether MAO-N was more 
stable stored in CFE rather than purified. 
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Figure 2.1.4.1. Stability studies of purified MAO-N stored in various buffers at 4°C. 
A = 1:1 (v/v) 25mM Tris/HCI pH 7.6, 300mM NaCl, 1mM 3-mercaptoethanol and 1mM 
PMSF (nickel affinity chromatography purification buffer lacking imidazole): glycerol 
B = Purification buffer lacking imidazole 
C = 1:1 (v/v) 0.1 M potassium phosphate buffer pH 7.6: glycerol 
D = 0.1M potassium phosphate buffer pH 7.6 
E = CFE sample in 25mM Tris/HC1 pH 7.6, 300mM NaCl, 1mM 3-mercaptoethanol and 
1mM PMSF. 
The highest MAO-N activities for the purified protein stored at 4°C were seen in buffer 
D (figure 2.1.4.1). These showed the best maintenance of MAO-N activity upon storage. 
The samples stored in purification buffer lacking imidazole (buffer B) showed the 
lowest MAO-N activities. Addition of glycerol in both buffer A and C lowered the 
measured MAO-N activities compared to the same sample without glycerol, this was 










A -20°C 	B -20°C 	C -20°C 	D -20'C E -20°C 
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the dilution difference been included, the difference in activity between the samples with 
and without glycerol is negligible. The addition of glycerol seemed to have no effect on 
the rate at which the MAO-N activity was lost on storage. Some of the samples seem to 
show a recovery in activity after a further period of storage. This may be caused by 
slight inaccuracies in the assay. All the samples showed significant loss of MAO-N 
activity after 6 weeks storage and 5 thaws. 
Protein sample 
• Initial rate 
•24 hours, 1 thaw 
D 48 hours, 2 thaws 
• 72 hours, 3 thaws 
• 168 hours, 4 thaws 
• 6 weeks, 5 thaws 
Figure 2.1.4.2. Stability studies of purified MAO-N stored in various buffers at -20°C. 
Composition of storage buffers as in figure 2.1.4.1. 
Storage at -20°C generally was worse for activity loss with time than storage at 4°C 
(figure 2.1.4.2). The CFE and the samples stored in purification buffer lacking imidazole 
(buffer B) lost almost all activity upon storage. Addition of glycerol to the purification 
buffer lacking imidazole (buffer A) appeared to stabilise MAO-N over 24 hours. The 
best conditions were the samples stored in 0.1M potassium phosphate buffer pH 7.6 
without glycerol (buffer D). There appears to be some erroneous rates measured were 
Results and Discussion 
the activity appears to be lost but then recovers (e.g. 48 hours in buffer A compared to 











A -80°C 	B -80°C 	C -80°C 	D -80C 	E -80CC 
Protein sample 
• Initial rate 
•24 hours, 1 thaw 
E 48 hours, 2 thaws 
• 72 hours, 3 thaws 
• 168 hours, 4 thaws 
• 6 weeks, 5 thaws 
Figure 2.1.4.3. Stability studies of purified MAO-N stored in various buffers at -80°C. 
Composition of storage buffers as in figure 2.1.4.1. 
The best storage conditions for -80°C was the same as for 4°C and -20°C (figures 2.1.4.1 
and 2.1.4.2) where the samples were stored in 0.1 M potassium phosphate without any 
glycerol added. CFE also showed good preservation of MAO-N activity upon storage. 
Samples stored in the presence of glycerol (buffers A and C) both suffered the greatest 
losses of MAO-N activity. 
Several conclusions can be made from this investigation into the effects of storage 
conditions on MAO-N activity. Firstly, the freeze/thaw cycles on purified MAO-N 
generally appeared to lower the activity. After six weeks storage and five thaws MAO-N 
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activity had significantly reduced in all samples. The best overall stability over the five 
freeze/thaw cycles examined was for MAO-N stored at -80°C in 0.1 M potassium 
phosphate buffer without glycerol (buffer D). The phosphate buffer (buffer D) generally 
gave better storage conditions than for the Tris buffer (buffer B) under these conditions 
for MAO-N storage. 
An alternative way of storing purified MAO-N is by precipitation of the protein. 
Ammonium sulphate precipitation of purified MAO-N with 60% saturation led to total 
loss of MAO-N from solution after centrifugation to give a bright yellow pellet. When 
the pellet was redissolved in 0.1M potassium phosphate buffer pH 7.6, it maintained the 
same activity as the freshly purified enzyme. 
2.1.5. Growth and Expression of MAO-N 
The mao gene had been constructed in pET-16b which adds an N-terminal histidine tag 
to the MAO-N protein, allowing nickel affinity chromatography purification to be 
employed in one step. It was shown that the level of MAO-N expression was found to be 
five times higher than the previous pECME3 construct 153 . 
The mao gene was cloned downstream of a bacteriophage T7 transcription site. A lac 
operator sequence is located downstream of the T7 promoter, so in ?DE3 lysogens the 
expressed lac repressor acts to repress transcription of the target gene. The lac repressor 
also interacts with lac UV5 promoter in the host chromosome to repress transcription of 
the T7 RNA polymerase by the host polymerase. The benefit of this expression system is 
that the expression of the target gene can be regulated so that expression can occur once 
induction has occurred. Upon induction with IPTG the lac UV5 promoter transcribes the 
T7 RNA polymerase gene. The T7 RNA polymerase can then transcribe the target DNA 
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of transcription in the uninduced state. This allows expression of genes whose products 
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Figure 2.1.5.1. Novagen' s pET-i 6b vector map with cloning sites and expression 
regiops indicated. 
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Leaky expression of the MAO-N pET- 1 6b construct was seen in the bacterial host E. 
coli BL21 (DE3) 153 . To increase levels of MAO-N expression further IPTG induction 
was performed. Novagen suggest that a final concentration of 1mM JPTG gives 
maximum induction and is recommended during the exponential phase of cell growth, 
OD 600nm  0.4-l.0'. MAO-N 1 variant was grown in lOml LB containing l00tgIml 
ampicillin overnight and lml was used to inoculate two duplicate 1 litre baffled flasks 
each containing lOOmi LB containing l00g/ml ampicillin. Once the cells had reached 
OD60onm of 0.4 one of the cultures was induced with IPTG. At various intervals imi 
samples were taken post-induction and frozen prior to assay for MAO-N activity (3.3.9). 
1 hour post 2 hours post 4 hours post 18 hours post 
Sample Point of 
induction induction induction induction 
growth induction 
(OD/sec) (OD/sec) (OD/sec) (OD/sec) 
IPTG 0 6.81 x 10 1.79 x 102 6.62 x 102 2.49 x 10 
No IPTG 0 0 0 1.65 x 10" 6.82 x 10 
Table 2.1.5.1. Comparison of MAO-N expression with and without IPTG induction. The 
rate of MAO-N activity of frozen/thawed samples measured against amylamine (amine 
1) using the peroxidase assay (3.1.1). 
MAO-N expression improved significantly with IPTG induction. The best expression 
was measured 4 hours post induction. Without induction of protein expression, MAO-N 
activity was first detected at the 4 hour time point. The rate of activity for this sample 
was nearly 10 times less than the activity measured after 4 hours post induction in the 
induced sample. The trend of the activity in the assay profile (table 2.1.5.1) was matched 
in the SDS PAGE (figure 2.1.5.2). 
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Figure 2.1.5.2. SDS PAGE with Coomaise blue staining analysis of the soluble protein 
from BL21 (DE3) samples expressing MAO-N with and without IPTG induction (3.2.5). 
[Lanes 4, 6, 8 and 10 are non-induced samples at 1, 2, 4 and 18 hours respectively. 
Lanes 3, 5, 7 and 9 are IPTG induced samples at 1, 2. 4 and 18 hours respectively. Lane 
2 is the 0 hour sample, the point of induction and lane 1 is the molecular weight protein 
markers]. 
Repeated shake flask experiments and using 10 litre fermentations (3.3.5.3) with these 
improved conditions (IPTG induction) gave poor reproducibility. Induction at OD600 1 
of between 0.4-1.0 with IPTG followed by harvesting 4 hours post induction produced 
inconsistent MAO-N expression. Often there was no apparent enhancement in the total 
MAO-N expression compared to a non induced fermentation which was harvested at 
stationary phase. Furthermore, the OD600 nm was seen to drop post induction on repeated 
fermentations. These unfavourable effects were shown to be particularly noticeable from 
inoculations where the starter cultures had an OD600 nm > 1.0. This empirical observation 
84 
Results and Discussion 
may arise from plasmid instability in the expression host. If the mao gene product is 
detrimental or toxic at high levels to the host (E. coli) then during the fermentation the 
population containing the plasmid DNA could be reduced as cell divisions of E. coli 
containing plasmid DNA is retarded or stopped. Another factor causing this effect could 
be the antibiotic selection. The pET vectors have been engineered to encode for 
ampicillin resistance so only cells containing the plasmid DNA are viable in media 
containing ampicillin. During the fermentation, E. coli containing the MAO-N pET-16b 
construct can either receive a copy of the plasmid or not. Under antibiotic conditions, 
those not containing the plasmid will not be viable because they do not have ampicillin 
resistance. However, during the fermentation 13-lactamase is excreted into the media 
degrading the antibiotic. Therefore once ampicillin levels had fallen to a sufficiently low 
level, cells not containing the plasmid DNA can survive in the fermentator. The 
population could proportionately rise to contain more non-plasmid containing cells. This 
effect would be magnified should the growth rate of cells containing plasmid DNA be 
decreased or stopped as cellular metabolic energy is directed into MAO-N production 
rather than cell division. 
In order to determine if this was the case a stationary phase culture was diluted and 
spread onto 2 LB agar plates, one containing ampicillin and the other with no antibiotic 
(3.3.7). There was a two fold excess of colonies on the LB only plate indicating that half 
of the colonies do not contain the ampicillin selection in this culture suggesting that a 
significant proportion of the E. coli population did not contain plasmid DNA. [There 
were 23 colonies on the LB only plate and 11 colonies on the LB containing 1 OO[tg/ml 
ampicillin plate]. However, this level of plasmid retention within the host is deemed 
acceptable 156 . 
The reproducibility problems of the IPTG induction and the observation of loss of 
plasmid from the host meant that routine fermentations for the production of MAO-N 
protein in this project were performed with no induction. Relying on just the leaky 
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expression of the pET-16b without induction meant that the potential yields of MAO-N 
were probably lower; but the fermentation performance was more robust and less likely 
to incur the problems of cell lysis and variable expression levels. To ensure maximal 
retention of the plasmid in the organism, the medium was inoculated with a single 
colony from a fresh transformant and the subculturing minimised. Inoculums were 
washed with fresh LB containing 1 OOp.gIml ampicillin to remove excreted -lactamase 
and the -lactam antibiotic changed to carbenicillin to improve the selection. It has been 
shown that carbenicillin is less prone to degradation by 3-lactamase than ampicillin 157 . 
Based on this effect, replacement of ampicillin with carbenicillin as the antibiotic 
selection for the fermentation may help alleviate the suggested problem of degradation 
of the antibiotic selection. Recombinant MAO-N fermentations were performed in the 
same manner as previously described (3.3.5) but with the replacement of ampicillin with 
carbenicillin at the same concentration (1 OOp.gIml) throughout the fermentation. After 
several attempts using carbenicillin, rather than ampicillin, no improvement in MAO-N 
expression was observed. 
2.1.6. Conclusions 
Recombinant MAO-N has been purified as a functional soluble protein. The previously 
reported ion exchange chromatography has been changed to the nickel affinity 
purification technique affording higher purity of protein. The stability problems 
associated with the purified protein have been addressed and an improved storage buffer 
• (phosphate) was found to increase the stability of the protein over the post purification 
buffer (Tris). Induction with IPTG during the fermentation has been shown to raise the 
expression of MAO-N compared with no induction. Problems with the lack of 
reproducibility of the induction method meant that it was not used when carrying out 
fermentations. The amount of protein obtained from a non-induced fermentation gave 
sufficient quantities to allow the kinetic and biotransformation experiments to be 
undertaken. 
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2.1.7. Future work 
The stability problem of purified MAO-N (2.1.4) was addressed, but with only a 
moderate degree of success. Other storage conditions could be investigated including 
alternative buffers, lypholisation of the purified protein and storage as an ammonium 
sulfate pellet. MAO's flavin is non-covalently bound, so storing the purified protein with 
addition of flavin cofactor may assist the stability of the protein. The problems 
associated with the current vector (pET-16b) could be investigated by using other 
expression systems. 
Should higher levels of MAO-N be required in the future then further investigation into 
improving expression would be required. Enriched media would probably give higher 
final OD600nm at stationary phase than the currently used LB media, yielding a higher 
biomass on harvest. Different growth media may also improve expression and solubility 
of the MAO-N protein. Other adjustments that could be tried to improve the 
fermentation yield include lowering the temperature, also addition of cofactor and/or 
substrate may help to increase the overall yield of functional soluble MAO-N enzyme. 
As the mao gene product is from a eukaryotic organism, Aspergillus niger, then 
switching the expression host from prokaryote (E. coli) to a eukaroyte system such as 
Sacchromyces or Pichia may also be beneficial. 
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2.2. Screening of MAO-N wild type and N336S M348K variant against 
panel of amines 
The substrate specificity of MAO-N from Aspergillus niger had been studied to a degree 
prior to this work 154  and existing work had only demonstrated the deracemisation of a-
methylbenzylamine (amine 24) with the MAO-N 1 variant. In order to determine the 
potential application of MAO-N wild type and the MAO-N I variant in the 
deracemisation of other chiral amines a more thorough substrate screening exercise was 
undertaken. For the amines that were found to be active in this screen a further 
investigation into the enantioselectivity was undertaken. For MAO-N to be used as a 
biocatalysis in the deracemisation of a racemic amine substrate, enantioselectivity and 
activity are crucial. The deracemisation concept of cycles of oxidation and reduction is 
reliant on an enantioselective oxidation to achieve high e.e. for the final amine product. 
2.2.1. The colorimetric peroxidase assay 
A key aspect of amine oxidation by MAO-N that allows the facile and accurate assay of 
catalytic activity is that the by-product of the amine oxidation is hydrogen peroxide. 
This by-product is generated by the reduction of molecular oxygen with water to give 
hydrogen peroxide in the regeneration of FAD to its oxidised form in the final stage of 
the MAO-N catalytic cycle (1.3). Horseradish peroxidase catalyses the reduction of 
hydrogen peroxide to water with simultaneous oxidation of a proton donor (figure 
2.2.1.1). The proton donor in this case was 4-aminoantipurine-120, which subsequently 
reacted chemically with 2,4,6-tribromohydrobenzoic acid-122 to give a soluble red dye 
which can be quantified by absorbance at 51Onm. This direct measurement of hydrogen 
peroxide production was used to calculate MAO-N activity in the following experiments 
(3.1.1). 
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Figure 2.2.1.1. The peroxidase coupled assay producing a soluble quinoneimine-123 
dye. 
2.2.2. MAO-N wild type and MAO-N I variant amine oxidation screen 
Existing work had shown the deracemisation of (rac)-amine 24 with the MAO-N J 
variant 64 . To examine the potential use of MAO-N to deracemise chiral amines other. 
than (rac)-amine 24 154  MAO-N wild type and the MAO-N J variant were screened for 
activity. The M348K mutation in MAO-N N336S has previously been reported to be an 
expression mutant of the MAO-N N336S variant and is not involved in the improvement 
of MAO-N catalysis in amine oxidation' 53 . The initial difficulties with isolating and 
storing stable pure protein (2.1.4) made detailed kinetic analysis difficult, therefore 
amine rates were measured relative to amine 24 (3.1.3). Each screening experiment 
included (rac)-amine 24 so that variability in the oxidation rate resulting from enzyme 
instability was eliminated. Amine activities were measured as percentages with activity 
RIE 
Results and discussion 
of (rac)-amine 24 set at 100%. To facilitate the screening of large numbers of substrates, 
the assays were carried out using a 96-well micotitre plate. The use of a 96-well 
microtitre plate to measure MAO-N activity offers advantages over the single (cell) 
cuvette method, as multiple samples can be measured in parallel saving time and money. 
The additional advantage is that it increases the through put of the screening and should 
it be desired, it can be automated. To allow the measured assay rates between substrates 
to be comparable, all amines were prepared at 10 mM in the assay mixture. Negative 
control assays were also carried out in the absence of MAO-N so that any non-
enzymatic production of the coloured product could be discovered and false positives 
eliminated from the screen. It was found that some of the commercial amines had 
impurities that caused a false positive response; often these impurities could be removed 
by Kugelrohr distillation of the amine. However after purification it was often found that 
the substrate became impure again after storage, reflecting the unstable nature of some 
of the amines in the free base form. Generally, amines supplied as the hydrochloride 
salts proved to be more stable than the corresponding free base amine and hence tended 
not to give false positives. Table 2.2.2.1 details the results of the screening. Each 
substrate has been allocated a number and its structure is indicated. All the rates were 
measured using racemic substrates (for those that were chiral) and were measured as 
relative percentages of the rate observed with a-methylbenzylamine (amine 24). 
Wild type activity MAO-N 1 variant Amine Structure 
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NH2 
24 100 1 00 
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185 1321 60.3 IItIIIIIIIIIJH 
186 0.6 1.4 
a NH2 
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OH 
188 0 0 (yLNH2 
dJMe 
189 0 0 
NH2 
Ph 	CN 
190 5.8 1.7 
phy*l2 
Ph 
191 0.5 0.1 H09 
NH 2 
192 9.7 0.8 
193 0 2•7 NH2 
 Ph 
194 0 0 OH 
• NH2 
195 3 396 NH2 
196 0 0 
HO - 
NH 2 
197 0 0.1 Et2N.-L 
198 0 0 NH20 
199 0.2 0 
H 
NH 2 
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201 Impure Impure 
H 




203 0.6 4.6 NH2 
204 0 0 &C 
205 68.3 175 
NH 2 
206 0 0 
I 
H 
207 0 1.0 
'-ON 
208 0 0.4 
209 499 4080 OPh 
210 0 0 LJLL 
H 
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211 0 0 CnN Ph H 
212 0 0• 
F"'- H 
213 Impure Impure 1I1I1H 
214 3.2 1.2 CaNH2 
215 Not determined 2053 1LNH 
216 Not determined 111 
EIIIXI$NH 
217 14 9.4 CI1Ph 
H 
218 Not determined 187 
OMe 
H 
219 Not determined 2447 
j1NHMe 
Table 2.2.2.1. Percentage relative rate of amines screened against MAO-N wild type and 
MAO-N 1 variant. 
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Figure 2.2.2.1. 96-well microtitre plate based screening of various amines with the 
MAO-N 1 variant. 
The results indicated an improvement in activity for a significant number of the amines 
(49 amines) for the MAO-N I variant compared to the wild type and only 19 amines 
tested were found to have greater activity with the wild type. This data shows that the 
N336S substitution has caused an improvement in MAO-N activity towards many more 
amines than a-methylbenzylamine-24 (this substrate was used for the generation of this 
variant through directed evolution). 
Although a 3-dimensional structure of the enzyme was unavailable at the time, the 
substrate specificity changes due to the N336S M348K substitutions have been 
summarised (figure 2.2.2.2). The wild type enzyme has activity towards simple achiral 
amines such as benzylamine and amylamine, but the N336S substitution has changed 
MAO-N specificity so that amines with NH2CH2 and NHMe functionality at the amino 
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position were active in the assay. The MAO-N 1 variant continues to be capable of 
oxidising amine substrates with the NH 2 functional group. The changes in MAO-N 
resulting from the N336S substitution have enabled hydrophobic alkyl and aryl groups at 
the R-position of the amine substrates to be tolerated. In particular, cyclohexyl and 
adamantyl type R-groups were both excellent substrates against the MAO-N J enzyme. 
The results of the MAO-N specificity broadening for the amines that were screened in 
the MAO-N wild type and the MAO-N I variant assays is summarised in table 2.2.2.2. 
Based on the relative rates measured (below 5% being considered as non-active 
substrates) the wild type showed activity against 13 amines and MAO-N J variant 
showed activity against 36 amines from the total 93 amines screened (excluding the 5 
impure substrates). 
Percentage rates relative 
>5% 5-25% 25-100% 100-200% >200% 
to (rac)-amine 24 
Wild type 76 7 2 0 4 
MAO-NI variant 57 16 6 9 5 
Table 2.2.2.2. Distribution of activities of amines from screening 
The MAO-N enzymes tend to have a preference for hydrophobic alkyl and aryl groups 
at the R-position. For the other position a to the amino group the amine screening has 
identified substrates that have groups other than methyl, as in the case of amine 24, that 
can be oxidised by the MAO-N I enzyme. The specificity of the MAO-N I variant is 
broadened, enabling substrates having CH20H (amine 151) and CH2CH20H (amine 
176) to be oxidised. However, the majority of substrates screened continued to show 
preference for a-methyl substrates, as these had the highest activities of the amines that 
were screened. It was interesting to observe that although the MAO-N 1. variant was 
selected during directed evolution experiments to have activity towards amine 24, 
101 
Results and discussion 
activity has been found to increase towards most of the amines tested compared to wild-
type with some chiral amines displaying higher activity than amine 24. 
preference for Me 
can tolerate CH20H 






preference for NH 2 
R "NH2 	 can tolerate NHCH2- 
and NHMe 
wild-type enzyme 	N336S mutation 
best substrates are simple 
achiral amines 
(e.g. amylamine, benzylamine) 
preference for branched 
alkyl and aryl 
tolerates unbranched alkyl 
Figure 2.2.2.2. Summary of MAO-N specificity changes arising from the N336S 
mutation in MAO-N. (N.B. the M348K mutation was shown to improve expression but 
not specificity of MAO-N' 53 ) 
2.2.3. Enantioselectivity of the MAO-N J enzyme 
The screening of MAO-N 1 variant against the amine panel identified numerous active 
chiral amines. If they were to be considered as substrates for deracemisation then the 
enantioselectivity of the MAO-N j.  enzyme in the oxidation of these substrates needed to 
be examined. The deracemisation principle used in this project relies on the 
enantioselective oxidation of a single enantiomer of a racemic substrate. If the enzyme 
displays poor enantioselectivity it will be unsuitable as a biocatalyst in the 
deracemisation. Substrates that showed activity in racemic form (table 2.2.2.1) and 
where the single enantiomers were commercially available, the individual enantiomers 
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were assayed to evaluate enantioselectivity. Each enantiomer was assayed at a 
concentration of 10mM and the oxidation rates were measured in the same manner as 
the previous experiment (table 2.2.2.1). All the rates were measured relative to (5)-
amine 24, which was set at 100% activity (3.1.3) (table 2.2.3.1). 
Amine (R)-activity % (5)-activity % (5)1(R) 
24 0.5 100 200 
76 0.2 3.1 15.5 
125 0.7 96.8 138 
126 1.3 126 96.9 
127 0.3 21.8 72.7 
128 0.2 38.7 194 
134 0.6 55.3 92.2 
139 26.3 353 13.4 
141 1.1 312 284 
144 0.2 23.1 116 
151 35.1 0.1 351 
Table 2.2.3.1. Oxidation rates of amine enantiomers based on the peroxidase assay for 
MAO-N I enzyme. The enantioselectivity is calculated by (5)-activity/(R)-activity 
(except amine 151 where enantioselectivity = (R)-activity/(5)-activity). 
Of the eleven amines tested in single enantiomer form, all showed high levels of 
enantioselectivity. Amine 151 showed the highest enantioselectivity in the MAO-N I 
catalysed oxidation, based on the ratio of the oxidation rates of the (R)- and (5)-
enantiomers. Amine 139 had the lowest enantioselectivity. The poor enantioselectivity 
of amine 76 arises because of the inherent poor activity of the (5)-enantiomer compared 
to other substrates; generally the observed high enantioselectivities for the other 
substrates was caused by increased (5)-enantiomer activity compared to wild type (data 
not shown). Amine 139 was a very active substrate in racemic form (table 2.2.2.1) and 
103 
Results and discussion 
had the highest (5)-activity out of the amines tested, but its poor enantioselectivity with 
the MAO-N L enzyme catalysed oxidation results from the (R)-enantiomer having 
significant activity. The high enantioselectivity of the amines screened are shown below 














125 	126 	127 	128 	134 	139 	141 	144 	151 
Amine 
 
Figure 2.2.3.1. The composition of substrate activity for the enantioselective oxidation 
with the MAO-N L enzyme. 
Amine 151 had the highest enantioselectivity of those tested, but with reversal of 
enantioselectivity to the (R)-enantiomer. The reversal of enantioselectivity is caused by 
the change in priority in the assignment of stereochemistry. The priority of the a-methyl 
carbon is raised relative to the other cc-carbon (phenyl) by the hydroxyl substitution on 
the cc-carbon. If it was assumed that the amino group and the R-group (phenyl) were 
important groups in substrate binding at the MAO-N active site then the face of 
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oxidation of amine 151 and amine 24 are the same, maintaining enantioselectivity. The 
reversal of enantioselectivity becomes more obvious with the Newman projection of the 
chiral centre, as shown in figure 2.2.3.2, with the coloured numbering of the constituents 






Amine 151 R = CH20H 
Figure 2.2.3.2. Assignment of stereochemistry of the active enantiomer for amine 24 
((S)-selective) and amine 151 ((R)-selective). 
2.2.4. Oxidation of MTQ (amine 76) 
It has been shown that MTQ (amine 76) was an active substrate in the oxidation 
catalysed by the MAO-N I enzyme and examination of the enantioselectivity of this 
oxidation showed high (S)-selectivity, making it a good candidate for deracemisation. 
Oxidation of MTQ results in a cyclic imine product; this is less likely to become 
hydrolysed under the aqueous deracemisation reaction conditions since the reduction in 
degrees of freedom compared to an acyclic imine stabilise the water labile bond. This 
should enable higher yields to be achieved in the deracemisation of this substrate than 
the 77% yield (93% e.e.) achieved with a-methylbenzylamine (amine 24). 
Although the MAO-N I variant catalyses an enantioselective oxidation of MTQ, the 
mechanism of the oxidation needed to be examined to investigate whether it gave an 
achiral imine product. There is a choice of regioselectivity for MTQ oxidation as there 
are two routes by which amine 76 can be oxidised by MAO-N (as shown in figure 
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2.2.4.1). For primary amines there is only one route because there is only a single proton 
cx to the amino group available. For secondary amines there are two choices of (X-protons 
that can be removed to give the imine and tertiary amines have three a-protons which 
would mean that there are 3 possible imine products. 
Oxidative route (a) 	iIIIIiIIiI Oxidative route (b) E'EIIIIu1 N 	 N H 	 N 
amine 76 
Figure 2.2.4.1. Two possible routes for amine 76 oxidation by MAO-N. 
If oxidative route (a) is performed by MAO-N an achiral product is generated. If 
oxidative route (b) is followed the imine still contains a chiral centre and deracemisation 
of this substrate is not possible. The availability of the (5)-enantiomer of MTQ allowed a 
stereoinversion experiment to be performed. A stereoinversion of (5)-MTQ can 
determine whether the MAO-N ]. enzyme follows oxidative route (a) or (b). Freshly 
prepared enzyme, ammonia borane and (5)-MTQ were left to react for 90 hours at 30°C 
(3.6.1). The reaction was then analysed by chiral HPLC (3.7.1 .A) (figure 2.2.4.2) (work 
carried out by T.S.C. Eve, University of Edinburgh). The analysis showed the presence 
of (R)-MTQ which indicated that, to some degree, oxidative route (a) was occurring; 
therefore a deracemisation of MTQ should be possible. By the end of the reaction there 
was no soluble protein left in the stereoinversion reaction (soluble protein measured by 
the Bradford assay) and precipitated protein was visible in the reaction tube. 
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Time = 0 hours 
Time = 90 hours 
(S )-MTQ 76 
(R)-MTQ76 
0 	10 	20 	30 	40 
Time (mins) 
Figure 2.2.4.2. Chiral HPLC monitoring of the stereoinversion of(S)-MTQ with purified 
MAO-N 11 enzyme and ammonia borane (courtesy of T.S.C. Eve, University of 
Edinburgh). 
2.2.5. Conclusion 
The instability of purified MAO-N meant that measuring specific activities of amine 
oxidation rates was unreliable. Instead a relative rate screen of amine oxidation rates was 
performed, with all the rates measured relative to (rac)-amine 24 (a-
methylbenzylamine). The MAO-N L enzyme was shown to have a broadened substrate 
specificity compared to the wild type enzyme. MAO-N J specificity has been 
summarised and shown to accept large bulky hydrophobic R-groups, with a preference 
for a-methyl and primary amino groups. The MAO-N I. enzyme has high (5)-
enantioselectivity which is important in the deracemisation reaction, where high 
enantioselectivity is crucial to achieve a high e.e. For the secondary amine 76, high 
enantioselectivity was observed and the oxidation by MAO-N was shown (at least to 
some degree) to proceed by a route which could allow its deracemisation. 
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2.2.6. Future work 
The amine panel screening can be continually updated as new substrates are identified, 
allowing the identification of further substrates that would be suitable for deracemisation 
by MAO-N. For substrates that react in the peroxidase assay, the enantioselectivity of 
the MAO-N catalysed oxidation will need to be tested. If necessary, the 
enantioselectivity could be determined by analytical techniques other than 
spectrophotometrically with the peroxidase assay, using chiral separation techniques 
such as chiral HPLC, chiral GC and CE. If secondary and tertiary amines are identified 
in the amine screen the route by which MAO-N catalyses the oxidation will need to be 
examined, to determine whether they can be deracemised. 
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2.3. Directed evolution of MAO-N 
2.3.1. Mutation strategy for MAO-N 
There are several protocols by which a mutant library can be generated as discussed, 
(1.4.1). The Epicunan coli, mutator strain XL1 -Red ' 58 was chosen as the choice for 
introducing mutations in mao because this was the successful approach that had led to 
the discovery of the MAO-N N336S variant ' 53 . Experience in'our laboratory meant that 
the handling and use of this technique was well understood. The XL1-Red strain 
provides a highly efficient, rapid and reproducible method for introducing random 
mutations. The major advantage of this method is that it is not labour intensive and is 
less time consuming than other methods. It has been experimentally measured that in 
pBluescript the mutation rate was 1 mutation per 2kb after 30 generations"'. In XL1-
Red the mutation rate is typically 1 mutation/5x 106  bp/generation/cell and because of the 
damaging effect this has on E. coli, the doubling time for this strain is lowered to 
approximately 90-120 minutes, compared to 20 minutes for wild type E.coli 
(Stratagene). Random mutations are introduced throughout the entire genome and 
include transitions, transversions and single base deletions/insertions. 
The mao gene is 1489 base pairs in length, so assuming an error rate comparable with 
the rate observed with pBluescript then it would take 22.3 generations for the 
introduction of a single mutation (assuming a doubling time of 120 minutes this would 
mean that a total of 44.6 hours would be required). The efficiency of the XL1-Red 
mutator strain has been calculated with pUC18, based upon screening for knocking out 
of -galactosidase activity. After 48 generations 1.2% of the colonies screened were 
found to no longer have 3-galactosidase activity' 53 . 
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XL1-Red competent cells were transformed with the mao 1 gene in pET-16b DNA using 
a modified version of the manufacturer's protocol (3.3.4). The transformed cells were 
used to inoculate lOml of LB containing lOOp.glml ampicillin. The cells were grown for 
18 hours and 201l of this overnight growth was added to a further 1 Oml of LB 
containing lOOp.g/ml ampicillin. After the inoculum had grown for 24 hours, imi was 
removed for isolation of the plasmid DNA (3.4.1). This procedure gave the first 
generation library of mutants. The plasmid DNA of the first generation mutants was then 
used in a second transformation of XL1-red competent cells; inoculation, growth and 
purification of plasmid DNA was repeated as before, giving a second generation library 
of mutants. This process was repeated four times until a fourth generation of mutants 
had been prepared. The extent to which mao was mutated was limited to the fourth 
generation mutant library because this level of mutagenesis with XL1-red had led to 
identification of the N336S mutation from the wild type 153 . 
2.3.2. Proposed directed evolution 
The existing MAO-N 1 variant had good activity towards chiral primary amines but 
showed only low activity towards secondary amines. Although the MAO-N I variant 
had been shown to be active towards the secondary amine MTQ (amine 76) the rate was 
low at ca. 9% relative to a-methylbenzylamine (amine 24) (2.2.2), making this amine a 
good target substrate for directed evolution of MAO-N to improve activity. Amine 76 
was selected as a candidate for screening the fourth generation MAO-N mutant library 
for a MAO-N variant that was more capable of oxidising a secondary amine. If a MAO-
N variant could be discovered, the deracemisation of this substrate compared with the 
acyclic amines might be higher yielding because the. corresponding imine product is 
more stable. A further reason for selecting amine 76 was that gram quantities of the 
amine were available in racemic, (5)- and (R)-enantiomer form. The proposed directed 
evolution of MAO-N towards amine 76 is outlined in figure 2.3.2.1. 
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benzylamine 	 a-methylbenzylamine-24 	 MTQ-76 
c directed evolution 	- I 	directed evolution NH NH NH 2 	 I  
wild type MAO-N 	 N336S M348K MAO-N 	 ??? MAO-N 
Figure 2.3.2.1. Proposed directed evolution of MAO-N 1 variant to identify a MAO-N 
variant with improved activity towards amine 76. The first round of directed evolution 
of MAO-N wild type to the MAO-N I variant is shown. 
2.3.3. Solid phase assay 
The solid phase assay used in the screening of MAO-N variant libraries is based on a 
similar approach to the liquid assay used in the earlier screen (2.2.1). Horseradish 
peroxidase (HRP) catalyses the reaction of hydrogen peroxide with another substrate. 
The hydrogen peroxide is produced as a by-product from the amine oxidation catalysed 
by MAO-N. However, rather than using aminoantipurine as in the liquid assay (figure 
2.2.1.1) an alternative substrate was used for the HRP step. The change of substrate for 
HRP was necessary because the product from the 4-aminoantipurine dye product was 
found to diffuse through the solid phase matrix resulting in a loss of resolution 153 . 
Switching to 3,3 '-diaminobenzidine DAB as the HRP substrate gave rise to a brown 
oxidation product which was less soluble giving higher definition and greater contrast 
between the matrix and colony. The appearance of a brown halo surrounding an E. co/i 
colony on the plate indicates MAO-N activity towards the amine substrate being 
screened. This colony is regarded as being a 'hit'. The mechanism by which the DAB 
dye product is generated is shown in figure 2.3.3.1. 
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Figure 2.3.3.1. Peroxidase coupled reaction of hydrogen peroxide and DAB in the solid 
phase assay. 
2.3.4. Screening of MAO-N variant library with MTQ 
Plasmid DNA from the fourth round of mutagenesis generated by XL 1-Red was used to 
transform BL21 (DE3) star E. coli competent cells, which were then plated on to 
nitrocellulose membranes on LB agar plates containing 100i.g!m1 ampicillin. The 
colonies were left to grow for 16 hours resulting in a library of ca. 12000 variants 
(3.1.1). The membranes were subjected to a freeze-thaw cycle to partially lyse the cells 
and allow the MAO-N activity to be accessible for the assay. The (rac)-MTQ (amine 76) 
assay mixture was poured directly onto the nitrocellulose membranes containing the 
partially lysed cells and the assay left to develop at room temperature (3.1.6). It was 
apparent that a single colony (MAO-N ) was visible after 24 hours which was more 
darkly coloured compared to the other colonies. MAO-N 2 was picked along with 
several other colonies (la, ib, 1  and id) which were randomly selected from the library 
and grown in 5m1 of LB containing 1 00tg/m1 ampicillin along with a control colony of 
a MAO-N ivariant from which the library was generated. After 16 hours growth, lml of 
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the cells was used for purification of plasmid DNA (3.4.1), the remainder of the cells 
were used for further characterisation of MAO-N 2 and the other selected colonies. The 
cell suspensions (1 Ojtl in each assay) were assayed against amylamine (amine 124), 
(rac)-a-methylbenzylamine (amine 24) and (rac)-MTQ (amine 76) in a 96-well 
microtitre plate using the previously described assay (3.1.1). After 2 hours monitoring 
on the plate reader there was no change in OD5IO nm so the microtitre plate was covered 
and left to react for 60 hours (figure 2.3.4.1). The results, as judged by colour formation 
supported the previous observation that MAO-N 2 had improved MTQ (amine 76) 
activity compared to the MAO-N I variant. The activity in the (rac)-a-
methylbenzylamine (amine 24) assays did not show significant production of colour as 
might have been expected. All the amylamine (amine 124) assays gave a positive 
response; the discrepancy seen with (rac)-a-methylbenzylamine (amine 24) may be 
influenced by the fact that this is a whole cell assay. Other factors which could account 
for the poor response of the (rac)-a-methylbenzylamine (amine 24) assays include 
diffusion of product across the cell membrane and possibly an endogenous E. coli 
enzyme interfering with the coupled assay. 
2 	la 
	
lb 	ic 	id 	1 
-a. 
(rac)-MTQ (amine 76) 
(rac)-a-methylbenzylamine 
(amine 24) 
amylamine (amine 124) 
Figure 2.3.4.1. Liquid phase peroxidase assay of MAO-N 2, MAO-N I variant and 
random colonies (la, lb, ic and Id) from variant library activities towards amylamine 
(amine 124), a-methylbenzylamine (amine 24) and MTQ (amine 76) after 60 hours. 
To further examine and validate whether MAO-N 2 had improved MTQ (amine 76) 
activity 50i1 of the 16 hours growth of MAO-N 2 and the MAO-N I variant were spread 
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on nitrocellulose membranes on LB agar containing lOOp.g/ml ampicillin and left to 
grow for a further 16 hours. The membranes were freeze/thawed and the solid phase 
assay repeated using racemic, (R)- and (S)-a-methylbenzylamine (amine 24) and MTQ 
(amine 76) (3.1.6). The nitrocellulose membranes from each were divided into quarters 
allowing each variant to be measured in each solid phase assay in duplicate. This 
removed any discrepancies that could arise between each of the solid phase assay plates. 
(R)-amine 76 	 (S)-arnink 7 
2 	 2 
1 
2 	 - 
- / 	 2 
2 
	
(R)-amine 24 	L 	
(S)-amje 24 
I 





Figure 2.3.4.2. Solid phase assay of MAO-N I variant and MAO-N 2 variant against 
(R)-amine 24, (5)-amine 24, (rac)-amine 24, (R)-amine 76, (5)-amine 76 and (rac)-
amine 76. 
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It is evident from the solid phase assay that there is an improvement in MAO-N 2 (5)-
MTQ (amine 76) activity when compared with the parent MAO-N I variant. There 
appears to be little difference in the solid phase assay in a-methylbenzylamine (amine 
24) activities. Encouragingly, the improvement in activity was only seen in the (S)-
enantiomer which was promising for potential use as a biocatalyst in a deracemisation 
reaction where high enantioselectivity is vital. MAO-N 2 plasmid DNA, isolated from 
the overnight growth, was transformed into BL2 I (DE3) cells and 50jzl spread onto a 
fresh nitrocellulose membrane on LB agar containing lOOggIml ampicillin. This gave 
single isolated colonies and verified the same result as seen in figure 2.3.3.3 with (S)
amine 76 and (rac)-amine 76 reacting faster with the MAO-N 2 than the MAO-N I 
variant in the peroxidase/DAB solid phase assay (3.1.6). 
- 	-"-.. 	 - 
/ 
(R)-amine 76 	(S)-amine 76 
Figure 2.3.4.3. Single colony solid phase of MAO-N 2 (right hand segment of 
nitrocellulose membrane) and MAO-N I variant (left hand segment of nitrocellulose 
membrane) against (R)-amine 76 (left plate) and (5)-amine 76 (right plate). 
2.3.5. Specificity or expression mutant? 
The solid phase screen had identified a variant that possessed improved activity towards 
MTQ (amine 76) with retention of high (S)-enantioselectivity. The solid phase screening 
does not distinguish between mutations that lead to an increase in expression of the 
enzyme or a change in the catalytic activity. The MAO-N I variant had been shown to 
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have a low, but measurable, activity towards MTQ (amine 76) so an improved 
expression could potentially cause the result observed in the solid phase assay, without 
changing the catalytic performance of the parent enzyme. To test whether a specificity 
or expression variant had been generated, a 96-well assay was performed on the cell free 
extract (CFE). A single freshly transformed BL21 (DE3) colony containing the MAO-N 
1 plasmid or MAO-N 2 plasmid was grown to stationary phase overnight. CFE was 
prepared and an assay of the amine was carried out (3.1.4). The 96-well microtitre plate 
was divided into 3-sections, each having 32 wells, one for MAO-N 2, one for the MAO-
N 1 variant and one third for as a control (i.e. no addition of MAO-N). From the original 
screening carried out on the MAO-N 1 variant (2.2.2) 32 substrates were selected to 
provide a structurally diverse selection of amines to assess the specificity of MAO-N 2. 
If ranking the 32 substrates, in order of reactivity, was the same in the assays for the two 
variants of MAO-N, then it is probable that the MAO-N 2 is-an expression variant. An 
expression variant can arise from a silent mutation of an amino acid codon to a 
degenerate codon which is more effectively translated in E. coli or by an effect 
elsewhere in the plasmid altering the level of transcription of the mao gene (e.g. the 
promoter region). The rate of oxidation for the screened substrates was measured 
relative to a-methylbenzylamine (amine 24) (normalised to 100%). Those substrates 
showing activity <10% relative activity to amine 24 are not represented in figure 2.3.5.1. 
Amines 124, 126, 129 and 139 rates were not measurable in this screen as the oxidation 
rate was too fast and levelled off before the microtitre plate could be read in the plate 
reader. 
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• MAO-N I variant 
• MAO-N 2 variant 
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NH2 	 NH2 	 NH2 
o IDTH a H2 	 ç O2N 
amine 24 	amine 76 	amine 130 	amine 134 	amine 145 
e NH2 NH2 OH 	 OH 	 Ph NH2 
amine 151 	amine 176 	amine 193 	amine 205 
Figure 2.3.5.1. Relative rate activities of MAO-N 2 variant compared with MAO-N I 
variant towards a range of amines. 
The relative rates were found not to be the same between the two variants indicating that 
there was indeed a change in specificity of MAO-N 2 against these substrates tested. 
Five of the amines (amines 76, 130, 176, 193 and 205) showed improved activity 
towards MAO-N 2 variant and three amines (amines 134, 145 and 151) had less activity. 
MTQ (amine 76) had improved activity for MAO-N 2 compared with MAO-N I variant 
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with an 8.5 fold improvement. Amine 176 showed the greatest improved activity in the 
rate of amine oxidation from the MAO-N 1 to MAO-N 2 variant, with over a 39-fold 
improvement. CFE analysis by SDS PAGE showed no noticeable difference in the 
MAO-N band between the two variants further supporting the evidence that the change 
in MAO-N 2 is a specificity change and not an expression mutant. 
2.3.6. Sequencing MAO-N 
The MAO-N 2 plasmid was transformed into E. coli (TOP 10) competent cells and a 
single colony from the transformation was picked and grown overnight in 1 Omi LB 
containing lOOp.gIml ampicillin (3.3.2). Plasmid DNA was purified and the full mao 
gene sequenced. In-order to sequence the complete gene five separate sequencing 
reactions were performed (3.4.4). Two commercial external primers were used which 
were complementary to the pET-16b plasmid sequence. Three internal sequencing 
primers were required to complete the sequencing within the mao gene. 
Sequencing results revealed a single nucleotide change A to G at position 738. This 
corresponded to the amino acid residue 246 in mao. In the wild type enzyme the codon 
is ATA which encodes for an isoleucine residue. The A to G transition mutation for this 
codon in the MAO-N 2 changes the codon to ATG which encodes for methionine. This 
is a conservative change in amino acid at 246 both isoleucine and methiomne are 
uncharged residues under physiological conditions and both are hydrophobic with 
methionine having a larger side chain volume than isoleucine. This conservative change 
in amino acid complements the overall change that the MAO-N 2 has undergone with 
regards to amine specificity. Of the amines screened there was no dramatic alteration of 
specificity just a general overall improvement in catalysis whilst maintaining the high 
level of (S)-enantioselectivity. On a molecular level, in the MAO-N enzyme it could be 
speculated that the 1246M mutation has subtly altered the active site enabling improved 
catalysis for amine 76. The change from isoleucine to methionine results in removal of a 
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-methyl branch in the amino acid side group. This removal of steric interference could 
improve the non-bonding van der Vaal contacts between enzyme and ligand. Enzyme 
specificity for substrate can be driven by hydrophobic exclusion and Van der Vaals 
interactions between the enzyme's active site and the substrate. For example aminoacyl 
tRNA synthases have the ability to discriminate subtle changes in amino acid side 
groups. Isoleucyl tRNA synthase has to select between isoleucine and valine. Valine, 
being shorter by one methylene group than isoleucine binds to isoleucyl tRNA synthase, 
but 150 times more weakly' 60 . 
2.3.7. Kinetic parameters of MAO-N 
The mutation introduced in MAO-N 2 was found to generally improve activity for the 
majority of the amines screened (2.3.8) and maintained the high enantioselectivity 
(2.3.9) compared to what was seen for the MAO-N 1 variant. To quantify more precisely 
the changes between MAO-N 2 and the parent MAO-N variant the 'cat  and KM for 
amylamine (amines 124), a-methylbenzylamine (amine 24) and MTQ (amine 76) was 
measured. Michaelis-Menten kinetic constants were calculated for these three substrates 
for both variants. Specific activity measurements were measured in the range 16.7mM to 
10gM (over these data points: 16.7mM, 10mM, 8thM, 6mM, 4mM, 2mM, 1mM, 
0.8mM, 0.6mM, 0.4mM, 0.2mM, 0.1mM, 50gM, 20gM and 10gM) and data analysed 
using SigmaPlot Enzyme Kinetic module (3.1.5). 
amylamine (amine (rac)-a-methyl 
MAO-N (rac)-MTQ (amine 76) 
124) benzylamine (amine 24) 
variant 
1(cat KM kcat KM kcat KM 
47.8 min' 0.359 mM 4.13 min 1 1.26 mM 0.69 min 0.034 mM 
1 
(±1.16) (±0.04) (±0.07) (±0.07) '(± 0.02) (±0.008) 
45.0 min' 0.462 mM 6.40 min 1 2.41 mM 4.57 min 0.234 mlvi 
2 
(±1.1) (±0.05) (±0.3) (±0.23) (± 0.17) (±0.04) 
Table 2.3.7.1. Kinetic constants for amines 1, 24 and 76 with MAO-N 1 and 2. 
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There are small changes in the amylamine (amine 124) k cat and KM between the MAO-N 
2 variant and the MAO-N I variant. However, for a-methylbenzylamine (amine 24) the 
differences are larger, the k cat has increased 1.5 fold for MAO-N 2 from the MAO-N I 
and the KM has risen by a similar order of magnitude. For MTQ (amine 76) the same 
trend is observed with an increase in the k cat and an increase in the KM for MAO-N 2. 
But the scale of the increases is significantly greater for amine 76 than amine 24, a 6.6 
fold improvement in kcat and a 6.9 fold rise in KM. This shows the changes in MAO-N 










1 133 min' mM 1 3.28 mind mM' 20.29 min- ' niM 
2 97.4 mind niM 2.66 min- ' mM 19.53 mind mM' 
Table 2.3.7.2. Specificity constants (k cat/KM) for amine 124, (rac)-amine 24 and (rac)-
amine 76 with MAO-N 1 and 2 variants. 
The increases seen in both keat and KM mean that the specificity constant (k cat/KM) is 
largely unchanged. MAO-N 2 has slightly lower specificity constants compared to the 
parent enzyme. However, the higher k cat for amine 76 should mean that the 
deracemisation should proceed faster. KM is defined as the concentration of substrate at 
half Vmax. The change in KM from the MAO-N 1 variant to MAO-N 2 is significant 
because the increase in KM will mean that the reaction will decelerate sooner for the 
MAO-N 2 variant. However, as the keat is 6.6 times higher for MAO-N 2 than the parent 
variant, even when the substrate concentration falls to the KM the reaction is still 
operating 3 times faster. For example, at a concentration of 0.234mM of amine 76 the 
rate would have fallen to half the Vmax for MAO-N 2 and at 0.0338mM of amine 76 the 
Vmax will have halved for the MAO-N 1 variant. The effect of the mutation in the MAO- 
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N 2 is to improve the turnover whilst lowering the affinity of the enzyme for the 
substrate. 
2.3.8. Screening MAO-N 2 variant against a panel of amines 
To investigate the catalytic change in the MAO-N 2 variant, the protein was purified and 
its activity assessed against a range of amines and compared to the activity of the parent 
enzyme (MAO-N 1). MAO-N 2 protein was purified as described previously (3.2.2). By 
using purified MAO-N 2 a more accurate comparison of the changes in catalytic activity 
from the parent can be made, than with CFE (2.3.5), because it is not affected by other 
component enzymes from E. coli. Amine rates were measured relative to the rate 
measured for (rac)-amine 24 as described earlier (2.2.2). The relative rate for MAO-N 2 
variant was divided by the relative rate measured for the same substrate with MAO-N J 
variant to indicate the change in specificity between the two variants. 
MAO-N 1 MAO-N 2 Ratio = 
Amine Structure 
variant (%) variant (%) (2)1(1) 
124 1307 653 0.5 N H 2 
NH2 
24 100 100 1 
76 9.1 47 5.1 I 
.- 	 NH 
126 89.3 298 3.3 
NH 2 
)~~ 
129 190 489 2.6 NH 
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134 22.6 31.0 1.4 
02 N 
138 2.7 3.1 1.2 
139 915 1984 2.2 
NH2 




145 9.1 1.5 0.2 




149 0.1 1.8 18 
- MeO )XTNH '-  
MeO  
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NH2 
151 49.5 67.0 1.4 OH 
Ph 
156 0.1 1.0 10 MeO__-L 
NH 
MeO-'  
160 0.7 0.6 0.9 
CNr 
161 2.2 0.6 0.3 NH2 
)OH 
NH2 
175 0 0.6 * 
&L.COOH 




183 0.2 0.9 4.5 
&MT
eNHMe . 
186 1.4 3.5 2.5 
S- 	 NH 2 
NH 2 
187 0.1 0 * 
CO2Me 
189 0 0 * 
190 1.7 0 * Ph 	
NH2 
Ph 
193 2.7 10.1 3.7 
Ph 
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197 0.1 0 * 
NH 2 
Et2N-.-L 




205 175 364 2.1 
N1 2 
206 0 .0 * 
aN Ph 
H 
207 1.0 0 * 
208 0.4 0.1 0.3 CQ- 
H 
209 4080 2629 0.6 OPh 
210 0 0 * 
H 
211 0 0 * 
aNPh 
H 
212 0 0 * F'NL 
H 
2.3.8.1. Percentage relative rate screening of amines with MAO-N 2 variant a 
its rate ratio compared with the MAO-N J variant. * = ratio not calculated when relative 
rate = 0% for either variant 
Tabb nd 
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The results from the screening of the MAO-N 2 variant against a panel of amines (figure 
2.3.5.1) further support the earlier indications that the MAO-N 2 variant's activity has 
been altered with respect to the parent variant enzyme. The ratio of the MAO-N : 
MAO-N 1 variant would be 1 if MAO-N 2 was an expression mutant, but the ratios 
deviate from 1 indicating a specificity change. There are six substrates (amines 1, 24, 39, 
40, 87 and 88) with ratios less than 1 indicating that the mutation introduced into the 
MAO-N 2 enzyme is detrimental for amine oxidation compared with MAO-N I. There 
are 17 substrates that have an improved activity with MAO-N 2 compared to the MAO-
N I variant, showing that for the majority of amines tested MAO-N 2 performed as a 
better catalyst in the oxidation. Amines that were shown to have good rates of oxidation 
with the MAO-N 1 variant are mostly shown to have an even higher activity with MAO-
N 2, e.g. the rate measured for amine 139 with MAO-NI enzyme was 915% and this is 
increased to 1984% with MAO-N 2. The rate of oxidation measured for amine 76, the 
substrate that MAO-N 2 variant was selected from in the directed evolution experiment 
had an improvement of 5 times that of the MAO-N 1 mutant: In conclusion, the MAO-N 
2 variant has generally improved rates for the oxidation of the amines that were 
screened; typically this improvement is 2-3 fold compared with the MAO-N 1 variant 
for substrates that previously were shown to be active. 
2.3.9. Enantioselectivity of MAO-N 
The change in MAO-N 2 resulted in a general improvement in the rate of amine 
oxidation which will be beneficial for the use of this MAO-N enzyme as a biocatalyst in 
the deracemisation of amines. However, it is important that the new variant enzyme 
maintains enantioselectivity in the deracemisation process. The enantioselectivity of 
MAO-N 2 enzyme was therefore assessed against a panel of amines and compared to the 
enantioselectivity of the parent MAO-N I enzyme. Single enantiomers were assayed at 
1 OmliVi amine concentrations and rates were measured relative to (5)-amine 24 as 
previously described (2.2.3). 
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Amine (R)-activity % (5)-activity % Enantioselectivity 
Enantioselectivity 
of MAO-N 1 
124 0 100 >200 200 
76 0.7 51.2 73 16 
125 2.5 220 88 138 
126 6.1 271 44 97 
134 0 54.7 >200 92 
139 64 2374 37 13 
142 4.3 12.6 3 Not determined 
145 0.3 22.8 76 Not determined 
Table 2.3.9.1 Rates of amine enantiomers based on peroxidase assay for MAO-N 2 and 
its enantioselectivity. 
The enantioselectivity of MAO-N 2 maintains the high (5)-enantiomer preference as was 
observed for MAO-N J. For the oxidation of MTQ (amine 76) by MAO-N 2 the 
enantioselectivity has risen to 73.1 from 15.5 compared with the MAO-N L variant, this 
is primarily caused by the increased in (5)-enantiomer reactivity. MAO-N 2 also shows 
improvements in the enantioselective oxidation of amine 139 which has risen to 37.1 
from 13 of the parent, again caused primarily by an increase in (5)-enantiomer reactivity 
rather than a change in (R)-enantiomer reactivity. In the MAO-N catalysed oxidation of 
the (R)-enantiomer of amine 139 reactivity has increased to 64% with MAO-N 2, 
compared with 26.3% for the MAO-N L variant. Despite this increase in the oxidation of 
(R)-amine 139 by MAO-N the enantioselectivity has still risen since the rate of oxidation 
of the (5)-enantiomer by MAO-N 2 has increased over six times. The enantioselectivity 
for the MAO-N 2 catalysed oxidation of amine 142 showed the poorest selectivity. 
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2.3.10. Conclusion 
XL1 -red was chosen as the mutation strategy for further evolving MAO-N I towards 
amine 76. The solid phase assay, a high throughput screen, was employed in the 
screening of 12,000 colonies to identify MAO-N 2. The evidence from the kinetic 
characterisation of MAO-N 2 in the amine screening showed it to be a specificity mutant 
whilst maintaining high (5)-enantioselectivity of the parent. There was an increase in k cat 
for amine 24, but the greatest increase was seen for amine 76 with a 6.6 fold 
improvement from the parent to MAO-N 2. The KM has risen for both substrates as well 
as the kcat, meaning that the catalytic efficiency of the enzyme slightly decreased. 
Sequencing of the mao gene identified the mutation in MAO-N 2 to be a transition of A 
to G at nucleotide 738. This translates to amino acid residue 246 in the protein sequence, 
which is encoded by ATA (isoleucine) in the parent and ATG (methionine) in MAO-N 
2. In concluding, the MAO-N 1 enzyme has been evolved for increased activity for a 
secondary amine by the introduction of the 1246M change. 
2.3.11. Future work 
Directed evolution can be used to make other improvements to MAO-N. It may be 
desirable to find a MAO-N variant that has other desirable features such as thermal 
stability, tolerance to organic solvents, reversal of enantioselectivity or activity towards 
novel substrates (i.e. tertiary amines). Preparation of the library of variants is reasonably 
straightforward and the mutation rate can be control by the number of times the gene is 
propagated in the XL1-red Mutator strain. Techniques such as replica plating and/or 
isolation of plasmid DNA from a positive colony could be used when selecting for a 
MAO-N variant when the E. coli itself may not be viable. Directed evolution is rapid 
with the discovery of new variants taking a matter of a few weeks compared to natural 
selection which takes thousands of years 161 . 
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As mentioned in section 2.2.6, further examination of amines screening of MAO-N I 
variant should also be carried out for the MAO-N 2 variant because of their differences 
in substrate specificity. 
Thus far, all MAO-N variants are(S)-selective, to broaden the scope of this 
deracemisation technology it would be advantageous to have an (R)-selective variant. 
This would allow the (5)-enantiomer product to be produced from the deracemisation of 
a racemic substrate. The requirement to produce an (R)-selective MAO-N would be 
desirable but a challenging task. Another approach which removes the necessity for an 
(R)-selective MAO-N is if an 'amine racemase' could be discovered (i.e. an amine 
oxidase with low enantioselectivity combined with a chemical reduction). This would 
allow the dynamic kinetic resolution and (S)-product could be isolated in a theoretical 
100% yield and 100% e.e. (figure 2.3.11.1). 
C~—X NI-12 NH3 BH3 + MAO-N 
(S)-amine 24 r .NJ Amine 
Racemase' 11 
NH 3BH 3 + MAO -N L 
QNH2 
(S)-selective _lipase 
acyl donor, e.g. vinyl acetate  C~~' 
(S)-acylated amine 223 
100% yield, 100% e.e. 
(R)-amine 24 
Figure 2.3.11.1. Principle of a dynamic kinetic resolution of amine 24 with an 'amine 
racemase' and an (5)-selective lipase acylation. 
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2.4. Saturation mutagenesis 
2.4.1. Exploration of the 1246M mutation 
The mutation producing the improvement of activity in the parental MAO-N J enzyme 
towards amine 76 was generated by introduction of a single nucleotide change in the 
mao gene. This mutation changed the amino acid residue in the protein sequence at 
position 246 from isoleucine to methionine. But is methionine the optimal amino acid at 
246 to improve MAO-N catalysis? The directed evolution approach used to identify this 
mutation was based on a library screen of 12000 colonies. The mutation rate of E. coli 
XL1 -red mutator strain used to generate this library, should, on average, introduce a 
single mutation per gene. This will result in a proportion of the library being non-
mutated parental MAO-N owing to silent mutations and the statistical spread of genes 
where no mutations have been incorporated. The library size that would be required to 
fully randomise each nucleotide within mao would be 4' (with n = 1489, the length of 
the mao gene). This is an astronomically large number which is vastly beyond the 
screening capabilities of the current screening method. Even if the library just fully 
randomised each amino acid, rather than each nucleotide, then a vast library size would 
be required 20 (with n = 495, the number of amino acids in the MAO-N protein 
sequence). The enormous library sizes required to represent all possible mutations 
means that in the previous 12000 library screen, the other nineteen amino acid residues 
that can arise at 246 were unlikely to have been represented. 
To explore the 246 amino acid mutation in MAO-N more thoroughly, a site directed 
mutagenesis approach was used. The 3 nucleotides that encode position 246 would be 
substituted for NNS, where N represents any of the 4 DNA bases and S either G or C. 
The S substitution reduces the occurrences of stop codons, whilst each of the amino 
acids is still represented. This does affect the degeneracy of the genetic code when an 
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NNS substitution is made. For instance isoleucine is represented three times in the 
genetic code by ATT, ATC and ATA but with the NNS substitution only the ATC codon 
is represented. The other advantage of using NNS rather than NNN is the library size to 
statistically represent each codon falls from 64 to 32. This reduces the library size 
required for screening. For a 99% probability of statistically representing each possible 
codon combination in a library is given by the equation in figure 2.4.1.1. The number of 
colonies required for a NNS single site directed saturation mutagenesis is calculated 
from this to be 147 colonies, based on a 99% probability with V = 32 (4x4x2). 
P = 1-e" 
where P = % probability 
N= number of colonies required 
V = total possible number of combination 
Figure 2.4.1.1. Calculation of the percentage probability of representing all possible 
mutations in a total combination size of V. 
2.4.2. Quikchange site directed saturation mutagenesis 
Preparation of the 246 site directed saturation mutagenesis was performed using 
Stratagene's Quikchange kit (3.4.5). The advantage with this method is there is no need 
to gel purify the mutated fragment of DNA from the PCR reaction and has the added 
benefit of no requirement for ligating PCR products into a plasmid. Firstly, two 
oligonucleotide primers are designed to encode the NNS sequence along with flanking 
regions of complementary sequence to allow hybridisation of the primer to the template, 
figure 2.4.2.1. 
Forward primer: 5 '-GGATGCATGGACTGCTTGNNSAGTTATAAGTTCAAGG-3' 
Reverse primer: 5'-CCTTGAACTFATAACTSNNCAAGCAGTCCATGCATCC-3' 
Figure 2.4.2.1. Oligonucleotide primers designed for the NNS saturation mutagenesis 
library at amino acid residue 246 in MAO-N. 
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The next stage is the PCR where the oligonucleotide primers are extended with 
PfuTurbo DNA polymerase completely around the plasmid. The template is subjected to 
Dpn I endonuclease digestion to selectively digest the template (parental) DNA. Dpn I 
endonuclease specifically digests the methylated strand of hemimethylated DNA. The 
template DNA used the PCR is methylated by the dam gene from E. coli and therefore 
susceptible to digestion by Dpn 1 endonuclease. The nucleotides added during the PCR 
are unmethylated and therefore are not digested. The nicked circular plasmid DNA 
incorporating the 246 saturation library was used to transform XL 1-blue competent cells 
which covalently closed the nicked DNA and repaired and propagated the plasmid 
library. The DNA was then ready to be screened and was used to transform the BL2 1 
(DE3) expression strain of E. coli. 
desired mutation site 
parental 	 primers with mutations —20mers 
plasmid 
• primers annealing 
12-18 cycles in PCR 
Digestion of parent DNA by Dpnl 
(i) nick repair 
(ii) transform into E.coli 
Library of site variants 
Figure 2.4.2.2. Summary of the Quikchange method for generating a saturation library at 
246 in MAO-N. Parental (methylated) DNA is represented in red, PCR product in blue 
and saturation mutagenesis site as a green cross. 
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2.4.3. Preparation of 246 saturation library for screening 
After transformation of the nicked DNA into XL1 -blue, 12 colonies were selected at 
random (clones 2a-21) and the nucleotide sequence at 246 analysed by DNA sequencing 
to verify that the library was representative and without bias (3.4.8). Sequencing showed 
a good representation of codons and only one ATG (methionine) from the parent was 
observed, showing that the mutagenesis at 246 was successful, table 2.4.3.1. The third 
nucleotide of all the codons sequenced was either G or C as designed in the mutagenic 
NNS oligonucleotide primer, further validating the success of the mutagenesis. 
Clone 246 codon amino acid 
2a GGC Gly 
2b TCG Ser 
2c TAC Tyr 
2d CCC Pro 
2e AAG Lys 
2f TTG Leu 
2g CGG Arg 
2h ACG Thr 
2i ACC Thr 
2j TGC •Cys 
2k GTC Val 
21 ATG Met 
Table 2.4.3.1. Random sequencing of 12 clones (2a —21) of 246 saturation mutagenesis 
library generated by the Quikchange kit. 
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E. coli XL1-blue competent cells were transformed with the crude DNA product 
yielding 200 colonies from a lml transformation (3.4.7). This exceeded the number 
required to statistically give a 99% probability of representing all 32 possible NNS 
codons. The repaired plasmid DNA was recovered and was used in the transformation of 
E. coli BL21 (DE3) competent cells giving 220 colonies when spread onto nitrocellulose 
membranes on LB agar containing lOOp.g/ml ampicillin. The membranes were then 
assayed against (rac)-amine 76 (MTQ) (3.1.6). After 16 hours, 8 colonies appeared to be 
browner than the rest of the colonies. The 8 colonies were picked and grown in LB 
containing 100tg/ml ampicillin along with the parent MAO-N 2 variant. The plasmid 
DNA was purified from each of the 8 'hits' and the sequencing of the 246 site in these 
mutants all gave the same codon ATG, encoding for methionine. Further confidence that 
the screen was representative of the mutagenesis was obtained by the observation that 
the remainder of the library was significantly slower to react in the solid phase assay 
than the 8 'hits' identified. The ATG codon has a 1 in 32 chance of occurring amongst 
the NNS library; therefore in the library size screened here it should be expected to 
occur on average (1/32) x 220 = 6.9 times. This frequency of average codon occurrence 
matches well with the frequency of the 'hits' that were identified from the screen. 
2.4.4. Screening of 246 saturation library against amine 178 
The screening of the 246 saturation library against (rac)-amine 76 (MTQ) showed that 
ATG methionine was the optimal residue in MAO-N for catalysing the oxidation of 
amine 76. The first round of evolution generated an improved (5)-amine 24 MAO-N 
enzyme (N336S variant) and the second round of evolution generated an improved (5)-
amine 76 MAO-N enzyme (1246M variant); amine 24 and amine 76 are related to each 
other by a core a-methyl benzylamine unit. Amine 76 could be considered to be 
conformationally restricted version of amine 24 by the presence of the amino group 
being locked in a 6 membered ring. Based on this substrate similarity and to further 
probe the active site changes that have occurred with the 246 mutation, other 
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conformationally locked versions of a-methyl benzylamine were examined. Three other 
amines can be drawn based on this concept, each containing the a-methyl benzylamine 
core along with some degree of conformational restriction (figure 2.4.4.1). Amine 178 
was shown from the amine screening to be more active than amine 217, so this was 
selected as the substrate to further screen the 246 saturation library. 
- 	- NH 






Figure 2.4.4.1. Conformationally restricted versions of amine 24. The a-methyl 
benzylamine core is shown in red and additional bonds that reduce the degrees of 
freedom are shown in black. 
Attempts to screen the library with (rac)-amine 178 failed to show any clones with a fast 
enough rate of amine oxidation to be identified. The DAB based peroxidase assay would 
slowly oxidise over several days, so slow reacting colonies would not be detectable as 
their response is not sensitive enough against the background. The exercise was repeated 
with 10 mM (S)-amine 178 rather than 10 mM (rac)-amine 178 to improve the activity 
of any potential clones having a distinguishable improvement in amine oxidation. From 
a library of around 2000 clones many appeared to be reacting, albeit much slower than 
the corresponding screening performed with (rac)-amine 76. The 10 clones (3a-3j) that 
appeared to be browner than the rest were picked and grown in 10 ml LB containing 
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1 OOp.g/ml ampicillin. After overnight growth, the 10 clones had their plasmid DNA 
recovered and sequenced. The results of the sequencing are shown in table 2.4.4.1. 
• 	 Clone 246 codon amino acid 
3a CGC Arg 
3b ATG Met 
•3c ATG Met 
3d ATC Ile 
3e ATC Ile 
3f ATG Met 
3g ATC Ile 
3h ATC Tie 
3i ATC Ile 
31 CGC Arg 
Table 2.4.4.1. Sequencing results of the 10 hits (3a-3j) from (S)-arnine 178 screened 
against the 246 saturation mutagenesis library. 
The sequencing results showed a new active residue at the 246 position, arginine (CGC), 
but the majority of those picked as being the most reactive was methionine (ATG) and 
isoleucine (ATC). This suggests that at the 246 amino acid position the methionine and 
isoleucine residues are the optimal for amine 178 oxidation by MAO-N. The appearance 
of arginine in this list of hits may arise from the low sensitivity of the screen because of 
the inherent low activity of MAO-N variants for amine 178 oxidation. This reduced the 
resolution of this qualitative assay. 
135 
Results and discussion 
2.4.5. Alignment of MAO-N and MAO-B sequences 
The human mono-amine oxidase MAO-B is the most closely related enzyme to MAO-N 
which has a three-dimensional structure available. There is 24% sequence identity and 
43% sequence similarity between the two amino acid sequences and the comparison 
between the two proteins gave a basis for evaluating the changes that have been 
introduced by the directed evolution approach used here. Previously a sequence 
alignment of MAO-B and MAO-N had been carried out by M. Alexeeva' 53 . 
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Figure 2.4.5.1. Schematic representation of pargyline suicide inhibitor covalently 
attached to FAD and bound in the active site of MAO-B 84 . MAO-B active site residues 
are shown in black (aromatic side chains in ellipsoidal frame and others in rectangular 
boxes). Aligned amino acids in MAO-N are shown in red and the 246 aligned residue is 
shown in blue. 
The prediction from the alignment of the amino acids at the active sites of MAO-B and 
MAO-N indicates that isoleucine 246 in MAO-N (shown in blue) aligns with glutamine 
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in MAO-B. The directed evolution of MAO-N towards secondary amine activity led to 
the 1246M change in the enzyme. Based on the homology model of MAO-N and MAO-
B the 246 residue in MAO-N is proposed to be located in the substrate binding cavity of 
the enzyme. The proposed 246 location within MAO-N supports the directed evolution 
of MAO-N towards amine 24 since mutating this residue affected the enzyme's 
specificity. This helps to validate the reliability of the alignment between MAO-N and 
MAO-B. Further confidence of the alignment's accuracy can be provided by the 'hot 
spot' variants identified by M. Alexeeva (table 2.4.5.1). Several of these 'hot spots' 
mutations were found at sites that align in MAO-B to have crucial roles in MAO-B 








relative rate (%) 
wild type 3.0 x 10 2 2.0 x 10 100 
G54 1S 
R494C 
4.0x10 2 1.0x10 3 133 
D385G 0.1 2.0x 10 333 
G4515 3.0x 10.2 9.0x 10-4 100 
M337R 0.2 1.7x10 3 667 
D385A 5.0 x 10 2 1.0 x 10 167 
G403E 8.0x10 2 7.0x10 267 
A289V 1.5x10 2 7.0x10 4 50 
R260K 2.0x10 2 4.0x10 67 
E145K 3.5x10 2 7.0x10 4 117 
N336S 4.5 1.0x10 2 15000 
N336S 
M348K 
4.0 1.0x10 2 13333 
Table 2.4.5.1. 'Hot spot' variants generated from XL1-red mutatagenesis selected from 
the screening of amine 24153. 
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Intriguingly, the lysine 296 in MAO-B this has been shown to compensate for change in 
flavin protonation state and aid catalysis' 62 . Recent saturation mutagenesis studies at 336 
and 337 in MAO-N have shown that the optimal residues at 337 are basic amino acids 
(Toni Fleming personal communication) supporting the hypothesis that the 337 residue 
performs a similar role in MAO-N, as 296 in MAO-B. The N336S M337K substitutions 
gave the greatest improvements in k cat  for (5)-amine 24 in this study and the aligned 
residue for 337 in MAO-B (296) is also lysine, which is responsible for the assistance in 
flavin catalysis. It is important to note that residue 337 is adjacent to residue 336, which 
is the site at which the first generation of MAO-N were mutated (2.2.2). 
Residues at (5)-amine 24 
336/337 in kcat mutant! 
Genotype VMax kcat KM 
MAO-N kcat Wld type 
(jimol/minlmg) 1 (min ) (MM) 
vanants . (mm) 
Ser/Tyr TCC/TAC 7.4x10 2±3x10 3 4.11±0.18 28 11.53±0.96 
Ser/Lys TCG/AAG 0.131±6x10 3 7.28±0.32 50 11.37±0.93 
Ser/Asn TCG/AAC 7.3x10 2±2x10 3 4.06±0.11 28 13.96±0.65 
Ser/Arg AGC/CGG 8.2x10 2±3x10 3 4.55±0.16 31 10.12±0.67) 
Ser/Met AGT/ATG 2.2x10 2±lxlO 3 1. 10±4x10 2 8 16.05±1.08 
(wild type) 
AAT/ATG 3x1 0 3±O 0.15±1x10 2 1 14.43±2.74 
AsnlMet 
Table 2.4.5.2. Optimal residues at 336 and 337 in site directed mutagenesis studies 
(Courtesy of T. Fleming). 
2.4.6. Saturation mutagenesis at aligned active site residues 
The sequence alignment prediction shows that previous mutations in MAO-N have a 
role of forming intimate contacts with the pargyline substrate in MAO-B. It was decided 
to investigate whether a rationalised approach could be employed for further directed 
evolution of MAO-N. 
138 
Results and discussion 
It has been shown that threonine 384 in MAO-N aligns with phenylalanine 343 in MAO-
B. Phenylalanine 343 in MAO-B contributes towards the hydrophobic nature of the 
active site and shelters the aromatic cage. Aspartate 385 in MAO-N has already been 
identified as a hot spot (see table 2.4.5.1) and it has been postulated that its mutation 
effected the active site organisation in MAO-N with respect to the aromatic cage. To 
further investigate this claim and to utilise the apparent reliability of the sequence 
alignment, a double amino acid saturation library was made at residues 384 and 385 in 
MAO-N. Preparation of a 384/385 saturation library has the advantage that because 
these residues are adjacent in sequence, only a single Quikchange reaction is needed to 
produce the variant libraries as both NNS codon changes can be introduced in a single 
oligonucleotide primer. An NNSNNS library is more challenging to screen than a NNS 
library as a larger library of clones is required to statistically represent all possible 
combinations. V (total possible number of combinations) is increased from 32 for a 
single amino acid change to 1024 for a double amino acid change. To have a 99% 
probability of representing all possible combinations, 4695 clones are required (figure 
2.4.1.1.). The size of the library to be screened could be reduced should a single amino 
acid change be made at one site and the optimal residue/residues be used as the parental 
template for the introduction of the second NNS change. The disadvantage with this 
approach is that the two libraries (albeit smaller) need to be screened rather than one and 
synergic benefits between the two sites could be missed. Although a larger library of 
variants are required for the NNSNNS compared to an NNS library, the solid phase 
assay screen can easily handle this increase. 
Two oligonucleotide primers were designed to incorporate the NNSNNS changes in the 
nucleotide sequence corresponding to residues 384 and 385 in MAO-N (figure 2.4.6.1.). 
The Quikchange reaction was carried out following the same method as the 246 
saturation library with some changes in concentration of primers and templates to 
improve yield of DNA product (3.4.6). Examination of the DNA purity by gel agarose 
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electrophoresis after DpnI digestion showed the majority of DNA product corresponding 
to DNA of 10-8 kilobase pairs on the DNA ladder. The DNA product band corresponded 
well to the parental lane indicating the success of the PCR (3.4.2) (figure 2.4.6.2.). There 
appeared to be several other bands present in the Quikchange product, probably arising 
from the digested fragments of the parental template by Dpnl. 
Forward primer: 5'-GGTGTGT11TCGGG\\ JN:GCGAATCATATCCAGC-3' 
Reverse primer: 5' -GCTGGATATGATTCGC \ N ' N N CCCGAAACACACC-3' 
Figure 2.4.6.1. Oligonucleotide primers designed for NNSNNS saturation mutagenesis 
library at 384/385 in MAO-N. 














Figure 2.4.6.2. Quikchange 384/385 saturation mutagenesis DNA product after digestion 
with DpnI. Lane 1 corresponds to 1 kilobase pair DNA marker, Lane 2 Quikchange 
DNA product, Lane 3 parental DNA template and Lane 4 100 base pair marker. 
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2.4.7. Screening of 384/385 saturation library 
In order to maximise the transformation efficiency in the next stage of the library 
generation, the major band corresponding to the nicked plasmid was purified from the 
DNA gel electrophoresis (3.4.3). Electrocompetent XL1 -blue cells were transformed 
with the purified DNA (3.3.3) but gave no transformants. However, transformation into 
supercompetent cells gave an average of 600 colonies per plate (3.4.7). Colonies were 
collected from 20 plates containing on average 600 colonies and the plasmid DNA was 
isolated (3.3.8). Combining all 20 plasmid preparations gave a DNA library size of 
12000 variants which is higher than the 4695 required to statistically give a 99% 
representation of the library. Prior to transformation of E. coli BL21 (DE3) competent 
cells with the variant library of DNA, 20 XL1-blue colonies were picked at random 
(clones 4a-4t) and plasmid DNA sequenced to verify that the mutagenesis had been 
successful, see 3.4.8 (table 2.4.7.1). 
BL21 (DE3) competent cells were transformed with plasmid DNA from the 384/385 
SDM library (3.3.1) giving a transformation efficiency of 800 colonies per plate. Six 
plates containing 800 clones were screened for (rac)-amine 76 (MTQ) activity and after 
24 hours the solid phase assay was examined and the thirteen colonies (5a-5m) deemed 
to be most active were picked (figure 2.4.7.1). The thirteen colonies were grown in 10 
ml of LB containing 100 jig/ml ampicillin and plasmid DNA was extracted (3.4.1). 
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clone 384 codon 384 amino acid 385 codon 385 amino acid 
4a CTG Leu CGC Arg 
4b CCC Pro TTC Phe 
4c CAC His ACG Thr 
4d CGC Arg CAC His 
4e GCC Ala AGC Ser 
4f CCC Pro ACG Thr 
4g ACC Thr GTC Val 
4h TCC Ser GAC Asp 
4i CGC Arg CGC Arg 
4j TAC Tyr TGC Cys 
4k CAC His CGC Arg 
41 GTC Vat CTC Leu 
4m GGC Gly AGC Ser 
4n AGG Arg CTC Leu 
4o GCG Ala CCG Pro 
AGC Ser CTG Leu 
4q GGG Gly * - 
4r ACC Thr CGC Pro 
4s ACC Thr CCC Arg 
4t CAG Gln GTC Val 
Table 2.4.7.1. Sequencing of 20 random clones (4a-4t) of the 384/385 saturation 
mutagenesis library (* poor resolution of chromotagraphy gave unreliable sequence 
data). 
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41111111ft ... - 	- 	- - - 
3 
Figure 2.4.7.1. Screening of 384/385 SDM library against (rac)-amine 76. Colonies 
circled in green were chosen as the most active and picked for further analysis (hits 5a-
5m). 
To verify the activity of the hits which was observed in the initial screen and to ensure a 
single colony was picked, plasmid DNA was isolated from the 13 fermented hits (5a-
5m). This was used to transform E. co/i BL2 I (DE3) competent cells and the screen 
repeated. A control transformation of E. co/i BL2I (DE3) competent cells with the 
parent gene enabled a qualitative assessment of whether the hits show improved amine 
76 activity. At this stage, both enantiomers of amine 76 were assayed separately in the 
solid phase assay (figure 2.4.7.2). 
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Parent 	Se 	Parent 
51 
5m 	 5f 5g 
5j 	Si 	 5c Sb 
5k 	Sb 	5d 	5a 
Parent 
51 
	 5e 	Parent 
Sm 	
Sf 5g 
Figure 2.4.7.2. Validation screen of the 13 hits (5a-5m), including the parent gene in one 
eighth membrane segments. Top two plates are (R)-amine 76 solid phase assays and 
lower two plates (S)-amine 76 solid phase assay. 
The screen showed each of the hits maintained the high degree of(S)-enantioselectivity 
observed in the parent. The qualitative result obtained from the assays showed that the 
hits were all more active than the parent gene. The hit plasmids were sequenced to 
discover the amino acid changes at the 384 and 385 in the mao gene (3.4.4). The 
sequencing results showed all the hits to be variants at both the 384 and 385 positions 
from the parent gene as expected (table 2.4.7.2). At the 384 position there was 
representation of 4 different amino acids, 2 of the 4 are represented in many of the hits. 
There is a preference for serine and asparagine at 384. At 385 there is less of a 
distinctive choice of amino acid with 5 being represented and less bias towards 
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particular amino acids than at the 384 position. Although the amino acids alanine, 
histidine and serine are all represented in several of the hits at the 385 position. 
hit 384 codon 384 amino acid 385 codon 385 amino acid 
5a TCG Ser GCG Ala 
5b TCG Ser CAC His 
Sc AGC Ser TCG Ser 
Sd AAC Asn AGC Ser 
5e AAC Asn CAC His 
Sf TCG Ser GCG Ala 
5g AAC Asn CAC His 
5h GGC Gly GCC Ala 
Si AGC Ser AAC Asn 
5j TCG Ser GCG Ala 
5k AAC Asn GCC Ala 
51 TIC Phe CGC Arg 
Sm TCG Ser AGC Ser 
Parent ACG Thr GAT Asp 
Table 2.4.7.2. Sequence of hits (5a-5m) and the parent gene at the 384/385 codons in the 
mao gene. 
2.4.8. Quantitative analysis of the selected variants 
To quantify the improvements made at the 384 and 385 positions and to select the best 
variants for Michaelis-Menten analysis a liquid phase colorimetric assay was 










• (5)-amine 24 
• (5)-amine 76 
I EJ (R)-amine 76 
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competent cells, each hit was grown in LB containing 100tgIm1 ampicillin and the cells 
harvested then lysed (3.3.5.1 and 3.1.4). The CFE of the lysate was assayed towards 
(rac)-amine 209, (S)-amine 24, (R)-amine 24, (5)-amine 76 and (R)-amine 76. 
5a 	5b 5c 	5d 5e 	5f 5g 5h 	5i 	5j 	5k 51 	5m (P) 
Hit 
Figure 2.4.8.1. CFE screening of (5)-amine 24, (5)-amine 76 and (R)-amine 76 against 
the 384/385 library hits (5a-5m) and (P) = Parent gene. 
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5a 0.290 5h 0.301 
5b 0.270 5i 0.373 
5c 0.201 5j 0.201 
5d 0.260 5k 0.272 
5e 0.240 51 0.0094 
5f 0.303 5m 0.317 
5g 0.151 Parent 0.267 
Table 2.4.8.1. CFE screening of (rac)-amine 209 against the 384/385 library hits (5 a-
5m) (rates shown are in pmol1min1mg). 
Figure 2.4.8.1 shows an overall general improvement in (5)-amine 76 oxidation with 
some variants now showing a higher rate of oxidation against amine 76 than with amine 
24. SDS PAGE analysis of the CFEs for the hits, showed no noticeable difference in 
expression of the MAO-N protein (except hit 51 where no band corresponding to MAO-
N appôared to be present in the CFE). Assaying (rac)-amine 209 showed improvements 
in the oxidation rates amongst the hits although they were generally more modest with 
the best improvement being 1.4 fold rather than the 7.1 fold improvement seen with (5)-
amine 76 (table 2.4.8.1). Hit 5d and hit 5i were selected to investigate the VM ax , KM and 
'cat constants against a panel of selected amines. The hits were chosen because they are 
the most active against (5)-amines 24 and 76, with both showing higher specific 
activities in the CFE assay for amine 76 than amine 24, which has not been previously 
observed. Interestingly, these two amines genotypes are the same AGC (serine) and 
AAC (asparagine) for the two hits, they differ in the fact that hit Sd is 384 asparagine 
and 385 is serine and vice-versa for hit Si. In order to assess the progress in evolution 
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from the wild type MAO-N strain, this exercise was also performed on the MAO-N wild 
type, the MAO-N .1 and the MAO-N 2 variants. 
2.4.9. Michaelis-Menten studies of the MAO-N variants 
To minimise the possibility of discrepancies in the kinetic studies, MAO-N enzyme was 
freshly purified using the previous protocol with a slight modification (3.2.4). The 
modification in the purification procedure was introduced to help stabilise the purified 
enzyme (2.1.4). Each enzyme variant of MAO-N was prepared from fermented E. coli 
and the protein purified following identical procedures (3.3.5.2 and 3.2.4). The assays 
were carried out in unison on a 96-well microtitre plate and specific activities calculated 
for each of the substrate concentrations (substrate range 50mM, 30mM, 20mM, 10mM, 
8mM, 6mM, 4mM, 2mM, 1mM, 0.8mM, 0.6mM, 0.4mM, 0.2mM, 0.1mM, 50j.tM, 
201.iM, 101.iM, 5tM and 1iM). Specific activities for each substrate concentration 
(measured in triplicate) were plotted in the SigmaPlot enzyme kinetics module to 
determine the VMaX  and KM (3.1.5). Protein concentration was measured using the 
Bradford assay (3.2.6) and the k eat  was determined by multiplication of the VMax by the 
molecular weight of the protein (55.6 kDa). Seven amines were selected for 
characterisation, (rac)-amine 209 and 24, (R)-amine 76 and 24 and (5)-amine 76 and 24. 
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Substrate VMax (p.mollminlmg) keat (min- ') KM (mM) 
(rac)-amine 209 0.23±0.30 12.7±16.5 0.30±0.02 
(R)-amine 76 6.2x10±9.5x10 5 3.4x10 2±5.3x10 7.6±3.0 
(5)-amine 76 1.48x10 3±1 .1x10 8.2x10 2±6x10 3 0.14±6.1x10 2 
amine 124 3.0±8.3x10 2 167±4.6 0.37±7.1x10 2 
(rac)-amine 24 5.5x10 3±1.8x10 0.31±1.0x10 2 4.6±0.5 
(R)-amine 24 1 .4x10 3±5.3x10 5 7.9x10 2±2.9x10 3 4.3±0.5 
(5)-amine 24 1.3x10 2±2.3x10 4 0.72±1.3x10 2 1.9±0.1 
Table 2.4.9.1. VMax, keat and KM results for MAO-N wild type. 
Substrate VMaX (jtmollminlmg) kcat (min) KM (mM) 
(rac)-amine 209 2.7±4.3x10 2 150±2.4 0.38±3x10 2 
(R)-amine 76 1 .0x10 3±7.3x10 5 5.6x10 2±4. 1x10 3 0.70±0.30 
(5)-amine 76 2.0x10 2±6x10 4 1 .10±3x10 2 6x10 2±1x10 2 
amine 124 1.3±2.9x10 2 72.1±1.6 0.69±9.1x10 2 
(rac)-amine24 0.108±2.3x10 3 6.01±0.13 1.11±0.11 
(R)-amine 24 1.82x10 3±1.2x10 0.101±7x10 3 3.56± 0.88 
(5)-amine 24 9.6x10 2±1x10 3 5.34±5.8x10 2 1.17±5.0x10 2 
Table 2.4.9.2. VMax, kcat and KM results for MAO-N. I. 
The wild type enzyme had poor activity to all of the amines screened other than amine 
124, the natural achiral substrate, demonstrating the limited amine specificity of the wild 
type enzyme (2.2.2). Introduction of the N336S M348K changes in MAO-N improves 
the kat several fold for all the substrates excluding the natural achiral substrate, where a 
fall in activity is observed. There are very small increases in the (R)-enantiomer turnover 
numbers but the large improvements are seen for the (5)-enantiomer where a 7.4 ((5)- 
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amine 24) and a 13.8 ((5)-amine 76) fold raise was observed. This improvement is less 
for amine 24 than was previously reported ' 53 . The improvement in (5)-amine 24 activity 
is likely to have been underestimated in this case because the kinetic measurements for 
the (5)-amine 24 and (R)-amine 24 were measured on purified protein that had been 
stored for a week at -20°C. During the storage the enzyme may have lost some of its 
initial activity. The kcat of (rac)-amine 24 was measured on the freshly prepared purified 
protein and was raised 20 fold from wild type, supporting the assumption that the (5)-
amine 24 kcat had been underestimated, because of the loss of enzyme activity with 
storage. 
Substrate VMax (.imollmin/mg) kcat (min') KM (MM) 
(rac)-amine 209 1.1 8±3x10 2 65.5±1.8 0.68±9x10 2 
(R)-amine 76 1 .39x 1 0 3±8x 1 0 7.7x 1 0 2±5x 1 0 9.5x 10-2 ±0. 12 
(5)-amine 76 0.103±2x10 3 5.74±9x10 2 0.261±2.2x10 2 
amine 124 1.29±3x10 2 71.9±1.5 2.22±0.17 
(rac)-amine 24 0.108±3x10 3 6.00±0.15 3.36±0.30 
(R)-amine 24 4.5x10 3±9x10 5 0.25±5x10 3 3.34±0.25 
(5)-amine 24 0.25±3x10 3 14.1±0.1 1.98±7x10 2 
Table 2.4.9.3. VMax, kcat and KM results for MAO-N 2. 
The addition of the 1246M mutation does not produce the large changes in turnover 
numbers seen from MAO-N wild type to MAO-N 1. But the activity of MAO-N 
enzyme for (5)-amine 76 was improved over 5 times from the MAO-N ]. variant. 
Comparison of the absolute values measured between those measured here and those in 
section 2.3.6 vary slightly. This could be due to a number of issues including the error in 
fitting the specific activities measured into the Michaelis-Menten type curve by the 
enzyme kinetics module, the error in measurement of the soluble protein concentration 
(2.4. 10) and the differences in the preparation of the MAO-N protein (3.2.3 and 3.2.4). 
Previously it had been observed that the KMS  for the substrates examined rose from the 
MAO-N 1 enzyme to the MAO-N 2 enzyme (2.3.6.1). In agreement with this, all of the 
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KM values have risen apart from (R)-amine 24 with the 1246M mutation with respect to 
the parent (MAO-N L enzyme). 
Substrate VMaX (prnollminlmg) 'cat (min') KM (mM) 
(rac)-amine 209 3.3±5x10 2 182±2.6 0.70±5x10 2 
(R)-amine 76 4.0x10 3±2x10 0.225±1.3x10 2 0.819±0.20 
(5)-amine 76 0.37 l±8x 1 0 20.6±0.4 0.69±6x 1 02 
amine 124 2.0±5x10 2 111±3 2.0±0.2 
(rac)-amine 24 0.284±3x10 3 15.8±0.1 2.95±9x10 2 
(R)-amine 24 1.4x1O 2±3x1O 0.83±2x10 2 5.34±0.34 
(5)-amine 24 O.835±1.1x10 2 46.4±0.6 2.64±0.11 
Table 2.4.9.4. VMax, '(cat and KM results for.MAO-N 3 (hit 5i). 
Substrate VMax (.tmo1Imin/mg) '(cat (min') KM (mM) 
(rac)-amine 209 5.96±0.11 331±6 0.93±7x10 2 
(R)-amine 76 2.3x10 2±3x10 3 1.26±0.15 2.12±0.88 
(5)-amine 76 1.99±4x10 2 111±2 1.7±0.1 
amine 124 6.69±9x10 2 372±5 2.2±0.1 
(rac)-amine 24 0.81±1x10 2 45.3±0.5 3.55±0.12 
(R)-amine 24 2.56x10 2±1x10 3 1.42±6x10 2 4.73±0.59 
(5)-amine 24 1.61±2x10 2 89.7±0.9 3.3±0.1 
Table 2.4.9.5. VMax, '(cat and KM results for MAO-N 4 (hit 5d). 
Much more significant improvements were seen with the MAO-N 3 variant and even 
greater improvements with the MAO-N 4 variant than was seen with the introduction of 
the 1246M mutation into N336S M348K. The MAO-N 4(5)-amine '(cat  values had 
increased even higher than the MAO-N 3 variant. For the first time the MAO-N I 
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variant has a kcat for (5)-amine 76 is higher than (5)-amine 24. There are a 3.4 and 18.5 
fold improvements in turnover for (5)-amine 76 for the MAO-N 3 and 4 variants 
respectively. The trend that was observed with the 1246M mutant is also continued with 
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Figure 2.4.9.1. A typical Michaelis-Menten plot. The example shown here is the activity 
of the MAO-N 2 variant towards (rac)-amine 209. 
152 






—  •l 	V 
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MAO-N variant 
Figure 2.4.9.2. Improvement in the turnover number (k cat) and the catalytic efficiency 
(kcat/KM) in the evolution of MAO-N for (rac)-amine 24 oxidation. 
The catalytic efficiency (kcattKM) is increased between the MAO-N variants during 
directed evolution, but there are much more significant improvements in the turnover 
numbers (shown in red in figure 2.4.9.2) for (rac)-amine 24 oxidation. It is advantageous 
to have a higher turnover number because this should allow a deracemisation reaction to 
be completed more rapidly and at higher substrate concentrations. The lower 
improvements in the catalytic efficiency should not significantly effect the rate of the 
deracemisations (for substrate concentrations >10mM) as most of the KMS measured are 
in the low mM range. In a biotransformation the KM can be considered as the degree to 
which the biotransformation decelerates. Since KM = VM/2, the higher KM the faster the 
rate of deceleration. For instance, if a deracemisation reaction is conducted at 100-
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it starts to approach the KM. Therefore if the biocatalyst's KM is low, e.g. 1-2 mM, the 
rate of oxidation will only start falling near the end of the reaction where it is essentially 
completed. Each of these variants has been examined and shown to maintain a high 
degree of (S)-enantioselectivity. This is beneficial for utilising the optimised MAO-N 
enzyme as a biocatalyst in a deracemisation. 
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Figure 2.4.9.3. Improvement in the turnover number (kcat) and the catalytic efficiency 
(kcatlKM ) in the evolution of MAO-N for (R)-amine 76 and (5)-amine 76 oxidation. 
A similar trend amongst the MAO-N variants in the turnover numbers and catalytic 
efficiency is seen for amine 76 as was observed for (rac)-amine 24. The improvement in 
catalytic efficiency from the first L variant to the optimal MAO-N 4 variant is more 
modest than the much larger gains in the turnover number. But as explained previously, 
as long as the KM remains in the low mM range the increases in the turnover numbers is 
more desirable (rather than improvements in the catalytic efficiency) in order to use this 
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enzyme as a biocatalyst in a deracemisation. The optimal variant now has a significantly 
higher level of activity for (R)-amine 76 oxidation than the wild type with a catalytic 
efficiency now higher than the level measured for the (5)-amine 76 with the wild type 
enzyme. However, this increase in (R)-amine activity should not be a problem in the 
deracemisation of this substrate since the rate of oxidation with the optimal MAO-N 
variant is still heavily in favour of the (5)-enantiomer, with an E-value of over 100. The 
E-factor can now be calculated for amine 24 and amine 76 because the catalytic 
efficiency (kcat/KM) of each enantiomer is known ' 63 . From the E-factor an estimated 
e.e.p. (predicted enantiomeric excess) can be determined 163  based on the relationship 
that e.e.p. = (E-1)/(E+1). As shown in table 2.4.9.6, all the MAO-N mutants will be 
expected to give an excellent final e.e. (>97.5%) in a deracemisation, assuming the 
deracemisation is rapid. 
MAO-N wild type 1 2 3 4 
amine 24 E- 
20.6 161 87.4 113 90.5 
factor 
(R)-amine 
90.8% 98.8% 97.7% 98.2% 97.8% 
24 e.e.p 
amine 76 E- 
131 229 1788 109 110 
factor 
(R)-amine 
98.5% 99.1% 99.9% 98.2% 98.2% 
76 e.e.p 
Table 2.4.9.6. Predicted enantiomeric excesses (e.e.p) using MAO-N biocatalysts in the 
deracemisation of amines 24 and 76 calculated from the measured E-values. 
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2.4.10. Thermodynamic improvements in specificity 
The specificity of an enzyme for a substrate is determined by the specificity constant 
(kcat/KM). This is the ability of an enzyme to discriminate a particular substrate from a 
mixture of substrates. In deracemisation reactions where the two substrates are 
chemically equivalent, but opposite enantiomers of a racemate, the specificity is 
determined by the E-factor. Transition state theory suggests that the energy barrier that 
needs to be overcome to achieve catalysis is given by AG. Enzymes normally achieve 
rate accelerations compared to the uncatalysed reaction by lowering the transition state 
energy of the high energy intermediate. It is catalytically advantageous for the enzyme's 
active site to be complementary to the structure of the transition state because it lowers 
the free energy of this species, thus reducing 	If the enzyme's active site is 
complementary to the structure of the substrate prior to conversion, the free energy of 
the ES complex is lowered, thereby increasing AG. 
AG 
Reaction Coordinate 
Figure 2.4.10.1. Gibbs free energy changes when the enzyme's active site is 
complementary to substrate (blue line) and to transition state (red line). 
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Enzymes can generate differences in substrate specificity by selectively binding the ES 
complex of a substrate more efficiently than the opposite enantiomer which reduces the 
free energy of ESI thus reducing 	This substrate selectivity generated by enzymes is 
shown in figure 2.4.10.1. In red the free energy of ES is raised and ES lowered, to 
lower LG and hence increasing specificity and in blue the free energy of ES is lowered 
and ESI is raised, thereby increasing AG. The free energy barrier of the transition state 
is given by: AG = AGbjndjng  + LGAC t (figure 2.4.10.2). AGhi nding is the energy 
contribution on binding the substrate and AGA Ct is the activation energy required to 
reach the free energy of the transition state ESt.  The  AAGt  between two enantiomers (A 
and B of a racemate) is given by: 
E = [(kcat/KM)A/(kcat/KM)B] = exp (-AAGIRT) 
AAGI can be considered as the difference in free energy required for catalysis between 
the 2 enantiomers, i.e. the enantioselectivity of an enzyme. 
AG 
Reaction Coordinate 
Figure 2.4.10.2. The free energy (AG) of an enzyme catalysed reaction is contributed by 
the binding energy (AGbj ndjng) and activation energy (AGA c). 
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It is possible to estimate the contribution of binding energy"' of the ES complex using 
the KM value; z\Gbjndjng = -RT In KM. If this is performed on both enantiomers of a 
racemate then the difference in binding energy (AAGbi nding) between enantiomer A and 
enantiomer B is given by: 
ALGbinding = -RT In [Km (A)/K m (B)1 
Using these relationships the differences in free energy and the kinetic constants k eat and 
KM allows the L\AGbinding and AAGt  to be calculated between the (5)-enantiomer (A) and 
(R)-enantiomer (B) of amine 76 for the MAO-N variants. [N.B. E-factor = 
(kcat/KM)A/(k cat/KM)B]. Note that the errors have not been included in the calculated 
values shown in table 2.4.10.1. If errors are calculated based on the error values of k eat 
and KM measured in tables 2.4.9.1, 2.4.9.2, 2.4.9.3, 2.4.9.4 and 2.4.9.5 then the 










wild type 131 0.0184 +10.1 -12.3 
I 	- 229 0.0857 +6.2 -13.7 
2 1788 2.75 -2.6 -18.9 
3 109 0.842 +0.434 -11.8 
4 110 0.802 +0.556 -11.8 
Table 2.4.10.1. Differences in energy of binding (AAGbjfldjfl g) and activation energy 
(AAG) for the (S)-enantiomer and (R)-enantiomer of amine 76 amongst the MAO-N 
variants. (RI = 2.52 1 kJ/mol at 30°C, the assay temperature). 
The difference in activation energy (AAG) between the (5)-amine 76 and (R)-amine 76 
for all the MAO-N variants is between -11.8 and -18.9 kJ/mol. On a molecular level, this 
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difference of activation energy between the MAO-N catalysed oxidation of the amine 76 
enantiomers is slightly less than the strength of an average hydrogen bond (hydrogen 
bonds are typically —20 kJ/mol in strength ' 65). The MAO-N 2 variant has the greatest 
difference in activation energy between the enantiomers but is the only variant to show a 
negative value for AAGbjndjng. The negative value for AAGbi nding results from the AGbi nding 
being lower for the (S)-enantiomer than the (R)-enantiomer. The other MAO-N variants 
have positive values for AGbi nding which contributes to the enantioselectivity for these 
variants. The enantio selectivity observed for the MAO-N 2 variant does not result from 
the contribution Of AGbi nding  but entirely from AAGI and relative stabilisation of the ES 
complex for (5)-amine 76. 
The wild type enzyme shows the highest degree of difference in energies of binding 
(AAGbinding) between the enantiomers of amine 76 with the ES complex for the(R)-
enantiomer being greater than 10 kJ/mol more stable than for the (5)-enantiomer. The 
enantioselectivity seen in wild type MAO-N is largely generated by poorer specificity of 
the active site for the (S)-enantiomer which raises the ES free energy and therefore 
reducing AGI relative to the (R)-enantiomer. The differences in energies in enantiomer 
binding in the ES complex for the quintuple MAO-N variants are small. 
Enantio selectivity for these two variants is mainly created by stabilisation of the (5)-
amine 76 transition states. 
MAO-N LAGbinding 
kcat/KM KM 
variant (kJ/mol) (kJ/mol) 
1 18.3 0.06 
+3.70 -0.46 
2 22.0 0.26 
Table 2.4.10.2. The AAGbinding  and AG between MAO-N I and MAO-N 2 variants for 
the (5)-amine 76 catalysed oxidation. 
The final two columns of table 2.4.10.2 shows the MGbid 5 and AAG for the MAO-N 
1 variant when the 1246M mutation is introduced. The 1246M mutation gave an 
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improvement in (5)-amine 76 catalysis compared to MAO-N 1 variant by less efficient 
binding of the substrate. There is a slight decrease in LG which assists in (5)-amine 76 
catalysis, but the main contribution is from the AGbindi,g  which can be considered to be a 
result of destabilisation of the ES complex caused by the 1246M change. 
2.4.11. Error in measuring protein concentration by the Bradford assay 
It is important to consider the potential errors that may have arisen in calculating 
Michaelis-Menten constants for the MAO-N variants, one source of error being the 
measuring of the protein concentration in the assays. The error in measuring the protein 
concentration by the Bradford assay can be estimated by taking multiple readings of a 
sample (3.2.7). The estimation of error for a measured VMax  based on the error in 
measuring the protein concentration can be calculated using the upper and lower error 
limits of the measured protein concentration. 95% confidence that the true value of the 
protein concentration can be estimated to be within 2 standard deviations from the mean. 
The mean protein concentration is calculated to be 0.236 mg/ml ± two standard 
deviations (2 x 0.047) for the MAO-N 4 variant. Recalculation of the VMaX  with the 
lower and upper protein concentrations gives the values shown in table 2.4.11.1. 
Soluble protein VMaX 
Estimate 
(mg/ml) (imol/minlmg) 
0:142 Lower estimate 4.26 
0.236 Mean estimate 5.96 
0.330 Upper estimate 9.91 
Table 2.4.11.1. Upper and lower error limits of the VMaX measured for the (rac)-amine 
209 catalysed oxidation by the MAO-N 4 variant. 
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The error in measuring the protein concentration using the Bradford assay generates a 
much higher error than is caused by the fitting of the rates by SigmaPlot's enzyme 
kinetics module. N.B. the KM remains unaffected by errors in measuring the protein 
concentration. 
2.4.12. Molecular modelling of MAO-N 
To gain a greater insight into the changes that have occurred within the structure of 
MAO-N during the evolution from wild type to the optimised MAO-N 4 a homology 
model was developed (U. Grogan, York). The basis of this homology model is taken 
from the three dimensional structure of MAO-B where the crystal structure has been 
solved 84 . The related MAO-N sequence is then overlaid over this model and a force field 
applied to minimise the potential energy of the system, in this case the CHARMM 
(Chemistry at HARvard Molecular Mechanics) force field was used. 
The predicted model generated by this approach (shown in figure 2.4.12.1) has been 
coloured to highlight the location of the mutated residues that have led to changes in 
MAO-Ns catalytic performance. The residues that have been shown to affect catalysis 
are shown in green, the FAD cofactor in red and the remaining residues are shown in 
white. From the model of the overall enzyme structure it becomes apparent that all of the 
mutated residues that influence MAO-N catalysis are in the vicinity of the part of the 
enzyme where catalysis is carried out, i.e. near the FAD cofactor. 
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Figure 2.4.12.1 The CHARMMEI) model of MAO-N from Aspei gil/us niger with 
residues in green identified to influence the catalytic properties of MAO-N and the 
flavin cofactor is shown in red. 
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It became apparent when viewing the model in three dimensional perspective (using 
Insight II Accelrys on a Silicon graphics computer) that there were two important 
features that regulate catalysis in MAO-N. The active site was identified as being 
immediately adjacent to and beneath the isoalloxazine ring of flavin. Isoleucine 246 was 
an integral part of the residues that comprise the active site. The other important feature 
was a cavity leading from the surface of the enzyme through to the active site. This 
appeared to be an access channel which could allow a substrate molecule to pass from 
the bulk solvent to the active site. An access channel for substrate admittance into an 
enzyme active site is a feature exhibited by some enzymes to regulate their activity. 
Cytochrome P450s have been shown to have a channel opening mechanisms which are 
adjusted to the physiochemical properties of the substrate, which can kinetically 
modulate protein-substrate specificity 166. In particular the catalytic activity of 
cytochrome P450 BM3 has been shown to be highly regulated by amino acid residues 
which flank the surface and heme end of the enzyme access channel. The F87V active 
site mutation in cytochrome P450 BM3 converted the activity to a regioselective and 
stereoselective arachidonic acid epoxygenase' 67 . 
Threonine 384 and aspartic acid 385 are not in the vicinity of the active site and so 
cannot directly alter the active site specificity; however it became evident that these two 
residues were at the entrance site of the access channel. The 384 and 385 residues were 
found to be on a loop structure and not involved in structurally important secondary 
structure of the protein such as an a-helix or a n-sheet. There found to be several of 
these loop features immediately surrounding the access channel. The residues that 
constitute these loops may give further potential for exploring the access channel 
because if they are involved in regulating substrate access into the active site it is 
reasonable to expect that mutation of these residues would influence catalysis. 
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The suggestion that the 246 residue is at the active site could explain the effect that the 
1246M variant had on amine catalysis. The 1246M variant generated specificity for (S)-
amine 76 whilst for amine 124 and amine 24 the improvements in catalysis were only 
marginally improved. The change with the 246 mutation specifically benefits (S)-amine 
76 oxidation. The mutation and screening of the 384/385 saturation library identified 
variants with improved (S)-amine 76 catalysis. Subsequent kinetic characterisation 
showed the optimal variants not only having improved activity for (S)-amine 76, but also 
to the other amines examined (2.4.9). This evidence supports the hypothesis that the 
384/385 residues are controlling substrate access since improvement of substrate access 
would be more likely to be beneficial to more substrates. 
Access 
*&*, I  
Active site 
Figure 2.4.12.2. The locations of the active site and substrate access channels in the 
MAO-N model. The loop regions located at the entrance of the access channel shown in 
red, pink and blue. The lower blue loop corresponds to the 246 residue and flavin is 
shown in ball and stick. 
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Energy minimisation manual docking of (5)-amine 76 structures into the model allowed 
further insight into how the mutation of 246 from isoleucine to methionine could cause 
improvement in catalysis for this substrate. The amino group of (5)-amine 76 was fixed 
within 5A of N-5 of flavin since it would need to be within this locality during 
oxidation. It was evident that the methyl branch of the isoleucine side chain was within 
van der Waals contact distance of the methyl group of (5)-amine 76. Mutation of residue 
246 to methionine may accommodate the methyl group of (5)-amine 76 more efficiently 
than isoleucine of the wild type enzyme because methionine lacks substitution at the P - 
position of its side chain. Other naturally occurring amino acids also lack 3-substitution 
in the side chain but they were not identified as improving (5)-amine 76 catalysis during 
the screening experiment (2.4.3). Presumably this is due to the necessity to maintain a 
hydrophobic environment at the active site which would exclude hydrophilic residues 
(1.3.1) and the remaining hydrophobic residues (Gly, Ala, Leu and Pro) have side chains 
that are either too small or are somehow detrimental to the organisation at the active site. 
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Figure 2.4.12.3. MAO-N model with (5)-amine 76 docked. Locations of residues 246, 
336, 384, 385 and flavin shown with all other residues removed for clarity. Interatomic 
distances shown (A). 
2.4.13. Conclusion 
Exploration by site directed mutagenesis of the 246 amino acid in MAO-N was 
necessary because of the limitations in screening with the XL 1-red generated DNA 
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libraries. Saturation mutagenesis found the methionine variant at 246 in MAO-N 
discovered by the random approach (2.3.3) was actually the optimal residue when the 
saturation library was screened against (rac)-amine 76. Screening of the same DNA 
library against amine 178 showed that methionine as well as isoleucine and arginine 
were selected as hits in this substrates screen. Alignment of the MAO-N and MAO-B 
sequences showed that the 246 position in MAO-N aligns to be glutamine 206 in MAO-
B. The published crystal structure shows that glutamine 206 in MAO-B to be located at 
the active site of this enzyme. 
The 384 amino acid residue in MAO-N is also aligned to be at the active site 
(phenylalanine 343 in MAO-B) so a 384/385 site directed mutagenesis saturation DNA 
library was prepared. After initial difficulties in obtaining enough transformants to 
represent the library, 13 hits were selected from screening variants against amine 76. 
CFE screening of the hits showed improvements amongst all the hits in amine 24 and 
amine 76 catalysis, whilst still maintaining the high (5)-enantioselectivity (except hit L 
which failed to express MAO-N during fermentation). Hits 5d and 5i were selected for 
further examination and characterisation by Michaelis-Menten kinetics. Improvements 
in kcat were found to be 19.3 and 3.6 times higher for (5)-amine 76 turnover for hit 5d 
(MAO-N 4 variant) and hit 5i (MAO-N 3 variant) respectively compared to the MAO-N 
parent. The optimal MAO-N variant for amine 76 oxidation (variant 4) has over a 
1300 fold improvement for (5)-amine 76 turnover compared to MAO-N wild type. By 
measuring the keat and KM,  the E-factor can be calculated and based on these values 
MAO-N should be expected to give high to excellent enantiomeric excesses to the (R)-
amine product in a deracemisation reaction. The changes in activation energy (AG) and 
free energy of substrate binding (AGbi nding) have been investigated. The thermodynamic 
causes of the changes amongst the MAO-N mutants' enantioselectivity and catalytic 
performance for the enantioselective oxidation of amine 76 have been suggested. 
Modelling of the MAO-N sequence onto the published MAO-B structure suggests that 
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the mutated residues are either positioned at the active site or control access into the 
active site of the enzyme. Investigation into the accuracy of the Bradford assay showed 
there to be a high level of error using this method to measure the soluble protein 
concentration. 
2.4.14. Future work 
The 246 saturation library was screened against amines 76 and 178 giving methionine as 
the optimal amino acid residue for amine oxidation by MAO-N. Is methionine the 
optimal residue for other amine substrates or if this library were to be tested against 
other amines would a different optimal residue occur? The crystal structure alignment 
prediction between MAO-N and MAO-B has several residues, that when mutated in 
MAO-N, cause a change in MAO-N specificity and in its catalytic performance. It is 
therefore reasonable to assume that by using the active site alignment model (figure 
2.4.5.1) those other residues that are located at the MAO-B active site in the crystal 
structure could be used to identify MAO-N active site residues. Optimisation of MAO-N 
catalysis for the 384/385 saturation library should be carried out for different substrates 
in a similar fashion to the 248 saturation library (2.4.7). A relative rate screening 
exercise should be undertaken for the MAO-N 4 variant to establish whether this variant 
enzyme has similar substrate specificity as the earlier versions of variant MAO-Ns? 
It would be interesting to see where or if there are limitations in the capability of the 
directed evolution strategy for improving MAO-N for use as a biocatalyst in 
deracemisations. In the work conducted here, a 1300 fold improvement in turnover from 
wild type to the optimised enzyme has been achieved for the (S)-amine 76 oxidation, 
could a similar achievement be possible with a substrate that currently has very poor 
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specificity? In future work it will probably be better to use an alternative method to 
measure the soluble protein concentration such as 	or using the absorbance of 
MAO-N's cofactor flavin because of the large inaccuracies in the Bradford assay 
(2.4.11). 
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2.5. Screening of reducing agents for reductions of imines 
In order to achieve the efficient deracemisation of a racemic amine using a cyclic 
oxidation and reduction sequence the oxidised product imine must undergo a chemical 
reduction to return the imine intermediate to the amine. Previous work in the area of 
amine deracemisation used ammonia borane to undertake this reduction 64 . Although this 
approach gave moderate degrees of success, it was apparent that the imine intermediate 
in the deracemisation reaction under went a competing hydrolysis reaction. An 
investigation into the reduction of imines was carried out to evaluate other reducing 
agents that could be used in place of ammonia borane. The goal was to identify reducing 
agents that could rapidly reduce an imine and thus minimise hydrolysis. The advantage 
of examining the reduction step independently in the deracemisation cycle of oxidation 
and reduction was that the performance of the reducing agents can be directly measured 
which is not possible in a deracemisation. The imine 1-methyldihydroisoquinoline 224 
(MDQ) corresponding to the oxidation of amine 76 was commercially available and 
therefore this substrate was selected for investigation. 
2.5.1. The screening of reducing agents 
To compare the relative reactivity of various reducing agents a 10mM solution of imine 
substrate 224 (MDQ) in aqueous buffer was screened against a selection of reducing 
agents (figure 2.5.1.1). Ten equivalents of the reducing agent were added to each 
reaction and for reducing agents which did not completely dissolve in aqueous buffer; a 
minimum amount of cosolvent was added to assist in dissolution (3.5.1). 
iI1IIIIIN reducing agent 	NH 
224 	 76 
Figure 2.5.1.1. The screening of reducing agents for the reduction of MDQ imine 224. 
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The amount of imine remaining after 24 hours was measured by reverse phase HPLC 
(3.7.4). The reducing agents were classified into two groups depending on their 
performance in the screen; those that reacted slowly and those that reacted quickly. The 
amount of imine convert to MTQ (amine 76) after 24 hours is given in table 2.5.1.2 for 
the slowly reacting group of reducing agents. 
[ 	COl NaBH [ 	CO2] NaBH 	 Me 







Reductant-225 (3%) 	Reductant-226 (6%) Reductant-227 (21 %)Red uctant-228 (27%) 
N Me2 
NH20H:BH3 	[ cBH2:NMeJ 
2 	BH3NH2 	
N 
BH3  NH2 
Reductant-229 (18%) Reductant-230 (11%) Reductant-231 (82%) Reductant-232 (53%) 
Figure 2.5.1.2. Conversion to MTQ (amine 76) after 24 hours with 10 equivalents of the 
reducing agent. 
The reducing agents shown in figure 2.5.1.2 were found to react slowly with the imine 
substrate. These will not be useful in the deracemisation because the rate of reduction is 
too slow and therefore they were not investigated any further. However, the set of 
boranes shown in figure 2.5.1.3 are faster and showed complete imine reduction in 24 
hours under the same reaction conditions. For these reducing agents the reactions were 
monitored by regular sampling in order to follow the rate of imine reduction and to 
evaluate which of these reducing agents produced the fastest rate of imine reduction. 
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NH3BH3 U N 	N 
H N 
BH3 OH BH3 
Red uctant-233 Reductant-234 Reductant-235 
OH 
 ç:L 	
N H Me 
6H3 	 6H3 OH 	YH3  
Reductant-236 Red uctant-237 Reductant-238 
Figure 2.5.1.3. Chemical structures of the reducing agents showing fast imine 
reductions. 
2.5.2. Monitoring the time course of reactive boranes 
Figure 2.5.2.1 shows that there are 2 amine boranes (reductants 235 and 236) that have 
superior rates of imine reduction than the previously reported ammonia borane 
(reductant-233) that was used in the deracemisation of (rac)-amine 24 (M. Alexeeva et 
al, Angew. Chem., (2002) 41, 3177-3180). There appears to be an effect in the chemistry 
of the reductants, with the only differences in the structure of reductant 232 and 237 
being the 2-position of the pyridine which is changed from aminomethyl to 
hydroxymethyl. The increased electronegativity from nitrogen and oxygen or the 
difference in pKa between the two functional groups may give rise to the improvement 
in chemical reactivity in the reduction. Further studies within the group 168  have shown 
that as little as 0.7 equivalents of reductant-235 afforded the complete reduction of 
10mM imine 224 in just 30 minutes. Although ammonia borane showed a lower 
reactivity than reductant-235, complete imine reduction was observed in 24 hours with 1 
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0 	0.5 	1 	1.5 	2 	2.5 	3 
Time (hours) 	
x red uctant 238 
Figure 2.5.2.1. Time course monitoring of the rate of imine reduction with the fast 
reacting group of reducing agents (reductant 237 shown complete imine reduction in 24 
hours). 
2.5.3. Conclusion 
To investigate the inherent problem of hydrolysis in the deracemisation a reducing agent 
screening was carried out. The reducing agents were classified into two main groups fast 
and slow reacting depending on the amount of imine remaining in the reduction after 24 
hours. The fast reacting group were further examined by time course monitoring and two 
other boranes were shown to react faster (reductants 235 and 236) than the previously 
reported reductant-233 (ammonia borane). 
2.5.4. Future work 
Other reducing agents could be incorporated into the screening for the chemical 
reduction of imines (2.5. 1) to see if any faster reducing agents could be found. Future 
X reductant 223 
X reductant 234 
—X reductant 235 
—X-- reductant 236 
—)( reductant 237 
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screens could examine the stoichiometry of reducing agents required in order to reduce 
the inhibitory effect of the amine boranes in MAO-N catalysed amine oxidations 
(2.6.11) whilst not compromising the imine reduction efficiency. There are few imines 
commercially available and this is partially due to their inherent instability, but it would 
be useful to perform the screening on other imines, especially for imines corresponding 
to amine substrates that are already known to be active towards current MAO-N 
variants. 
It maybe advantageous to look for a biological route to achieve the chemical reduction 
because the likelihood is that an enzymatic reduction of the imine would not inhibit the 
MAO-N oxidation as the reductant is not present in the bulk solvent. There is a 
precedent for this in keto-reductions; fungal oxidoreductases have been used for the 
asymmetric reduction of 13-ketoesters to the corresponding chiral alcohol' 69  Early work 
has been conducted in employing the anaerobic bacterium Acetobacterium woodii in a 
dynamic combinatorial library to discover new imine reductase activity 170  (figure 
2.5.4.1). An imine reductase could offer the opportunity to engineer the compatibility of 
the enzyme by directed evolution to suit substrate specificity and enantioselectivity. 
R' NH2 	+ 	 - RN R 
A. woodii 
R_N R 
Figure 2.5.4.1. The discovery of novel imine reductase activity by Acetobacterium 
woodii using a dynamic combinatorial library. 
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2.6. Deracemisation experiments 
2.6.1. Deracemisation objectives 
Directed evolution has been used to engineer MAO-N towards the desired goal of 
achieving successful amine deracemisations. To evaluate the success of the 
improvements in MAO-N for deracemisation purposes, a series of deracemisation 
experiments were conducted. Prior to the work described here, only (rac)-amine 24 had 
been deracemised with a high e.e. but in a moderate yield, due principally to the unstable 
irnine being hydrolysed 64 . The early amine 24 deracemisation had been attempted at a 
low substrate concentration (1mM substrate) and had only been monitored analytically 
by chiral HPLC. Could the deracemisation of amines be conducted at higher substrate 
concentrations and preparatively? Unless indicated during the deracemisation studies 
conducted here the MAO-N 2 variant was used. The selection pressure used in the 
directed evolution of MAO-N to identify the 1246M change was made by its ability to 
oxidise MTQ (amine 76) enantioselectively, therefore this substrate appeared the best 
candidate to conduct preliminary deracemisations. The advantage with using this 
substrate rather than cx-methylbenzylamine (amine 24) is the hydrolysis problem 
associated with amine 24 should not affect MTQ (amine 76) to the same degree because 
the imine intermediate is more stable. 
2.6.2. Deracemisation of (rac)-MTQ with whole cell expressing MAO-N 
To investigate the deracemisation of (rac)-MTQ (amine 76) a trial reaction was 
attempted using whole cells. The advantage of a whole cell reaction is there is no 
requirement to purify the enzyme post-fermentation. It is merely a case of adding the 
required portion of the harvested cell pellet required for the reaction. The disadvantage 
is that fermentation variability in the recombinant protein expression can led to 
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differences in the level of performance of a whole-cell biotransformation. However, due 
to the simplicity of a whole cell reaction this was a simple starting point to investigate 
the deracemjsatjon of(rac)-amine 76. A solution of lOml of 10mM (rac)-MTQ (amine 
76) was successfully deracemised over 24 hours at 30°C with 0.5 g of freshly thawed 
whole cells (3.6.2). Analysis by chiral HPLC (3.7.1.B) determined the deracemisation to 
be >99% e.e. with a yield of 69% for (R)-MTQ (amine 76). 
Red = initial racemate 
WO 
	 Blue = reaction after 24 hours 





2 	 4 	 6 	 8 	 10 	 12 	 14 	 16 	 mu 
Figure 2.6.2.1. Chiral HPLC trace of the whole cell deracemisation of(rac)-MTQ 
(amine 76). Red line is the t = 0 hour sample and the blue line is the t = 24 hour sample. 
Time course monitoring of the deracemisation showed the reaction to decelerate towards 
the end of the reaction as expected (figure 2.6.2.2). The KM for this enzyme is 0.31mM 
for (5)-amine 76 so once the substrate concentration falls to this concentration the 
enzyme will be operating at half its maximum velocity (VM ax). In a 10mM 
deracemisation when the (5)-amine 76 is at a concentration of 0.31mM this corresponds 
to a 93.8% e.e. of the (R)-enantiomer in the reaction, although in reality, the turnover of 
the enzyme will start falling before it reaches the KM concentration After 48 hours the 
(R)-MTQ (amine 76) e.e. has risen to >99.5% with a yield of 84.9%, compared to a 
98.5% e.e. and 97.6% yield after 29 hours. 
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Figure 2.6.2.2. Time course monitoring of the deracemisation of 10mM (rac)-MTQ 
(amine 76) to (R)-MTQ (amine 76). 
2.6.3. Deracemisation at higher substrate concentrations of (rac)-MTQ (amine 76) 
with whole cell expressing MAO-N 
The deracemisation of(rac)-MTQ (amine 76) was achieved at 10mM substrate 
concentration, the next objective was to determine what concentration of substrate can 
be deracemised under similar conditions (3.6.2). In this study the amount of whole cells 
added to each of the deracemisations was varied to see whether this improved the e.e. of 
the deracemisation. This experiment was performed as described (method 3.6.2) but 
with adjustments in the amount of cells and substrate used as indicated (figure 2.6.3.1). 
As seen in figure 2.6.3.1 the deracemisation of (rac)-MTQ (amine 76) at 10mM was 
virtually completed with 0.59g of whole cells. The e.e.s for the 20mM deracemisations 
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cells. The 40mM reaction also showed a similar improvement but the e.e. did not 
improve from the 93% observed with 1.2g of whole cells. 
0.33 	0.59 	 1.2 	 1.6 
whole cells (g) 
Figure 2.6.3.1. The deracemisation of higher (rac)-MTQ (amine 76) concentrations with 
various amounts of whole cells after 40 hours. 
2.6.4. Immobilisation of MAO-N 
Early results indicated that the deracemisation of (rac)-MTQ (amine 76) worked well 
using the MAO-N in whole cell form from the fermentation harvest of recombinant E. 
coli. However, the use of whole cell in a biotransformation has several drawbacks which 
maybe alleviated with an immobilised enzyme. An immobilised enzyme can avoid the 
problems of diffusion limitations of substrate and loss of product by side activity that 
can occur with a whole cell process. Whole cell processes tend to pose difficulties with 
the workup of the reaction, emulsions can occur upon extraction of the aqueous reaction 
into an organic solvent. If an immobilised enzyme were to be used it could be recovered 
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and potentially reused. The other attractive features about an immobilised enzyme are 
that often it stabilises the protein and lengthens the life of the biocatalyst. As a simple 
protocol has been developed for purifying MAO-N (2.1.3) it was decided to investigate 
the immobilisation of purified MAO-N protein. 
Within the group Eupergit had previously been used and it was available in the lab this 
was selected to be the immobilisation method attempted. Successful applications of 
other immobilised enzymes has been reported with Eupergit, including an enzyme from 
the same species as MAO-N, Aspergillus niger' 71 . The matrix of Eupergit is formed 
from the copolymerisation of methacrylamide, N,N'-methylene-bis(methacrylamide) and 
monomers containing oxirane groups. The oxirane groups are the reactive chemical 
groups that irreversibly attach to the protein via a covalent linkage with the proteins 
amino and sulthydryl groups. 
2.6.5. Immobilisation of MAO-N on Eupergit 
In order to establish the efficiency of MAO-N immobilisation on Eupergit the uptake of 
enzyme onto the resin was monitored by the loss of enzyme activity from the buffer 
solution. This gave a quick and convenient method to follow the progression of the 
immobilisation. Table 2.6.5.1 gives a typical immobilisation of MAO-N on Eupergit. 
The MAO-N was assayed towards amine 124 because MAO-N has a high level of 
activity for amine 124 oxidation making the monitoring of the progression of 
immobilisation more rapid and reliable. The assay was carried out as described (3.1.7). 
During each immobilisation reaction a control immobilisation was performed with a 
protein sample that had no Eupergit added. Typically in a 30ml immobilisation volume, 
a 1 OOj.il aliquot was removed and placed in the blood rotator alongside the 
immobilisation. Therefore if loss of MAO-N resulted from denaturation, loss of cofactor 
or proteolysis, this could be monitored through the control reaction. 
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0 0.0208 OD/sec 100% - - 
24 0.0200 OD/sec 96% 0.00795 OD/sec 38% 
42 00198 OD/sec 95% 0.00122 OD/sec 6% 
Table 2.6.5.1. Monitoring of MAO-N immobilisation onto Eupergit by monitoring the 
loss of amine 124 activity in solution. 
Once the residual MAO-N activity in the immobilisation had fallen below <5% of the 
initial activity the resin was capped with 3M glycine pH 8.5 to react any 
unfunctionalised oxirane groups on the resin (3.6.4). 
2.6.6. Calculation of the - activity of MAO-N activity on the resin 
To monitor the immobilisation the loss of MAO-N activity from solution was measured. 
However, does the loss of MAO-N activity from solution translate to a complete 
recovery of activity to the resin? Often during an immobilisation procedure the overall 
enzyme activity will fall to varying degrees as a result of attachment of enzyme to the 
resin; this can impede the substrates access to the active site and/or cause detrimental 
global changes in the conformational structure of the enzyme. The method by which the 
enzyme is attached to Eupergit is by accessible nucleophilic side chain residues in 
MAO-N that chemically react with the epoxide group on the resin. This process is not 
selective and will inevitably cause some loss in enzyme activity. There is also the 
physical change that can affect the biocatalytic properties of the enzyme (diffusion and 
substrate permeability effects) from going from solution to solid phase. 
To account for these changes a solid phase assay was developed to measure the MAO-N 
activity on Eupergit (3.1.7). Initial attempts at a continuous assay approach that had been 
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used previously in the solution phase (3.1. 1)  failed because of the problem of product 
diffusion. In a lml cuvette, the resin would sink to the bottom of the cuvette and the 
colourimetric red product would sit just above the resin as a dark pink band. As the 
colourimetric product was not evenly distributed through the cuvette the rate of amine 
oxidation could not be accurately measured. Instead, a discontinuous assay was required.. 
A weighed portion of the resin, typically 1-4 mgs, in a imi eppendorf tube was assayed 
after 4 minutes, 3 x 200p1 of the assay mixture was removed and the OD iønm measured. 
Division of the mean OD of the three measurements by 240 gave the rate in OD/sec; this 
is then used to calculate a specific activity for the resin (3.1.7). In table 2.6.6.1 is an 
example of the resin specific activity measured in the preparation of the immobilisation 
from table 2.6.5.1. 
Amount of resin Mean OD510nm Specific Activity 
0.0017g 0.186 / 240 = 7.75 x 104  Au/sec 1.752 i.moI/min/g 
Table 2.6.6.1. Measurement of the specific activity of MAO-N-Eupergit activity towards 
10mM amine 124 
From the measurement of the immobilised MAO-N activity the percentage recovery of 
MAO-N activity from the immobilisation can be calculated and was determined to be 
2%. [This based on the total rate of the freshly purified being 521.7 OD/sec for the 30ml 
sample and a total activity of 10.41 OD/sec for the total mass of resin used in the 
immobilisation (22.88 g)].  This efficiency of immobilisátion appeared to be poor; 
however it was used in subsequent deracemisation experiments. 
2.6.7. Evaluation of immobilised MAO-N stability 
During initial studies with immobilised MAO-N it became apparent that activity was 
being lost upon storage. To establish the amount of activity being lost and to find the 
optimal conditions for MAO-N-Eupergit storage a stability study was undertaken. 
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MAO-N-Eupergit samples from the same preparation were stored at room temperature, 
4°C and -20°C. Samples were stored with and without 0.1M potassium phosphate buffer 
pH 7.0 to determine whether this influenced the longevity of MAO-N activity. Activity 
was measured after 4 weeks storage (3.1.7) and residual activity is determined by 
comparison to the specific activity of the freshly prepared MAO-N-Eupergit (1.752 
tmolImin1g). The results (table 2.6.7.1) seem to indicate that the best storage 
temperature is at 4°C and the addition of buffer to the resin made little difference to 
improve stability. Room temperature and -20°C storage were both worse. 
Disappointingly, the best storage conditions at 4°C still gave a significant fall in the 
residual activity. Subsequent preparations of MAO-N-Eupergit throughout these studies 





Room temp (-buffer) 0.137 8% 
Room temp (+buffer) 0.244 14% 
4°C (-buffer) 0.849 48% 
4°C (+buffer) 0.816 47% 
-20°C (-buffer) 0.432 25% 
-20°C(+buffer) 0.551 31% 
Table 2.6.7.1. Measurement of MAO-N-Eupergit activity after 4 weeks storage under 
different conditions. 
2.6.8. Preparative deracemisation of (rac)-amine 76 (MTQ) 
Deracemisation of (rac)-MTQ (amine 76) with MAO-N-Eupergit was carried out in a 
similar fashion to, the whole cell deracemisation used previously (3.6.5). 20mIVI substrate 
with 5 equivalents of ammonia borane was added to 5.68 g of MAO-N-Eupergit in a 
1 OOml reaction volume. The MAO-N-Eupergit had a specific activity determined to be 
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4.16 j.tmol/minlg, giving the Units (1 Unit = 1 .tmol/min) of MAO-N activity used in this 
deracemisation to be 23.6 Units. After 4.5 days the (R)-MTQ (amine 76) e.e. was 
determined to be >99.5% and the reaction was worked up giving the HCI salt in 100% 
yield (3.6.5). Satisfyingly, the crude reaction mixture was shown to be pure by 'H-NMR 
and required no further purification after the organic extraction. The optical rotation 
matched well with previously documented values 172  it was measured at CCD  +42, 
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Figure 2.6.8.1. Monitoring of the preparative deracemisation of(rac)-amine 76 (MTQ) 
with immobilised MAO-N-Eupergit. 
2.6.9. Preparative deracemisation of (rac)-MTQ (amine 76) with whole cells 
Although the deracemisation of (rac)-MTQ (amine 76) to (R)-MTQ (amine 76) gave an 
excellent e.e. and yield the reaction was slow, taking 108 hours to reach an e.e. >99%.  It 
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had been shown that the whole cell deracemisation was completed within a day (2.6.2). 
In order to complete the whole cell deracemisation preparatively the earlier analytical 
reaction with whole cells was repeated but with a greater quantity of cells to allow more 
substrate to be deracemised. The reaction was repeated but scaled-up to a 1 OOml volume 
(3.6.3). After 18 hours chiral HPLC analysis (3.7.1.B) showed the e.e. >99% and the 
reaction was worked up. The extraction of product during the workup was problematic 
addition of TBME gave poor partitioning of the aqueous and organic phases. Even after 
several hours the phases failed to separate and the crude mixture tended to remain as an 
emulsion. To alleviate this problem the whole cells were removed by centrifugation, the 
supemantent basified (pH> 10) and then filtered (0.2j.tm) to remove any precipitated 
protein during the basification step. Even after this clean up on the crude aqueous 
reaction, the partitioning of the organic and aqueous layers tended to be poor, but further 
centrifugation of the organic/aqueous mixture gave better partitioning. Inevitably, the 
final (R)-amine yield suffered as a result of the problems associated with the extraction 
with an e.e. >99%, but an isolated yield of 72%. The 'H-NMR and (XD matched well 
with the published data' 72  for (R)-MTQ (amine 76). 
2.6.10. Deracemisation of (rac)-amine 209 
After the successful deracemisation of MTQ (amine 76) had been achieved it was 
decided to investigate whether other amines could be deracemised in a similar fashion. It 
has been shown that numerous other amines are capable of being oxidised by this 
evolved MAO-N variant (2.2.2 and 2.3.7) and the screening has consistently shown that 
the enzyme has the high degree of enantioselectivity required for a deracemisation. 
Amine 209 appeared to offer a good chance of achieving the deracemisation of another 
chiral amine. Firstly, it is a secondary cyclic amine and therefore has the same advantage 
that MTQ (amine 76) possesses, the imine intermediate is more stable than an acyclic 
amine and should suffer less to hydrolysis. Secondly, in the screening of amine 209 it 
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the racemic substrate, it is reasonable to expect high enantioselectivity owing to the 
evidence of MAO-N's inherent excellent enantio selectivity. To explore the possibility of 
deracemising amine 209 and to determine the relative performance of amine 209 with 
MTQ (amine 76) the same reaction conditions (2.6.8) was employed in the 
deracemisation of(rac)-amine 209 (3.6.6). [i.e. 4.71g of MAO-N-Eupergit with a 
specific activity of 5.01 p.mol/minlg was used in the deracemisation giving a total-of 
23.6 Units]. The results of the deracemisation of (rac)-amine 209 (figure 2.6.10.1) 
shows the deracemisation is completed a lot more quickly than the equivalent (rac)-
MTQ (amine 76) deracemisation, in a matter of hours rather than days. The shape of the 
curve is also different to the one seen in the MTQ (amine 76) deracemisation; essentially 
here it is linear rather than curved indicating no deceleration effects. This shows the 
better performance of MAO-N biocatalyst in the deracemisation of (rac)-amine 209 
whereas the deracemisation of (rac)-MTQ (amine 76) was decelerating towards the end 
Time hours 
Figure 2.6.10.1. The deracemisation of (rac) 2-phenylpyrrolidine 209 to (R) 2-
phenylpyrrolidine 209 under the same conditions used for the deracemisation of (rac)-
MTQ (amine 76). 
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After achieving a faster deracemisation analytically it was decided to attempt the 
preparative deracemisation of amine 209 at a higher substrate concentration. Slightly 
more MAO-N-Eupergit was used in this reaction with 4.75 g of resin used (23.8 Units) 
100mM (rac)-amine 209 substrate was included and 250mM ammonia borane (3.6.7). 
This time the deracemisation was not as rapid as the 20mM substrate deracemisation 
with the reaction taking 48 hours to achieve a (R)-amine 209 e.e. >95% (figure 2.6.10.2). 
The same workup that had been used for the (rac)-MTQ (amine 76) deracemisation was 
attempted, but trial amine 209 crystallisations with HCl failed and so the crystallisation 
was not performed on the crude oil. The colourless oil product was isolated in 83% yield 
and was shown to be -90% pure by 'H-NMR and the CCD  +45.2° compared satisfactorily 
to OLD  +64° for the reported value 
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Figure 2.6.10.2. The preparative deracemisation of (rac)-amine 209 at 100mM with 
MAO-N-Eupergit. 
2.6.11. Effect of alternative reducing agents on the deracemisation of (rac)-MTQ 
(amine 76) 
It has been shown the reduction of the MDQ (imine)-224 is not solely limited to 
ammonia borane in an aqueous system (2.5.3). Several other boranes have shown 
ICR 
Results and discussion 
superior rates of imine reduction over ammonia borane. However, it is not known how 
they perform in the deracemisation reaction. To explore the possibility of being able to 
use none ammonia borane reducing agents in the deracemisation of (rac)-MTQ (amine 
76) several identical deracemisations were attempted, varying only in the choice of 
borane. From the quicker group of faster reducing agents reductant- 11 and 14 were 
selected, along with ammonia borane to determine the differences in the deracemisation 
of MTQ (amine 76) with each of these reducing agents. A control oxidation was also 
performed where no reducing agent was added. To 10mM of (rac)-MTQ (amine 76) was 
added 2 g of 0.373 p.mol/minlg MAO-N-Eupergit (0.746 Units) and 10 equivalents of 
the reducing agent (3.5.4). The bar chart (figure 2.6.11.1) shows that all of the reducing 
agents significantly retard the rate of oxidation compared to the control reaction were no 
reducing agent was added. Although the reducing agents all lower the biocatalysts 
performance, they did not all inhibit the rate of oxidation to the same degree. Reductant-
233 (ammonia borane) shoed the least inhibition in the trial deracemisation producing an 
e.e. of 81.4% after 96 hours; reductant-238 had a final e.e. of 18.4% and reductant-235 
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Figure 2.6.11. 1. The effect of various reducing agents on the rate of (rac)-MTQ (amine 
76) oxidation in a deracemisation. 
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2.6.12. Catalytic transfer hydrogenation (CTH) in the deracemisation of amine 76 
Evidence in the literature led to the concept that CTH could be used in the 
deracemisation process 174 ' 175" 76 . CTH offers the advantage of being a cheaper method 
than ammonia borane for imine reductions and although the cost is not significant on 
small scale deracemisations attempted here, on scale up cost evaluation becomes more 
important. To make this deracemisation process more attractive in terms of transferring 
the technology into a process the use of CTH needed to be examined. Typically the cost 
of the metal catalyst in CTH is relatively expensive and the source of formate used in 
CTH (e.g. ammonium formate) is cheap. [The Aldrich 2003-2004 list prices for lOg of 
ammonia borane is £72.50 compared to 1 OOg of ammonium formate at £24.10]. The 
metal catalyst can be removed in the workup of the reaction and potentially reused 
saving on cost. It had been shown (correspondence with I.Archer) that 2.1mol% catalyst 
was sufficient to generate enough of a reducing environment to affect the amino-acid 
oxidase catalysed deracemisation of pipecolic acid prior to the CTH work under takeh 
here. Before deracemisations with CTH were attempted the physical absorbance of 
MTQ (amine 76) and its imine substrate (224) onto the catalyst had to investigated and it 
was shown that neither amine nor imine was significantly absorbed onto the catalyst 
(3.5.2). Two catalysts were selected for examination in their ability to reduce 10mM 
MDQ 224 (3.5.3). After 18 hours the imine and amine peak areas were measured and the 
results showed that at 1 5mM ammonium formate the reduction was failing. At 200mM 
ammonium formate both showed almost total reduction of the imine. The 5mol% 
Pd/alumina appear to a better catalyst than 10% Pd/carbon because it showed partial 
imine reduction at 50mM ammonium formate and even better reduction at 100mM 
ammonium formate. The 10% Pd/carbon catalyst showed no reduction at 50mM 
ammonium formate and less reduction at 100mM ammonium formate than the 
Pd/alumina catalyst. 
Results and discussion 
4000 
	
3500 	 Uiniinepeak 
3000 • amine peak 




Al 	All MIT AIV BI 	BIT Bill BIV 
CTH sample 
Figure 2.6.12.1. The reduction of MDQ 224 with CTH using ammonium formate and Pd 
catalyst. A = 2.lmol% of 5% Pd/alumina; B = 2.lmol% of 10% Pd/carbon; I = 15mM 
NH4CO2, 11= 50mM NH4CO2, III = 100mM NH4CO2 and IV = 200mM NH4CO2 . 
Based on these findings, the deracemisation of 10mM (rac)-MTQ (amine 76) was 
attempted using 2.1mol% of Pd catalyst with 200mM ammonium formate and 0.642 
Units of 0.366g MAO-N-Eupergit (specific activity = 1.75 tmol/minIg) (3.6.8). Two 
control oxidations were carried out with and without the presence of 200mM ammonium 
formate, reactions 2 and I respectively. Reaction 3 had 2.1mol% of 5% Pd/alumina 
catalyst added and reaction 4 had 2.1mol% of 10% Pd/carbon catalyst added. The rate of 
oxidation of (rac)-MTQ (amine 76) in reaction 1 was rapid but this rate was 
substantially reduced by 200mM ammonium formate in reaction 2. The observed rate of 
reaction in reaction 2 was reduced in reaction 3 and the rate slowed even further with the 
Pd/carbon catalyst of reaction 4. The CE method used to follow the progress of the 
deracemisation, allows the monitoring of imine formation as well as determining 
product e.e. The imine peak area for reaction 3 after 68 hours was the same for reaction 
2 suggesting the reduction was failing. The imine peak area was present in 
approximately 30% relative area in both reactions 2 and 3 indicating the reduction was 
failing for reaction 3. 
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Figure 2.6.12.2. Deracemisation of(rac)-MTQ (amine 76) with CTH. Reaction 1 = 
control oxidation (MAO-N-Eupergit only), reaction 2 = control oxidation + 200mM 
ammonium formate, reaction 3 = deracemisation with 2.1mol% of 5% Pd/alumina and 
reaction 4 = deracemisation with 2.1mol% of 10% Pd/carbon. 
The imine reduction was successful with 2.1 mol% catalyst, but failed to achieve 
complete reduction in the equivalent deracemisation reaction. Doubling the amount of 
palladium catalyst to 4.2mol% from 2.1mol% allowed the complete deracemisation of 
(rac)-MTQ (amine 76) to (R)-MTQ (amine 76) with the 5% Pd/alumina catalyst. This 
reaction was completed in 40 hours (97.6% e.e., yield not determined) using 2.92 Units 
of MAO-N-Eupergit (1.665g resin) with no detection by CE of any imine being present 
(3.6.9). 
2.6.13. Conclusions 
The MAO-N 2 variant has been used in the preparative deracemisation of (rac)-MTQ 
(amine 76) and (rac)-2-phenylpyrrolidine (amine 209) to the (R)-enantiomer product at 
20mM and 100mM substrate concentrations respectively. MAO-N has been applied in 
the deracemisation reaction either in the whole cell form or as the immobilised purified 
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protein. Both forms of MAO-N gave excellent final e.e.s in the deracemisation. Whole 
cells giving a faster reaction, but at the expense of yield and the immobilised enzyme 
gave a slower reaction but with a higher isolated yield. The deracemisation of (rac)-
MTQ (amine 76) has been shown to moderately successful with reducing agents other 
than ammonia borane that had previously been shown to efficiently reduce MDQ imine 
(2.5.2), but generally these other reducing agents retarded the deracemisation. The CTH 
has successfully been demonstrated in the (rac)-MTQ (amine 76) deracemisation, 
however again the presence of the reducing agent (200mM ammonium formate) 
significantly retarded the rate of substrate oxidation compared to the oxidative half 
reaction. Another approach has recently reported for the enzymatic resolution of (rac)- 
MTQ (amine 76) using Candida rugosa lipase69 . The main disadvantage of this kinetic 
resolution compared with the deracemisation technique used in this report is outlined 
earlier (1.2.2). The benefit with the deracemisation of(rac)-MTQ (amine 76) to (R)-
MTQ (amine 76) is that it has been achieved in a 100% yield here, compared to the 46% 
yield with the kinetic resolution method. 
This work has been conducted alongside Vicente Gotor-Fernandez 168 and because of the 
relevance of this work to the study here, it is appropriate to include these findings here. 
These studies have compared the whole cell deracemisation of (rac)-MTQ (amine 76) 
expressing the MAO-N J and the MAO-N 2 variants which leads to a 52% and a 99% 
e.e. respectively for (R)-MTQ (amine 76) under identical reaction conditions. The 
difference in e.e. between the MAO-N variants correlates well with the difference in 
kinetic measurements (2.3.6). The improvement in turnover for the 1246M mutation in 
(S)-MTQ (amine 76) oxidation rates is translated into an improvement seen in the whole 
cell deracemisation. 
This study also investigated the effect of different boranes, in place of ammonia borane, 
in the deracemisation of (rac)-MTQ (amine 76). It was found that reductant-14 giving a 
poorer e. e. than with ammonia borane and reductant-1 1 strongly inhibited the amine 
oxidation. Although reducing the equivalence of reductant-14 from 10 equivalents used 
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in the deracemisation did allow higher e.e.s to be achieved, with 58% and 99% e.e. seen 
for a 1 equivalent of reductant-14 for the MAO-NJ variant and MAO-N 2 variants 
respectively. 
Further studies by V. Gotor-Fernandez' 68 into the use of organic solvents to suppress the 
inherent hydrolysis problem in the deracemisation reaction showed that use of polar 
solvents led to inactivation of the enzyme. Non-polar solvents such as cyclohexane, 
octane and toluene allowed the deracemisation to proceed in a biphasic reaction. In the 
deracemisation of(rac)-amine 24 up to 80% cyclohexane in buffer allowed complete 
(5)-amine 24 oxidation in 24 hours. In fact, even better enantioselectivities in amine 24 
oxidations were seen when cyclohexane was used in the biphasic reaction rather than 
with buffer alone. Addition of ammonia borane into these biphasic reactions was 
deleterious and led to lower e.e.s than the buffer only deracemisation. This was probably 
a result of concentrating the reducing agent into the aqueous phase and therefore 
increasing inhibition of the enzyme. Attempts to increase the reactivity of the 
deracemisation by raising the temperature to 40°C in the biphasic reaction and reducing 
the ammonia borane concentration to 5 equivalents in the reaction led to 50% e.e. being 
achieved. Employment of a higher boiling point non-polar organic solvent, octane in 
place of cyclohexane, prevented the evaporation of the organic solvent and the 
deracemisation of amine 24 was achieved with (R)-amine 24 measured to be 99% e.e. 
and 85% yield after 20 hours. 
More recently the MAO-N 4 variant has been shown to deracemise (rac)-a-
methylbenzylamine (amine 24)'. Interestingly it was shown that by increasing the a-
methylbenzylamine (amine 24) concentration in a biphasic deracemisation gave higher 
yields of (R)-ct-methylbenzylamine (amine 24). A deracemisation of 10mM of (rac)-a-
methylbenzylamine (amine 24) with 2.5 equivalents of ammonia borane gave >99% e.e. 
and 68% yield, whilst performing the reaction under the same conditions but with 
100mM gave a98% e.e and 86% yield in 24 hours' 77 . Presumably the ability to 
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deracemise higher concentrations of (rac)-a-methylbenzylamine (amine 24) results from 
the improvements generated by directed evolution (see figure 2.4.9.2) 
2.6.14. Future work 
Many of the issues that relate to future work are concerned with bringing together the 
biocatalyst and the reducing agent in the deracemisation process. Particularly important 
are scaling up the reactions, reduction of cost *and improved productivity. For instance, 
would it be possible to carry out the 2-phenylpyrrolidine (amine 209) deracemisation at 
concentrations greater than at 100mM? Could the CTH deracemisation be achieved 
preparatively? Would alternative immobilisation supports be advantageous in terms of 
cost, reusability, stability and immobilisation efficiency? 
All of the deracemisation studies carried out here involved the use of the MAO-N 2 
variant. However it has been shown that the MAO-N 4 variant had a 19 fold 
improvement in keat for (S)-MTQ (amine 76) (2.4.9.). The higher kcat should translate to 
a much more efficient biocatalyst and enable the deracemisation of (rac)-MTQ (amine 
76) to be completed at higher substrate concentrations and over a shorter time as was 
observed for (rac)-a-methylbenzylamine (amine 24). The deracemisation studies 
described in this thesis have focussed on just 2 amines out of the many that are known to 
be active from the screening of amines performed (2.2.2. and 2.3.7.). It will be important 
to investigate whether similar deracemisation protocols will allow the deracemisation of 
other amines that are known to shown activity in MAO-N catalysed oxidations. The 
problem of imine hydrolysis has been investigated 161,117  with the best acyclic amine 
deracemisation being achieved at 86% yield. It is interesting to speculate whether it will 
be possible to suppress the hydrolysis further. 
It is known that prochiral ketones can undergo reductive amination to give the racemic 
amine with ammonium formate and PdJC under aqueous reaction conditions 17'. The 
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amine product could potentially be enantioselectively oxidised by MAO-N and thus 
deracemised. This would give a one-pot asymmetric reductive amination of a ketone to 
an optically active amine. Any material lost by hydrolysis could be potentially recovered 
by the reductive amination, thereby achieving higher yields than the equivalent 
deracemisation process. 
NH2 	NH2 
(R)-amine 24 :amine 24 
MAO catalysed 
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Figure 2.6.14.1. The asymmetric reductive amination from a prochiral ketone 
(acetophenone) to an optically active amine (R)-MTQ (amine 76). 
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3.1. MAO-N assay methods 
3.1.1. The horseradish peroxidase coupled liquid assay 
The following chromogenic solution was prepared; 1M aminoantipurine (37.5[d), 2% 
(w/v) TBHBA in DMSO (500 jil), 10mM (after dilution) of amine 124 (54p.l), 1M 
potassium phosphate buffer pH 7.6 (5m1) and finally water to give a final volume of 
5Oml. 
5tl of 1mg/mi HRP (Horseradish peroxidase, Sigma P-6782) was added to lOj.il of the 
purified MAO-N protein sample in a U-shaped 96-well microtitre plate. To this was 
added 185 j.il of the chromogenic solution giving a final volume of 200p.l.  The 
colourimetric production formation was monitored by the 51 °flm  absorbance with a plate 
reader (Molecular Devices, Versa Max tunable microplate reader) at 30°C (= 29400 M 
cm')' 78 . Theactivity of MAO-N towards 10mM amine 124 was calculated from rate of 
change of the 51 °nm  absorbance. The specific activity can be determined (as shown 
below) by dividing the activity measured on the assay by the measured soluble protein 
concentration from the Bradford assay (3.2.6) 
[(Activity/( x L)) x 20 x 60 x 1x10 3]IP = Specific Activity Umg' 
Activity = rate measured on the peroxidase assay (OD/sec) 
= Extinction coefficient of colourimetric product, 29,400 M 1 cm 
L = path length (cm) 
P = protein concentration based on Bradford assay (mg/ml) 
U = Units (.tmol min-) 
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3.1.2. Measurement of U-shaped well path length 
When a 96-well plate was used to measure the change in OD51O nm there is not a fixed 
path length, as is the case for a single 1cm cuvette. It is dependent on the volume used in 
the measurement since the path is measured from top to bottom in the microtitre plate. 
The path length of 200tl volume in a U-shaped 96 well microtitre plate was measured 
based on the averaging of three measurements of an identical sample measured in 
triplicate from the reading of a 1cm path length cuvette. The 1cm fixed path gave an 
average path length measured to be 0.318 OD. This compared with 0.170 OD average 
measured in the microtitre plate in a 200p.l volume. Therefore the path length for a 200iil 
volume in a U-shaped 96-well microtitre plate was measured to be 0.53cm. 
3.1.3. Relative rate calculation 
The unreliability of measuring consistent specific activities for the rate of amine 
oxidation by purified MAO-N was primarily caused by the inherent instability of the 
enzyme upon storage (2.1.4). To circumvent this difficulty it was decided a % relative 
rate activity would be undertaken. 
Amines were either purchased from commercial sources (Aldrich, Lancaster, Sigma, 
Lancaster or Acros) or synthesised in house (V. Gotor-Fernandez, C. E. Humphrey or G. 
J. Roff). Chromogenic solutions were prepared with replacement of amine 124 with the 
desired substrate a final concentration of 10mM (3.1.1). A second chromogenic solution 
was prepared with part 3 replaced with (rac)-amine 24. The rate of (rac)-amine 24 was 
measured and the rate of the sample amine was measured in parallel on a 96-well 
microtitre plate. The rate of the sample amine was then calculated by division of the rate 
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measured against (rac)-amine 24 to give the percentage relative rate. For each assay a 
negative control assay was performed to ensure the rate measure is a result of enzyme 
turnover and an artefact of the particular assay. If a response was recorded with the 
negative control, the amine was purified by distillation and fresh chromogenic solution 
prepared. The negative control assay had the addition of 10tl of purified MAO-N 
protein sample replaced with 1 Op.l of water. 
3.1.4. CFE rate calculation 
Method as 3.1.3. except that the lOp.l of the purified MAO-N protein sample is replaced 
by lOp.l of CFE. 
3.1.5. Michaelis-Menten calculations 
Chromogenic solution was prepared but with amine substrate added to give a final 
substrate concentration of 50mM (3.1.1). The chromogenic solutions pH was measured 
and the pH lowered if necessary back to pH 7.8 by dropwise addition of 2M sodium 
hydroxide. A second preparation of chromogenic solution was used to dilute the stock 
50m1V1 amine substrate chromogenic solution to give the following chromogenic 
solutions with amine substrate concentrations of 50, 30, 20, 10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, 
0.2, 0.1 mM and 50, 20, 10, 5 and 1i.M. Each chromogenic solution was assayed for 
MAO-N activity as described (3.1.1). These measurements were carried out on freshly 




The calculated specific activities were entered into the Enzyme kinetic module of 
SigmaPlot' 79 selecting the Michaelis-Menten type calculation to generate the Vmax 
(tmoIIminImg) and KM (mM). The kcat is calculated by multiplication of the by the Vmax 
and the molecular weight of MAO-N (55.6 kDa). 
3.1.6. The solid phase assay 
The DNA sample was transformed into E. coli BL21 (DE3) competent cells (3.3. 1) but 
rather than spread directly onto the agar, a nitrocellulose membrane (Amersham) was 
overlaid the agar. The transformation was spread over the membrane. After 16 hours 
growth at 37°C to allow the colonies to develop to an adequate size, the membrane was 
peeled off the agar and the membrane frozen at -20°C until required. Prior to the assay, 
the membrane was thawed and allowed to warm up to ambient room temperature. The 
following chromogenic solution was prepared; 2 DAB tablets (Sigma, D4418), 1 M 
potassium phosphate pH 7.6 (8m1), water (72m1), HRP lmgIml (24p1) and 10mM (after 
dilution) of(rac)-amine 76 (104tl). 
2% (w/v) agarose in water was melted and then cooled to 50°C in a water bath. lOmi of 
the chromogenic solution was mixed with 1 Oml of the molten agarose and immediately 
poured over the thawed nitrocellulose membrane (2.3.3). The assay was left to develop 
on the bench at room temperature. 
3.1.7. Solid phase MAO-N-Eupergit assay 
Due to the problem of measuring the MAO-N activity on immobilisation a 
discontinuous assay was required (2.6.6). A weighed amount of MAO-N-Eupergit 
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(3.6.4) in an eppendorf tube (typically 2-5 mgs of resin), had 5.tl of 1mg/mi HRP added, 
followed by 995 tl of 10mM amine 124 chromogenic solution. The reaction was left to 
proceed for four minutes with occasional inverting of the tube (-20 second intervals) to 
allow even distribution of the colourimetnc product throughout the assay. The final 
013510nm was measured and the rate calculated. 
The rate of the activity of the resin can be calculated by: 
Final OD5i0m/4 = Activity (OD 5ionm/min) 
The activity (OD 51 0nm/min) is converted to tmol/ml1min with: 
[(Activity/( x L)) x IX  103] = Activity (pmo11mIJmin) 
Division of the activity (tmol/ml/min) by the mass of resin (g) gives the specific activity 
of the MAO-N-Eupergit towards amine 124 (tmol min 1 g') 
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3.2. MAO-N purification techniques 
3.2.1. Q-Sepharose purification 
Cell pellet (8.2g) from the MAO-N 1 variant fermentation (3.3.5.2) was thawed on ice 
and resuspended in 50ml of Q-Sepharose resuspension buffer (Q Sepharose 
resuspension buffer; 25mM Tns/HC1 pH 7.8, 1mM PMSF and 1mM DTT). The sample 
was subjected to sonication and centrifugation (3.3.6) to give the CFE. The CFE was 
diluted with resuspension buffer to give a lOOml final volume. A HiLoad 26/10 50m1 Q 
Sepharose column operated by a UPC-900 Amersham pharmica biotech FPLC was used 
during the purification at 4°C. The column was pre-equilibrated with 2 column volumes 
of buffer A (identical to Q Sepharose resuspension buffer), 2 column volumes of buffer 
B (Q Sepharose resuspension buffer and 1M NaCl) and 3 column volumes of buffer B. 
The CFE was loaded onto the column and the column washed with 2 column volumes 
(lOOmi) of 100% buffer A to remove unbound sample, the flow rate set at 5mllminute. 
The column was subsequently washed with buffer A in buffer B linear gradient (0-1M 
NaCl) over 20 column volumes (1 litre) at Smllminute with collection of 30m1 fractions 
after the dead volume (50m1) had eluted. The column was cleaned with 4 column 
volumes (200m1) buffer B. All fractions were assayed (3.1.1) and MAO-N activity was 
found in fractions 35-37 corresponding to a NaC1 concentration of 238-277mM. The 
active fractions were aliquoted in lml portions and stored at -80°C. 
3.2.2. Nickel affinity purification 
Cell pellet (lg) from the MAO-N 1 variant fermentation (3.3.5.2) was thawed on ice and 
resuspended in Ni-NTA resuspension buffer (Ni-NTA resuspension buffer; 25mM 
Tris/HCI pH 7.8, 300mM NaCl, 1mM PMSF and 1mM 3-mercaptoethanol) (lOml). The 
sample was subjected to sonication and centrifugation (3.3.6) to give the CFE. Ni-NTA 
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slurry (Qiagen 30210) (1 Oml) was applied to a sintered resin column and equilibrated 
with Ni-NTA resuspension buffer (30m1) at 4°C. The CFE was applied to the top of the 
column and passed through the column under gravity. The column was washed with 
wash buffer (Ni-NTA resuspension buffer and 60mM imidazole) (30m1) and the protein 
eluted in imi fractions with elution buffer (Ni-NTA resuspension buffer and 200mM 
imidazole) (1 Omi). Each of the fractions was checked for MAO-N activity (3.1. 1)  and 
the active fractions combined, divided into lml portions and stored at -80°C. 
3.2.3. PD1O desalting 
Desalting of the freshly purified protein from the nickel affinity resin (3.2.2) was 
attempted to help improve the stability of the protein (2.1.4.). Disposable Amersham 
Bioscience PD-10 desalting columns were used (Amersham Biosciences). The column 
was equilibrated with 25m1 of the chosen storage buffer (2.1.4). 2.5m1 of the sample was 
loaded onto the top of the column and the flow through discarded. 3.5m1 of the choice 
storage buffer was applied to the top of the column and the flow through collected. 
3.2.4. Ammonium sulfate precipitation 
Ammonium sulfate precipitation is an alternative method to PD- 10 desalting (3.2.3) to 
replace the storage buffer from the preparation of purified MAO-N protein from the 
nickel affinity purification (3.2.2). Post purification, the protein sample was placed onto 
ice on a stirrer plate. Aliquot addition of ammonium sulfate was added to a stirred 
solution of the purified MAO-N sample, ensuring complete dissolution after each 
addition before the next. 60% ammonium sulfate saturation (36.6gI100ml) was found to 
complete precipitation of the MAO-N protein. The sample was centrifuged at 4000 rpm 
for 20 minutes affording a bright yellow pellet. The supernatant was discarded and the 
MAO-N protein pellet was redissolved into 0.1M potassium phosphate buffer pH 7.0. 
201 
Experimental 
3.2.5. SDS PAGE protein gel 
Analysis of the purity of protein and MAO-N expression samples was done using SDS 
PAGE. Precast gels were purchased (SDS Biorad 10-15% polyacrylamide gel) and New 
England Biolabs markers (P77085) were used as with the molecular weights of the 
standard proteins being 175, 83, 62, 47.5, 32.5, 25, 16.5 and 6.5 kDa. 20p.1 of the protein 
sample was mixed with 20pJ of the loading buffer, boiled for 1 minute and centrifuged 
at maximum speed in a desktop centrifuge for. 1 minute. Each sample was loaded into 
each lane (30.il) of the SDS PAGE gel and the gel was placed into the gel apparatus 
(Biorad) and submerged in SDS gel running buffer. The electrophoresis was carried out 
at 200V for appropriately 80 minutes. The gel was placed into staining solution for 1 
hour minimum and then destained to develop the bands in the destaining solution. 
3.2.6. The Bradford assay 
Protein concentrations were determined using the Bradford. 	The protein sample 
(20tl) had the Bradford reagent (980p1) added. The sample was left to develop for 2 
minutes and then the 0D 595nm was measured in triplicate (200p.1) on a 96-well microtitre 
plate using a plate reader. The protein concentration was obtained by comparison with a 
calibration curve derived from known concentrations of BSA. Bradford reagent (980il) 
was added to a known BSA concentration sample (20tl) (BSA standard concentrations; 
0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 .tg/ml). The sample was left to develop for 2 minutes 
and then the 0D 595nm measured in triplicate (200pl) on a 96-well microtitre plate using a 
plate reader. A straight line of best fit was overlaid the plot of BSA concentration 
against OD 595nm . 
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3.2.7. Estimation of error in the Bradford assay 
The same purified protein sample was measured six times by the Bradford assay method 
described (3.2.6). The 0D 595nm for the six measured samples was 0.573, 0.543, 0.550, 
0.593, 0.574 and 0.602. From this data set the mean = 0.5725 and the standard deviation 
= 0.023 10. Rearranging the equation for the line of best fit of the protein concentration 
for the known BSA standards plotted against 0D 595nm allowed the concentration for the 
purified protein sample to be calculated. Using the mean of 0.5725 the protein 
concentration for the sample was determined to be 235.6g/ml. The Michaelis-Menten 
rate was measured (3.1.5) for the mean protein concentration. The error in VMaX resulting 
from the error in protein concentration measured by the Bradford assay can be 
determined by the 95% likelihood that an individual value falls within 2 standard 
deviations of the mean; mean = 0.5725 0D 595nm ± (2 x 0.023 10 = 0.0462). There is a 
95% likelihood that the measured 0D 595nm of the sample is within the range 0.5263 to 
0.6187 OD units and by using the upper limit and lower limits, a new VMaX  can be 
determined. The upper and lower estimation of VMaX  for (rac)-2-Phenylpyrrolidine 209 
with the MAO-N 4 variant, at 95% confidence was determined (table 2.4.11.1). 
3.2.8. Mass spectrometry characterisation of MAO-N 
Mass spectrometry was performed on a MicroMass Platform II quadrupole mass 
spectrometer equipped with an electrospray ion source. The spectrometer cone voltage 
was ramped from 40 to 70 V and the source temperature set to 140°C. Protein samples 
were separated with a Waters HPLC 2690 with a Phenomenex CS reverse phase column 
directly connected to the spectrometer. The proteins were eluted from the column with a 
5-95% acetonitrile (containing 0.01% trifluoroacetic acid) gradient at a now rate of 
0.4m1/min. The total ion count in the range 500-2000 mlz was scanned at 0.1 s intervals. 
203 
Experimental 
The scans were accumulated and spectra combined and the molecular mass determined 
by the MaxEnt and Transform algorithms of the Mass Lynx software (MicroMass). 
3.2.9. UV-visible spectrum of MAO-N 
The purified MAO-N sample was placed in a imi quartz cuvette and the UV-visible 
spectrum measured in a Perkin Elmer instrument, Lambda 900, UV/VISINTR 
spectrometer. The spectrometer was zeroed against water and then the sample placed. in 
the holder and the UV-visible spectrum recorded from 300-750nm. 
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33. MAO-N transformation and fermentation methods 
3.3.1. Transformation of E. coli BL21 (DE3)JBL21 (DE3) star chemically competent 
cells 
Plasmid DNA and a single shot of E. coli BL21 (DE3) or BL21 (DE3) star chemically 
competent cells (Invitrogen C6000-03 or C603003) were thawed on ice. lj.il  of the 
plasmid DNA was added to the shot and the DNA mixed by gentle tapping of the tube. 
The tube was returned to ice for 30 minutes. The sample was then subjected to heat-
shock for 30 seconds at 42°C and quickly placed back on ice. After a few minutes on ice 
500.il of pre-warmed SOC media was added and the sample was left shaking at 250rpm 
37°C for 1 hour. 100 j.xl was spread onto a LB agar plate containing 100tg/ml ampicillin 
and the plate left to grow overnight at 37°C. 
3.3.2. Transformation of E. coli TOP10 chemically competent cells 
Plasmid DNA and a single shot of E. coli TOP 10 chemically competent cells (Invitrogen 
C4040-1 0) were thawed on ice. Remainder of method is as described in section 3.3.1. 
3.3.3. Electroporation of E. coli XL1-blue electrocompetent cells 
Plasmid DNA and a single shot of E. coli XL1-blue electrocompetent cells (Stratagene 
20015 8) were thawed on ice. 1 tl of the plasmid DNA was added to the shot and the 
DNA mixed by gentle tapping of the tube. The sample was transferred to an electrode 
cuvette and tapped to ensure removal of trapped air bubbles. A 4.32msec electroporation 
was carried out at 1.7kV, 25F and 200Q. The sample had 940p1 of pre-warmed SOC 
media added and the sample was left shaking at 250rpm 37°C for 1 hour. lOOp.l was 
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spread onto a LB agar plate containing 1 OOp.g/ml ampicillin and the plate left to grow 
for 16 hours at 37°C. 
3.3.4. Transformation of E. coli XLI-red chemically competent cells and 
preparation of library of variants 
Plasmid DNA and a single shot of E. coli XL1-red chemically competent cells 
(Stratagene 200129) were thawed on ice. Prior to the addition of DNA 1.7tl of 13-
mercaptoethanol was added to each shot (giving a final concentration of 25mM) 
followed by 1 p.1 of the plasmid DNA and the DNA was mixed by gentle tapping of the 
tube. The tube was returned to ice for 30 minutes. The sample was subjected to heat-
shock for 45 seconds at 42°C and quickly placed back on ice. The sample had 940p.l of 
pre-warmed SOC media added and the sample was left shaking at 250rpm 37°C for 1 
hour. lOOp.! was spread onto a LB agar plate containing 100p.g/ml ampicillin and the 
plate left to grow overnight at 37°C to check the transformation efficiency. To the 
remaining 900p.l, 9ml of LB containing 1 00p.g/mI ampicillin was added and the sample 
was returned to grow at 250rpm 37°C overnight. 100p.l of the overnight culture was 
added to a further 1 Oml of LB containing 1 00p.g/ml ampicillin and returned togrow for 
a further 24 hours at 250rpm 37°C. After sub-culturing, lml was removed and the 
plasmid DNA purified (3.4.1). This generated the first library of variants and this DNA 
was retransformed, as before, into E, coli XL1-red and the process repeated giving the 
second generation of variants. This cycle was repeated four times to give the fourth 
generation of variants. The fourth generation of variants was screened by the solid phase 
assay technique using (rac)-amine 76 (3.1.6). 
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3.3.5. Fermentation of E. coli BL21 (DE3) expressing MAO-N 
Small scale expression 
A single colony from a fresh transformation (3.3. 1) was picked and added to 1 0m1 of LB 
containing lOOp.g/ml ampicillin in a 50m1 falcon tube. The culture was left to grow 
overnight at 30°C after which the cells had reached stationary phase (013 60m = 3.0-4.0). 
The cells were harvested by microcentrifuge at 10,000rpm for 10 minutes. The pelleted 
cells had the supernatant discarded and the cells were stored at -20°C until required. 
Medium scale expression 
A single colony of a fresh transformant (3.3. 1) was picked and added to lOml of LB 
containing lOOp.g/ml ampicillin. The cells were left to grow at 30°C until OD 60m was 
between 0.6 and 1.0. At this point the cells were subcultured by a 1000 fold dilution 
addition into further LB containing 100tgIml ampicillin. In the medium scale 
expression, 6 x 200m1 fermentations in 1 litre baffled flasks were each inoculated with 
200tl of the starter culture. The fermentation was left to grow for a further 24 hours at 
200rpm and 30°C in an Innova 4430 incubator shaker. After the fermentation had 
reached stationary phase it was harvested by centrifugation at 6000rpm for 10 minutes at 
4°C in a Sorval RC5C refrigerated centrifuge. The pelleted cells had the supernatant 
discarded and the cells were stored at -20°C until required. 
Large scale expression 
A single colony of a fresh transformant (3.3. 1) was picked and added to 1 OOml of LB 
containing 100 j.tg/ml ampicillin. The cells were left to grow at 30°C until O.D. 600nm 
was between 0.6 and 1.0. At this point the cells were subcultured by addition of the 
entire contents into a 10 litre batch fermentor (New Brunswick Scientific, BIOFLO 
4500, Fermentator/Bioreactor). The cells were grown at 200 rpm 30°C in 10 litres of LB 
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containing 1O0tg/ml ampicillin overnight. The cells were harvested by centrifugation at 
6000rpm for 10 minutes at 4°C in a Sorval RC5C refrigerated centrifuge. The pelleted 
cells had the supernatant discarded and the cells were stored at -20° C until required. 
3.3.6. Preparation of CFE 
The cell pellet was thawed on ice and resuspended in the desired buffer (lOmlJg 
concentration of wet weight cells in buffer). The sample was sonicated at 10 micron 
amplitude on ice in a Soniprep 150 for 30secs with 30secs intervals. The homogenate 
was centrifuged for 20,000rpm at 4°C for 1 hour and the pellet discarded. The CFE was 
stored on ice prior to use. 
3.3.7. Spreading of fermentation onto LB agar +1- ampicillin plates 
A stationary phase culture (013 600nm —3.5) was serially diluted 106  fold in LB (10tl of 
sample into 990tl of LB three times). The dilution (100 j.il) was spread onto 2 plates, one 
containing LB agar with 1 00pg/ml ampicillin and the other with LB agar only. The 
plates were left to grow overnight at 37°C and the colonies counted the following 
morning. 
3.3.8. Isolation of plasmid DNA from clones on LB agar plate 
To a plate containing colonies of E. coli 1 ml of LB was added. The LB was gently 
spread over all the plate until all the colonies had been resuspended (i.e. no more 
individual colonies were visible). The E. coli broth suspension was drawn off the plate 
by pipetting and the cells pelleted by microcentrifugation at 10,000rpm for 10 minutes. 
The supernatant was discarded and the plasmid DNA extracted from the E. coli cells as 
described (3.4.1). 	 . 
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3.3.9. IPTG induction during fermentation 
2 x 1 OOml LB containing 1 OOp.g/ml ampicillin in 1 litre baffled flasks were inoculated 
with lml of the same overnight starter culture. The cultures were left to grow at 250rpm 
and 30°C until their OD 60m reached 0.4. At which point one flask had lOOp.l of 1M 
IPTG added. Periodically during the fermentation imi aliquots were removed for 
evaluation of MAO-N expression. The analyses of MAO-N expression was determined 
by SDS PAGE (3.2.5) and by the peroxidase coupled liquid assay (3.1.1). The 
fermentation (20m1) had loading buffer (20m1) added and the sample was analysed by 
SDS PAGE (3.2.5). For the peroxidase assay the samples were frozen/thawed prior to 
analysis by the peroxidase coupled liquid assay (3.1.1). 
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3.4. DNA purification and manipulation 
3.4.1. DNA plasmid purification 
imi of fermentation was spun using a maximum microcentrifuge at maximum speed for 
10 minutes and the supernatant was discarded. The remainder of the method was 
followed as described in the manufacturer's protocol (Qiagen, QIA prep Spin Miniprep 
kit protocol). The purified plasmid DNA was stored at -80°C. 
3.4.2. DNA agarose gel 
The DNA agarose gel was prepared by addition of agarose (0.4g) to TAB x 1 (50m1), the 
mixture was melted and the molten agarose was left to cool by stirring at room 
temperature. Ethidium bromide (10mg/mi) was added (2.5 p.l)  and the molten agarose 
was left stirring for a further 2 minutes. The gel was poured into a small gel tray and a 
loading comb inserted. 
To each of the DNA samples (I 8[d) blue juice x 10 (2p.l) (New England Biolabs) was 
added. Each sample (15 [d) was loaded into each lane and the gel was ran at full power 
until the bromophenol blue band had travelled just over half way through the gel. The 
gel was visualised by UV irradiation. 
3.4.3. DNA gel extraction 
The desired DNA band as visualised by UV irradiation, was cut from the rest of the gel 
and weighed. The DNA was recovered from the gel using the Qiagen QiAquick gel 




3.4.4. DNA sequencing 
Plasmid DNA from E. coli was purified using the Miniprep kit (3.4.1). The following 
reaction mixture (20il) was prepared in a PCR tube: 
Oligonucleotide primer (3.2pmol) 
	
1 j.tl 
ABI Prism BigDye Terminator v3.1 cycle sequencing ready reaction kit 4tl 
Plasmid DNA template (250ng) and water 	 final volume of 20p1 
To sequence the internal region of the MAO-N gene, three primers were used (design by 
T. Fleming) in separate reactions: 
MAO-N complementary start site at the 169 nucleotide 
5' gacttgactgtagcaggcttc 31(21  mer 52%GC) 
Molecular weight 6438.2 g/mol 
MAO-N complementary start site at the 512 nucleotide 
5' cgcatgacatgttctatgttcctgagt 3' (32 mer 46%GC) 
Molecular weight 9822.4 glmol 
MAO-N complementary start site at the 830 nucleotide 
5' gtccggttaggagtgttgttaatgagagag 31(30  mer 46% GC) 
molecular weight 9398.1 glmol 
For the end regions of the gene, commercial oligonucleotides were used: 
5'-end of the gene 
5' taatacgactcactataggg 3' (Novagen T7 promoter primer 69348-3) 
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3'-end of the gene 	 -- 
5' gctagttattgctcagcgg 3' (Novagen T7 terminator primer 69337-3) 
The PCR was carried out in the following manner on the Eppendorfmastercycler 
personal: 
95°C 1 minute 
Pause 
96°C 30 seconds 
50°C 30 seconds 
60°C 4 minutes 
Repeat steps 3-5, 30 cycles 
4°C hold 
Samples were transferred into a 1 .5m1 eppendorf tube; water added to give a final 
volume of 20p1 and sent for sequencing at the ICMB automated sequencing service, 
Swann Building, King's Buildings, University of Edinburgh. 
3.4.5. Quikchange PCR 1246 saturation library 
The two mutagenic oligonucleotide primers containing the NNS site (figure 2.4.2.1) 
were made up to 100pmol/t1 with water and the reaction prepared in a PCR tube: 
Reaction buffer lOx (Stratagene 600 153-82) 	 5tl 
Plasmid DNA containing MAO-N 2 variant gene (33ngIjil) 	 1 il 
Oligonucleotide primer - forward NNS 	 1 tl 
Oligonucleotide primer - reverse NNS 1 jtl 
dNTP mix (Sigma D-7295) 
	
1 tl 
Water 	 - 	 20il 
212 
Experimental 
The last addition was Pfu Turbo DNA Polymerase (1tl) (2.5UIi.l) (Stratagene 600250- 
52) into the PCR mixture. The PCR was carried out in the following manner on the 
Eppendorf mastercycler personal: 
95°C 1 minute 
95°C 1 minute 
55°C 1 minute 
68°C 8 minutes 
Repeat steps 2-4, 16 cycles 
4°C hold 
The PCR product was prepared for screening the library by nick repair and 
transformation into the E. coli expression system (3.4.7). 
3.4.6. Quikchange PCR 384/385 saturation library 
The two oligonucleotide primers containing the NNSNNS site (2.4.6.1) were made up to 
1Opmol/tl with water and the reaction prepared in a PCR tube as follows: 
Reaction buffer 1 Ox 
	
5 [d 
Plasmid DNA containing MAO-N 2 variant gene (3 1ng/tl) 	 1 .6j.tl 
Oligonucleotide primer - forward NINS 	 1 .3.xl 









After the addition of Pfu Turbo DNA Polymerase (I [d) (2.5U/tl) to the PCR mixture; 
the PCR was carried out in the following manner on: 
95°C 30 seconds 
95°C 30 seconds 
55°C 1 minute 
68°C 9 minutes 
Repeat steps 2-4, 30 cycles 
4°C hold 
The PCR product was prepared for screening the library by nick repair and 
transformation into the E. coli expression system (3.4.7). 
3.4.7. Nick repair and preparation of DNA for screening 
The crude PCR product had Dpnl restriction enzyme (1t1) (New England Biolabs 
R0176S) added and the reaction was mixed by gentle pipetting and spun for 1 minute at 
maximum speed in a microcentrifuge. The digestion of methylated DNA was allowed to 
proceed at 37°C, 200rpm for 1 hour. MeanwhileE. coli XL1-blue chemically competent 
cells (Stratagene) were thawed on ice. The cells were divided into two 50p.1 samples in 
pre-chilled eppendorf tubes and the digested PCR product (lp.l) was added to one tube 
and to the other was added the pUC18 control (1.tl). The tube was gently tapped to mix 
the contents and returned to ice for 30 minutes. Both tubes were heat shocked at 42°C 
for 45 seconds and quickly placed back on ice. Pre-warmed LB (500p.l) was added to 
each tube and the samples were placed at 200rpm, 37°C for 1 hour. 100.il of E. coli 
pUC 18 control transformation was spread onto a LB agar plate containing 1 00tgIml 
ampicillin. lOOp.l of E. coli saturation library transformation was spread onto five LB 
agar plates containing 1 OOp.gIml ampicillin. All the plates were placed overnight at 
37°C. The pUC18 control transformation had several thousand colonies the following 
morning. The saturation library tended to produce fewer colonies per plate than the 
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pUC 18 control, but enough transformants were used to represent the library adequately 
(figure 2.4.1.1). The DNA was isolated (3.3.8) and the library screened by the solid 
phase assay incorporating the desired amine substrate (3.1.6). 
3.4.8. Verification of representation of the mutagenesis 
In order to verify the success of the saturation mutagenesis random clones were picked 
after the E. eoli XL1-blue transformation (3.4.7). They were grown overnight in (lOml) 
LB containing 1 O0.tg!ml ampicillin at 200rpm, 37°C and the plasmid DNA isolated 
(3.4.1). The plasmid DNA was sequenced with the appropriate primer (3.4.4). 
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3.5. Reducing agent screening 
3.5.1. The half reaction reduction screen 
10mM of imine MDQ 224 (lOml) in Q-Sepharose resuspension buffer had 10 
equivalents of the sample reducing agent added. If dissolution was not possible dropwise 
addition of DMSO to assist solubility of the reducing agent was required. The reaction 
was left in a sealed tube shaking at 200rpm 37°C. 
To measure the amount of imine remaining after the desired period of time, lml was 
drawn up with a syringe from the reaction and filtered (0.2tm) prior to HPLC analysis 
(3.7.4). The percentage of remaining imine was calculated by dividing the imine peak 
area measured by the peak area at the start of the experiment. 
The reducing agents were either commercially purchased (Aldrich) or synthesised in the 
group (V. Gotor-Fernandez). 
3.5.2. Measurement of amine 76 and imine substrate onto palladium catalyst 
Three mixtures were prepared each had 10mM of (rac)-amine 76 (5m1) in 0.1 M 
potassium phosphate buffer pH 7.0. To the first mixture, 2.1mol% of 5% Pd/alumina 
was added, to the second 2.1mol% of 10% Pd/carbon and to the third mixture nothing 
was added (i.e. a control). Duplicate mixtures were prepared with replacement of(rac)-
amine 76 with the corresponding imine. All six preparations were left for 24 hours on a 
blood rotator at room temperature, after which time a lml aliquot was removed and 
analysed by CE (3.7.2.2). 
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3.5.3. Catalytic transfer hydrogenation of MDQ 
Each reaction was prepared with 10mM of MDQ 224 (5m1) in 0.1 M potassium 
phosphate buffer pH 7.0 and the addition of ammonium formate to the required 
concentration (to give a final concentration of either 15, 50, 100 or 200mM). After 
dissolution of the ammonium formate, 2.1mol% of the palladium catalyst was added 
(either 5% Pd/alumina or 10% Pd/carbon) and the reactions were left on the blood 
rotator at room temperature overnight, after which time a 1 ml aliquot was removed and 
analysed by CE (3.7.2.2). 
3.5.4. Deracemisation of (rac)-amine 76 with various boranes 
Each reaction was prepared with 10mM of(rac)-amine 76 (5ml) in 0.1M potassium 
phosphate pH 7.0 followed by the addition of reducing agent (2.6.11.1) to give a final 
concentration of the reductant at 100mM (except the control oxidation were no reducing 
agent was added). To each reaction was added MAO-N-Eupergit (2g) (3.6.4) with a 
specific activity 0.373tmo1Imin/g (3.1.7). The reactions were left on the blood rotator at 
room temperature overnight, after which time a lml aliquot was removed and analysed 
by CE (3.7.2.1). 
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3.6. Deracemisation reactions 
3.6.1. Stereoinversion of (S)-amine 76 with purified MAO-N protein 




A 600pi  solution of (5)-amine 76 (final 20mM) and ammonia borane (final 400mM) in 
Ni-NTA resuspension buffer was left shaking at 200rpm 30°C. A 1 00il aliquot was 
removed and the t = 0 sample's e.e. was measured by chiral HPLC (3.7.1.A). To the 
remaining 500.il of the solution was added 0.430mg/ml purified MAO-N 2 protein 
(500tl) (3.2.2). The mixture was left shaking at 200 rpm 30°C for a further 90 hours and 
a further 10øj.ti aliquot was removed and analysed by chiral HPLC (3.7.1.A). 
Microcentrifugation of the reaction after 90 hours and measurement of the concentration 
of the supernatant to quantify the soluble protein by the Bradford assay (3.2.6) found 
there to be no protein remaining in solution. 
3.6.2. Deracemisation of (rac)-amine 76 to (R)-amine 76 with whole cells expressing 
MAO-N 




Whole cells (0.456g) containing the expressed MAO-N 2 protein (3.3.5) were thawed on 
ice. The cells were resuspended in 0.1M potassium phosphate buffer pH 7.0 (lOmi). To 
this cell suspension was added (rac)-amine 76 (1 4p1, final 10mM) and ammonia borane 
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(0.0309g, final 100mM). The reaction was left shaking at 200 rpm, 30°C and 
periodically lml samples were removed for analysis. The sample was spun at maximum 
speed on a microcentrifuge, the supernatant drawn off by pipetting and the e.e. 
determined by chiral HPLC (3.7.1 .B). 
3.6.3. Preparative deracemisation of (rac)-amine 76 to (R)-amine 76 with whole 
cells expressing MAO-N 
Whole cells (10.3g) containing the expressed MAO-N 2 protein (3.3.5) was thawed on 
ice. The cells were resuspended in 0.1M potassium phosphate buffer pH 7.0 (lOOmi). 
(Rac)-amine 76 was added (0.294g, final 20mM) followed by ammonia borane (0.309g, 
final 100mM). The reaction was left shaking at 200rpm and 30°C. Periodically, a lml 
sample was removed and the sample spun at maximum speed on a microcentrifuge. The 
supernatant was drawn off by pipetting and the e.e. determined by chiral HPLC 
(3.7.1.B). After 18 hours the (R)-amine 76 e.e. had reached >95% e.e. as determined by 
HPLC and the reaction was worked up. 
The crude reaction mixture was centrifuged at 4000rpm for 1 hour. The supernatant was 
decanted off and basified with 2M NaOH until pH> 10 as determined by universal 
indicator paper testing and the reaction mixture was filtered (0.45p.m). The crude 
reaction was extracted (5 x 50m1) into tert-butylmethylether (TBME). The organic 
extractions were combined, dried over magnesium sulfate, filtered and dried to 
evaporation giving a clear oil. The oil was taken up in acetone and several drops of 2M 
HC1 were added until pH <2 as determined by universal indicator paper testing. After 
evaporation, a white crystalline solid was isolated in 0.258g yield (71.2% after 
accounting for the loss of removal of samples for HPLC analysis). The crude (R)-amine 
76 product was shown to be pure by 1 H-NMR without the need for further purification. 
The optical rotation was measured to be [aID +42° in DCM which compared well with 
published data' 71  [aI D +42 0 . 
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oH (250MHz, D20) 1.55 (3H, d, J= 6.9Hz, CH3), 2.95 (2H, m, CH2), 3.32-3.47 (211, m, 
CH2), 4.55 (1 H, q, J= 6.9Hz CH), 7.20 (4H, m, ArH). 
3.6.4. Immobilisation of MAO-N onto Eupergit-C 
The ammonium sulfate precipitated purified MAO-N protein (3.2.4) was redissolved in 
0.1M potassium phosphate buffer (40m1). Eupergit C (Degussa) was added (3.038g) and 
the immobilisation left on a blood rotator at room temperature for 24 hours. The resin 
was filtered and washed with 0.1M potassium phosphate buffer pH 7.0 (5 x 20m1). The 
resin was capped with 3M glycine pH 8.5 and left on the blood rotator for a further 24 
hours. The resin was washed with 0.1M potassium phosphate buffer pH 7.0 (5 x 20m1) 
and stored at 4°C. 
3.6.5. Preparative deracemisation of (rac)-amine 76 to (R)-amine 76 with MAO-N-
Eupergit 
MAO-N-Eupergit (6.642g), specific activity measured to be 1.011 tmo11minIg (3.1.7), 
was added to a 0.1M potassium phosphate solution (lOOmI) containing (rac)-amine 76 
(0.294g, final 20mM) and ammonia borane (0.309g, final 100mM). The reaction was left 
shaking at 200 rpm and 30°C. Periodically, lml samples were removed and the e.e. 
determined by CE (3.7.2). After 5.5 days the (R)-amine 76 e.e. had reached >95% e.e. 
and the reaction was worked up. 
The MAO-N-Eupergit resin was filtered and extensively washed with 0.1M potassium 
phosphate buffer pH 7.0. The washes and crude reaction mixture were combined and 
basified to pH>10 with 2M NaOH and the reaction extracted into TBME (5 x 50m1). 
The organic extractions were combined, dried over magnesium sulfate, filtered and dried 
to evaporation giving a clear oil. The oil was taken up in acetone and several drops of 
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2M HC1 were added. After evaporation a white crystalline solid (R)-amine 76, was 
isolated in 0.350g yield (994%) and shown to be pure by 'H-NMR. 
3.6.6. Deracemisation of (rac)-amine 209 to (R)-amine 209 with MAO-N-Eupergit 
QmcTh 
	
H L 7 	 H 
(rac)-amine 209 	 (R)-amine 209 
0.1M potassium phosphate buffer pH 7.0 (lOOml) containing (rac)-2-phenylpyrrolidine 
(CHESS, Germany 1840) (0.294g, final 20mM) and ammonia borane (0.3087g, final 
100mM) had MAO-N-Eupergit (4.71g), specific activity measured to be 
5.01tmol/minIg (3.1.7.), added to the reaction mixture. At various time intervals 500j.xi 
aliquots of the reaction were removed and 500il of 0.1 M potassium phosphate buffer 
pH 7.0 was added. The e.e. was determined by CE (3.7.3). 
3.6.7. Preparative deracemisation of (rac)-amine 209 to (R)-amine 209 with MAO-
N-Eupergit 
0.1 M potassium phosphate buffer (SOml) containing (rac)-2-phenylpyrrolidine 209 
(0.735g. final 100mM) and ammonia borane (0.385g, final 250mM) was adjusted to pH 
7.5 with a few drops of 2M HC1. MAO-N-Eupergit (4.751g), specific activity measured 
to be 5.01 jimol/minlg (3.1.7), was added to the reaction. The mixture was left shaking at 
250 rpm and 30°C. Periodically, lOOp.l samples were removed and diluted with 0.1M 
potassium phosphate buffer pH 7.0 (900tl). The e.e. was determined by CE (3.7.3), after 
48 hours the (R)-2-phenylpyrrolidine 209 e.e. had reached >95% e.e. and the reaction 
was worked up. 
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The MAO-N-Eupergit resin was filtered and extensively washed with 0. 1M potassium 
phosphate buffer pH 7.0. The washes and crude reaction mixture were combined and 
basified to pH>10 with 2M NaOH and the reaction extracted into TBME (5 x 50m1). 
The organic extractions were combined, washed with brine, dried over magnesium 
sulfate, filtered and dried to evaporation giving a clear oil in 0.604g yield (83%). The 
crude product was shown to be pure (R)-amine 209 by 'H-NIvIR without the need for 
further purification. The optical rotation was measured to be [a]D +45.2° in DCM 
compared to published [a] 0 64.00 173 
H (250MHz, CDC13) 1.82-2.45 (41-1, m, CH 2 , C112), 3.22 (1H, m, NH-CH 2), 3.42 (11-1, 
m, NH-CH2), 4.36 (1H, t, J= 7.71-lz Ar-CH), 7.42-7.67 (5H, m, ArH). 
3.6.8. Deracemisation of (rac)-amine 76 to (R)-amine 76 using CTH and MAO-N-
Eupergit 
Each reaction was prepared in the same manner. To 10mM (rac)-amine 76 (5m1), in 
0.1M potassium phosphate buffer pH 7.0, was added MAO-N-Eupergit (0.366g) 
(specific activity measured to be 1.75 tmoIJminIg (3.1.7)). This was followed by the 
addition of ammonium formate (0.062g, final 200mM) and 2.lmo!% of the palladium 
catalyst (either 5% Pd/alumina catalyst or 10% Pd/carbon catalyst). The reactions were 
!eft on a blood rotator at room temperature. Samples were taken and filtered prior 
(0.2tm) to analysis by CE to determine e.e. 
3.6.9. Deracemisation of (rac)-amine 76 to (R)-amine 76 using CTH with palladium 
catalyst and MAO-N-Eupergit 
To 10mM (rac)-amine 76 (5m!), in 0.1M potassium phosphate buffer pH 7.0, was added 
MAO-N-Eupergit (1.665g) (specific activity measured to be 1. 75.tmol/min/g  (3.1.7)). 
This was followed by the addition of ammonium formate (0.062g. final 200mM) and 
4.2mol% of 5% palladium/alumina catalyst. The reaction was left on a blood rotator at 
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room temperature. After 40 hours a sample was taken and filtered prior (0.2tm) to 
analysis by CE to determine e.e. 
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3.7. Analytical methods 
3.7.1. Chiral HPLC of MTQ 
HPLC analysis was performed on a Waters 2695 separation module with a Waters 486 
tunable absorbance detector. 
HPLC method A. 
The sample from the reaction (lOOi.tl) was extracted with hexane (2 x 150tl) and the 
combined hexane extracts were combined and injection (20p1) was analysed directly by 
HPLC. Chiralcel OD-H column 46cm, eluent hexane:ethanol 98:2 (v/v), flaw rate = 
0.5mllmin, column temperature = 0°C. Retention times, imine 224 = 18.7 mm, (5)-amine 
76 = 22.4 min and (R)-amine 76 = 26.2 min with monitoring at 195nm. 
HPLC method B 
The sample from the reaction (500 j.il) was basified with a few drops of 2M NaOH and 
the reaction was extracted into an equal volume of TBME. The organic phase was 
analysed directly by injection (40t1) onto the HPLC. Chiralcel OD-H column 250 x 
4.6mm, eluent methanol: isopropyl alcohol:hexane 8:3:89 (v/v/v), flow rate = imi/min, 
column temperature = 0°C. Retention times, imine 224 = 7.9 mm, (5)-amine 76 = 11.4 
min and (R)-amine 76 = 14.5 min with monitoring at 21Onm. 
3.7.2. CE analysis of MTQ 
An Agilent CE system G16O1A was used to carry out these analyses. A capillary 
diameter of 50pm and length 64.5cm (effective length 56cm) using a 30kV potential and 




Chiral CE method 
0.1M potassium phosphate buffer pH 3 containing 20mM HP-13-cyclodextrin. Injection 
pressure of 200 mbar/sec. Migration times; (5)-amine 76 = 10.6 min and (R)-amine 76 = 
11.5 min with monitoring at 195nm. 
Non-chiral CE method 
0.1M potassium phosphate buffer pH 3. Injection pressure of 200mbar/sec. Migration 
times; imine 224 = 10.8 min and (rac)-amine 76 = 11.5 min with monitoring at 195m. 
3.7.3. CE analysis of 2-phenylpyrrolidine 
0. 1M potassium phosphate buffer pH 3 containing 75mM HP-13-cyclodextrin and 75mM 
18-crown-6. Injection pressure of 50 mbar/sec. Migration times, (5)-amine 209 = 10.6 
min and (R)-amine 209 = 11.5 min with monitoring at 195nm. 
3.7.4. Reverse phase MDQ analysis 
The sample was filtered (0.2tm) prior to analysis and injected (50tl) onto a 250 x 
4.6mm Hichrom 250A (C-18) column. Water (containing 0.5% 
triethylamine): acetonitrile 1:1 (v/v) flow rate = 1 ml/min, column temperature = ambient 
temperature. Retention times, imine 224 = 8.5 min and amine 76 = 18.9 min with 
monitoring at 254nm. 
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3.8. Buffer and reagent recipes 
3.8.1. SDS loading buffer 
0.5M Tris/HC1 pH 6.8 (2m1), glycerol (2m1), 10% (w/v) SDS (3.2m1), - 
mercaptoethanol (0.8m1) and 0.05% (v/v) bromophenol blue (0.4m1). 
3.8.2. SDS gel running buffer 5x 
In 50m1: Tris (15.1g), glycine (94g) and 10% w/v SDS. 
3.8.3. SDS gel staining solution 
Methanol (450m1), acetic acid (lOOmi), water (450m1) and Coomassie blue G-250 
(5 00mg). 
3.8.4. SDS gel destaining solution 
Methanol (450m1), acetic acid (lOOml) and water (450m1). 
3.8.5. Bradford reagent 
Coomassie blue G-250 (100mg), ethanol (50m1), 85% phosphoric acid (100m!) and 
water (850m1). 
3.8.6. soc media 
In 1 litre: yeast extract (5g), tryptone (20g), 5M NaCl (2m1), KC1 (0.19g), 1M M902 
(lOml), 1M MgSO4 (lOmi) and D-glucose (3.6g). 
3.8.7. LB medium 
In 1 litre: tryptone (lOg), NaCl (lOg) and yeast extract (5g). 
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3.8.8. LB agar medium 
LB medium (lOOmi) and agar (1.5g). 
3.8.9. TAE (Tris acetate EDTA buffer) 50x 
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MAO wild-type sequence: 
M T S R D G Y Q W T P E 
1 ATG ACC TCC CGA GAC GGA TAC CAG TGG ACA CCC GAG 
T G L T Q G V P S L G V 
37 ACA GGG CTC ACG CAG GGC GTC CCC TCT CTA GGA GTC 
I 	S p p T N I E D T D K 
73 ATC TCC CCG CCC ACT AAT ATC GAA GAC ACG GAC AAA 
D G P W D V I V I G G G 
109 GAT GGT CCA TGG GAC GTG ATT GTC ATT GGT GGA GGG 
Y C G L T A T R D L T V 
145 TAC TGC GGG TTG ACT GCC ACT AGG GAC TTG ACT GTA 
A G F K T L L L E A R D 
181 GCA GGC TTC AAA ACC CTT CTC CTC GAA GCC CGA GAC 
R I G G R S W S S N I D 
217 CGC ATA GGC GGC CGC TCC TGG TCC TCT AAC ATC GAC 
G Y P Y E M G G T W V H 
253 GGC TAT CCT TAC GAG ATG GGC GGC ACA TGG GTC CAC 
W H Q S H V W R E I T R 
289 TGG CAC CAA TCG CAC GTA TGG CGC GAA ATC ACG CGC 
Y K M H N A L S P S F N 
325 TAC AAG ATG CAC AAC GCC CTA TCA CCC TCC TTC AAC 
F S R G V N H F Q L R T 
361 TTC TCC CGC GGC GTG AAT CAC TTC CAG CTA CGG ACC 
N P T T S T Y M T H E A 
397 AAC CCC ACC ACA TCA ACC TAC ATG ACT CAC GAA GCC 
E ]J E L L R S A L H K F 
433 GAG GAC GAG CTC CTC CGC TCC GCA TTG CAC AAG TTC 
Appendices 
T N V D G T N G R T V L 
469 ACC AAC GTG GAT GGC ACC AAC GGC CGT ACT GTC CTG 
P F P H D M F Y V P E F 
505 CCC TTC CCG CAT GAC ATG TTC TAT GTT CCT GAG TTC 
R K Y -D E M S Y S E R I 
541 AGG AAG TAT GAT GAG ATG TCA TAC TCG GAG CGG ATT 
D Q 'I 	R D E L 	S 	L N E R 
577 GAT CAA ATC CGG GAT GAG TTG AGC CTT AAT GAA CGG 
S S L E A F I L L C S G 
613 AGT TCT CTG GAA GCG TTT ATA TTG CTT TGC TCT GGC 
G T L E N S S F G E F L 
649 GGA ACG CTG GAG AAT AGC TCA TTT GGA GAA TTC CTG 
H W W A M S G Y T Y Q G 
685 CAT TGG TGG GCG ATG AGC GGA TAT ACG TAT CAG GGA 
C M D C L I S Y K F K D 
721 TGC ATG GAC TGC TTG ATA AGT TAT AAG TTC AAG GAT 
G Q S A F A R R F W E E 
757 GGG CAG TCT GCA TTT GCG AGG AGG TTT TGG GAG GAG 
A A G T G R L G Y V F G 
793 GCG GCC GGG ACG GGG AGG TTG GGG TAT GTG TTT GGG 
C P V R S V V N E R D A 
829 TGT CCG GTT AGG AGT GTT GTT AAT GAG AGA GAT GCG 
A R V T A R D G R E F A 
865 GCG AGA GTG ACG GCG AGG GAT GGC AGG GAG TTC GCT 
A K R L V C T I P L N V 
901 GCG AAG CGG CTG GTT TGC ACT ATT CCC CTC AAT GTC 
L S T I Q F S P A L S T 
937 TTG TCC ACG ATC CAG TTC TCA CCT GCG CTG TCG ACG 
E R I S A M Q ,A G H V N 
973 GAG AGG ATC TCT GCT ATG CAG GCA GGT CAT GTG AAT 
239 
Appendices 
N C T K V H A E V D N K 
1009 ATG TGC ACG AAG GTG CAT GCC GAA GTG GAC AAT AAG 
D M R S W T G I A Y P F 
1045 GAT ATG CGG TCG TGG ACG GGC ATT GCG TAC CCT TTC 
N K L C Y A I G D G T T 
1081 AAT AAA CTG TGC TAT GCT ATT GGT GAT GGG ACG ACT 
P A G N T H L V C F G T 
1117 CCC GCG GGA AAC ACG CAT CTG GTG TGT TTC GGG ACG 
D A N H I Q P D E D V R 
1153 GAT GCG AAT CAT ATC CAG CCG GAT GAG GAC GTG CGG 
E T L K A V G Q L A P G 
1189 GAG ACG TTG.AAG GCG GTT GGG CAG TTA GCG CCT GGG 
T F G V K R L V F H N W 
1225 ACA TTT GGA GTG AAG CGG TTG GTG TTT CAC AAT TGG 
V K D E F A K G A W F F 
1261 GTG AAG GAT GAG TTT GCG AAG GGC GCG TGG TTC TTC 
S R P G M V S E C L Q G 
1297 TCT AGG CCT GGG ATG GTG AGT GAG TGT TTG CAG GGG 
- 	 L R E K H R G V V F A N 
1333 	TTG AGG GAG AAG CAT CGC GGT GTT GTG TTT GCG AAT 
S D W A L G W R S F I D 
1369 	TCA GAT TGG GCG TTG GGG TGG AGG AGC TTT ATT GAT 
G A I E E G T R A A R V 
1405 GGG GCG ATT GAG GAG GGG ACG AGA GCT GCT AGG GTG 
V L E E L G T K R E V K 
1441 GTG TTG GAG GAA TTG GGA ACG AAG AGG GAG GTG AAG 
A R L * 
1477 GCT CGT TTG TGA 
240 
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The Genetic code 
T C A G 
TTT Phe TCT Ser TAT Tyr TGT Cys 
T 
TTC Phe TCC Ser TAC Tyr TGC Cys 
TTA Leu TCA Ser TAA Ter TGA Ter 
TTG Leu TCG Ser TAG Ter TGG Trp 
CTT Leu CCT Pro CAT His CGT Arg 
CTC Leu CCC Pro CAC His CGC Arg 
CTA Leu CCA Pro CAA Gin CGA Arg 
CTG Leu CCG Pro CAG Gin CGG Arg 
ATT lie ACT Thr AAT Asn AGT Ser 
A 
ATC lie ACC Thr AAC Asn AGC Ser 
ATA Tie ACA Thr AAA Lys AGA Arg 
ATG Met ACG Thr AAG Lys AGG Arg 
GTT Val GCT Ala GAT Asp GGT Gly 
G 
GTC Val GCC Ala GAC Asp GGC Giy 
GTA Val GCA Ala GAA Glu GGA Gly 
GTG Val GCG Ala GAG Glu GGG Gly 
Symbols for amino acids 
Letter code Amino acid Letter code Amino acid 
A Ala Alanine M Met Methionine 
C Cys Cysteine N Asn Asparagine 
D Asp Aspartic acid P Pro Proline 
E Glu Giutamic acid Q Gin Glutamine 
F Phe Phenylalanine R Arg Arginine 
G Gly Glycine S Ser Serine 
H His Histidine T Thr Threonine 
I lie Isoleucine V Val Vaiine 
K Lys Lysine W Trp Tryptophan 







Directed Evolution of an Amine Oxidase 
Possessing both Broad Substrate Specificity and 
High Enantioselectivity** 
Reuben Carr, Marina Alexeeva, Alexis Enright, 
Tom S. C'. Eve, Michael  Dawson, and 
Nicholas I. Turner* 
Enantiomerically pure chiral amines are of increasing value in 
organic synthesis, especially as resolving agents. 1 chiral 
auxiliaries/chiral bases. [21  and catalysts for asymmetric syn-
thesis. 131  In addition, chiral amines often possess pronounced 
biological activity in their own right and hence are in demand 
as intermediates for agrochemicals and pharmaceuticalsi 4 t 
Current methods for the preparation of enantiomerically 
pure chiral amines are largely based upon the resolution of 
racemates, either by recrystallization of diastereomeric salts 
or by enzyme-catalyzed kinetic resolution of racemic sub-
strates using lipases and acylases. 161 To develop more efficient 
methods, attention is turning towards asymmetric approaches 
or their equivalent, for example, the asymmetric hydrogena-
tion of iminest 71 or the conversion of ketones into amines by 
using transaminases. 181 Attempts to develop dynamic kinetic 
resolutions, which employ enzymes in combination with 
transition-metal catalysts, have unfortunately been hampered 
by the harsh conditions required to racemize amines, 191 
Recently we reported a novel catalytic method for the 
preparation of optically active chiral amines by deracemiza-
tion of the corresponding racemic mixture (Figure 1)J°1  The 
deracemization approach relies upon coupling an enantiose-
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Figure i. Deracemization of a.methylbenzylamine using an enantiose-
lective amine oxidase in combination with arnmonia.borane as the 
reducing agent. 
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effect stereoinversion of the S to R enantiomer via the 
intermediate achiral imine. 
The S enantiomer selective amine oxidase used for the 
deracemization of (R/S)-a-methylbenzyl amine was identified 
from a library of variants of the wild-type enzyme, from 
Aspergillus niger. by using a high-throughput colorimetric 
screen to guide selection. 1101 The library of variants was 
generated by randomly mutating the plasmid harboring the 
amine oxidase gene by using the E. coli XLI-Red mutator 
strain. Using (S)-ct-methylbenzylamine as the target substrate 
we were able to identify a variant (Asn336Ser) that possessed 
significantly improved catalytic activity (47 fold) and enan-
tioselectivity (sixfold) towards this particular substrate com-
pared to the wild type enzyme. To explore the opportunities 
for using this variant amine oxidase to deracemize other 
racemic chiral amines we decided to undertake a more 
detailed study of its substrate specificity. Herein we show that 
the Asn336Ser variant possesses broad substrate specificity 
and high enantioselectivity towards a wide range of chiral 
amines. 
Prior to carrying out further studies with the Asn336Ser 
amine oxidase, an additional mutation was introduced into 
the sequence (Met348Lys) that resulted in a variant enzyme 
(hereafter referred to as Asn336Ser) with higher specific 
activity and expression levels although its substrate specificity 
appeared unchanged (data not shown). Incorporation of an 
N-terminal histidine tag into the amine oxidase allowed facile 
purification of both the wild-type and Asn336Ser variant in 
one step, by a nickel-affinity column, to yield protein of 
> 90% purity as evidenced by gel electrophoresis (Figure 2, 
see Experimental Section). Solutions of the amine oxidases 
prepared in this manner were used for all the subsequent 
substrate specificity studies. 
1 	 - 
MW markers 	- 
call free extract 
After Nl-cokjuin 
Figure 2. Polyacrylamide gel of amine oxidase enzyme after affinity 
purification on a nickel column. 
A panel of amine substrates 1-51, with broad structural 
features, was selected to characterize both the wild-type 
amine oxidase and Asn336Ser variant (Figure 3). Each 
substrate was screened individually, at 10 mm substrate 
concentration, against the partially purified wild-type and 
mutant amine oxidase in 96-well microtitre plate format using 
a UVIVis plate-reader. The rate of oxidation was monitored 
by measuring hydrogen peroxide production by using a 
coupled enzyme assay. 1 "t For each substrate the k,1 , and Km 
values were calculated but for clarity only the relative 
activities are shown. These values have been calculated by 
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Figure 3. Panel of amines used in the screening experiments. Numbers in italics beneath the structures refer to relative rates of oxidation for 
Asn336Ser mutant/wild-type enzyme compared to a-methylbenzylamine. 
setting the activity of the Asn336Ser variant towards a-
methylbenzylamine as 100% and reporting all other rates as 
relative values. In addition, for a number of the chiral racemic 
substrates which gave positive assay results, the individual R 
and S enantiomers were also examined to determine the 
enantioselectivity of the reaction. 
The wild-type amine oxidase was found to be inactive 
towards most of the amines shown in Figure 3. Of the 
51 substrates examined, only nine gave relative activities of 
over 5% - The wild-type enzyme is most active towards simple 
straight-chain amines (e.g. pentylamine (11)) and generally 
shows poor activity towards more sterically demanding  
branched amines. By comparison, however, the Asn336Ser 
variant amine oxidase showed a quite different substrate 
profile with significant activity (5%) towards more than 
half of the substrates examined (33 out of 51). Eight of the 
substrates tested (3, 10. 11, 13, 14, 17, 31. and 36) were more 
reactive than a-methylbenzylamine itself with 1-cyclohexyl-
ethylamine (10) reacting approximately nine-times faster. 
The Asn336Ser variant amine oxidase showed high reactivity 
towards certain classes of chiral amines, particularly substi-
tuted phenethylamines (2,3.5-8) and 1-alkylethylamines (12-
17, 19, 20). Secondary amines reacted more slowly (cf. 42 
versus 1) although 2-methyltetrahydroisoquinoline 44 was 
08 	C) 2003 Wiley.VCH Verlag GmbH & Co. XCaA, Weinheim 	 www.angewandte.org 	 Mgew. Chem. hit. Ed. 2003, 42, 4807-4810 
Angewandte 
oxidized with a relative activity of 20% and the dimethoxy 
derivative 45 with a relative activity of 8%. Other substrates 
of interest that showed good activity were 2-phenyl-2-amino-
ethanol (27; rel. activity =50%), endo-1-amino-norbornane 
(36; 183%). and 3-amino-3-phenylpropanol (29; 20%). 
The enantioselectivity of the Asn336Ser variant towards 
11 selected chiral amine substrates was then examined and 
the results are shown in Figure 4 and Table I. The enantio- 
1:11111 11111 !0IIIII 	11111 
20 I nil .11.11.1 
1 44 12 16 2 7 6 10 3 5 27 
AmW 
Figure 4. Graph showing relative rate of oxidation of individual Sand 
Renantiomers by Asn336Ser amine oxidase. The rate of each substrate 
has been normalized to 100%. 
Table i: Enantioselectivity of Asn336Ser mutant towards selected chiral 
amines. 11 
Amine E Amine E 
1 199 6 86 
44 13 10 13 
12 142 3 275 
16 96 5 110 
2 84 27 270 
7 184 
[a) The numbers reported refer to the enantiomeric ratio (E) for the 
individual substrates. 
meric ratio E1121 for ct-methylbenzy [amine was very high (E = 
199) and was in general maintained with most of the other 
chiral amines. Such E values translate to ee values of around 
97-99%. Only 1-methyltetrahydroisoquinoline (44) and 1-
cyclohexylethylarmne (10) gave significantly lower values 
(both E = 13) although even these values would equate to an 
ee value of about 85%. Significantly. in all cases the 
Asn336Ser variant amine ox.idase was found to be selective 
for the S enantiomer of the amine substrate (note that for 27 
the R enantiomer is oxidized owing to the change in priority 
of the substituents). 
For secondary amine substrates, for example, 42, 44, 45. 
49, and 50 the possibility arose as to the regioselectivity of 
oxidation with respect to the amine functionality. Thus 44 
could, in principle undergo oxidation to yield either imine A 
or B, or a mixture of both (Figure 5). To establish that the 
former pathway operated at least to some extent, we carried 
out the Asn336Ser amine oxidase catalyzed oxidation of (S)-
44 in the presence of the reducing agent ammonia'borane 
which we have previously shown to be effective for reduction 
of the intermediate imineJ 10' Analysis of the chiral HPLC 
profile clearly showed that after 90 h significant production of 
(R)-44 had occurred. The formation of (R)-44 from (S)-44 can 
only occur via the achiral imine A and not the chiral imine B 
(see Experimental Section). 
CI~NH 	 03 
me oxidase 	 I 
Me 	 Me 
(S)-44 NH3 BH3 	 a 
Me EOEINH 	A 
Me 
(R).44 
Figu.'e5. Stereoinversion of (S)-44 to (R)-44, via imine A, by using 
Asn336Ser amine oxidase with ammonia borane. 
In summary, we have shown that a directed evolution 
approach, based initially upon screening a library of mutant 
amine oxidases for activity against one enantiomer of a 
specific substrate ((S)-a-methylbenzyl amine), has lead to the 
identification of an enzyme possessing much broader sub-
strate specificity whilst retaining high enantioselectivity. The 
Asn336Ser variant shows highest activity towards substrates 
containing a primary amine group flanked by a methyl group 
and a bulky alkyl/aryl group (Figure 6). In all cases so far 
examined the variant enzyme is selective for the S enantiomer 
preference for Me 
(can tolerate CH20H 
and CH2CH20H) 
directed 
evolution 	 Me 
	
2 	
Aan336Ser mu tant 	
RNH2 
wild-type enzyme 	 / \ 
best substrates are simple 	 preference for branched 	preference for NIl5 
aciliral amines 	 alkyl and aryl 	 (can tolerate NHCH 2- 
(eg amytamine, benzylamine) 	 (tolerates unbranched alkyl) 	and NHMe) 
Figure 6. Comparison of substrate specificity of wild-type and Asn336Ser 
mutant amine oxidase. 
of the chiral amine substrate. Other groups have also reported 
the identification of highly enantioselective enzymes by 
screening against single enantiomer substrates. 1131 Although 
the A. niger Asn336Ser amine oxidase is suitable at present 
for small-scale deracemization reactions, 1101 we are continuing 
to evolve this enzyme to develop an enzyme that has the 
required characteristics (e.g. stability, activity, selectivity) to 
be used for large-scale applications. 
The development of enzymes possessing broad substrate 
specificity combined with high enantioselectivity remains an 
important goal in biocatalysis. Previous studies have demon-
strated that directed evolution can be used to alter the 
substrate specificity and enantioselectivity of enzymes and 
moreover such variant enzymes often possess broader spe-
cificity when compared with the wild-type enzymei' 41 The 
results described herein represent the most in-depth study to 
date of how the substrate specificity of an enzyme can be 
dramatically altered by a point-mutation. The ability to select 
for such enzymes, using appropriate high-throughput screens, 
is critical to success in this area and highlights the need for 
new methods to enable the detection of a wider range of 
enzyme activities than is currently possible. 1151 
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ommunications 
Experimental Section 
Expression and purification of amine oxidase: BL2I star was trans-
formed with the wild-type/mutant amine oxidase gene and plated onto 
LB (70 igmL' ampicillin) petri dishes. A single colony was added to 
LB media (6 x 300 ml) containing ainpicillin and grown at 30°C for 
24 h. The cells were spun and the cell pellet stored at -20°C. Lysis of 
the cells was performed in 25 ms TnsIHCI pH 7.8. 10 mm imidazole. 
1 m -mercaptoethanol, 1 mm phenylmethanesulfonyl fluoride 
(PMSF), and 300 mm NaCl and the lysate centrifuged. The cell-free 
extract from a 1 g pellet was loaded onto a 1-m.L Ni-N.N-bis(carboxy-
methyl) glycine (nitrilotriacetic acid (NTA)) column. Column wash 
(five column volumes); 25 ms TrisIHCl pH 7.8.60 mt imidazole. 1 mm 
-mercaptoethanol, 1 mm PMSF, and 300 mm NaCI. Protein elution 
(the amine oxidase elutes in 2nd-.7th 1 ml fractions) : 25 mm TrislHCl 
pH 7.8.200 mm imidazole, I mM (3-mercaptoethanol. 1 mM PMSF. and 
300 nim NaCl. The protein was desalted in 25 mm TrisIHCl pH 7.8. 
1 mM threo-1,4-dimercapto-2,3-butanediol (dithiothreitol (DM), 
1 mm PMSF, and 300 m NaCl using a Pharmacia PD10 column. 
Samples were stored frozen at -80°C and thawed prior to use, 
Szereoinversion of (S)-44: A solution (600 iL) containing 20 mm 
(S)44. 400 ms NH 3'BH 3, 25 mti Tris/HCI pH 7.8, 1 mm Dli'. 1 mm 
PMSF, and 300 ms NaCl aqueous buffer was held at 30°C with 
shaking for 2 h. A 100-jsL aliquot was removed and analyzed by 
HPLC as a t = 0 sample. amine oxidase (0.215 mg) in 500 sL of 25 mm 
Tns/HCI pH 7.8. containing 1 mm DTr. 1 mm PMSF and 300 mm 
NaCl was added to the remaining 500 ijL of the (S)-44 solution. The 
mixture was shaken at 30°C and after a' = 90 h a 100 p1.. aliquot was 
removed and analyzed by HPLC. Some precipitation was observed 
over the course of the reaction. 
HPLC sample preparation: An aliquot (100 ;.LL) of the reaction 
mixture was extracted with hexane (2 x 150 pL). The combined 
hexane extracts were analyzed directly by HPLC: Chiracel OD-H 
column 46 cm, eluent hexane:ethanol 98:2 (v/v), flow rate= 
0.5 ml min- ', column temperature= O*C; retention times, imine A= 
18.7 mm, (S)-44 = 22.4 mm. (R)-44 = 26.2 mm. 
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t c- 
Directed evolution has been employed to generate new enzymes for the deracemisation of chiral amines. 
Introduction 
The use of combinatorial methods for lead discovery and opti-
misation has become a powerful and now firmly established 
technique within the pharmaceutical industry. More recently, 
analogous approaches of parallel synthesis and screening have 
been applied to the discovery and development of new catalysts 
for asymmetric synthesis.' The underlying principles are simple 
and very appealing, namely coupling systematic variations in 
catalyst structure, ligand composition, reaction conditions etc., 
with effective methods for high-throughput screening for a 
range of properties (e.g turnover number, enantioselectivity) 
resulting in catalysts that are fine tuned and optimised for 
specific applications.' Not surprisingly, similar concepts of 
combinatorial optimisation have recently gained popularity in 
the discovery and development of biocatalysts. However, here 
the situation is somewhat different given the relative complexity 
of enzymes. A typical enzyme is composed of between 250- 
1000 amino acids and hence the notion of systematically vary-
ing even a small number of amino acids in an enzyme sequence, 
to explore the effect on activity or selectivity, is unrealistic since 
the number of possible permutations rapidly exceeds the 
capabilities of high-throughput screens, let alone conventional 
analytical HPLC or GC-MS methods. Even if only one amino 
acid in any part of the sequence is replaced by any other of the 
19 other amino acids the number of permutations' is in the 
region of ca. I W whereas for combinatorial mutagenesis, where-
in two or more residues are simultaneously randomised, the 
library sizes can become truly vast (no. of permutations = 20" 
where n is the number of amino acids that are simultaneously 
varied). Furthermore, it is generally not obvious which amino 
acids, or combinations thereof, are important for controlling 
specific characteristics (e.g enantioselectivity, catalytic activity, 
stability). Although the increased availability of X-ray struc-
tures can help to guide identification of important residues, in 
practice it is mainly active-site residues that are targeted on the 
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Fig. I Strategies for the directed evolution of enzymes involving (a) generation of libraries of variant genes and (b) high-throughput screening of 
the libraries using different analytical methods. 
basis that they make important non-bonding interactions with 
the substrate." 
The past 5-10 years has witnessed the emergence of 'directed 
evolution' strategies in order to change the properties of 
enzymes in a targeted manner. -' Directed evolution of enzymes 
combines two distinct events, namely (i) random mutagenesis 
of the parent gene to provide a library of variant enzymes and 
(ii) methods for screening the individual members of the library 
for specific characteristics (e.g reactivity towards a specific sub-
strate, resistance to product inhibition, thermal/organic solvent 
stability) (Fig. 1). The power of this approach is that it requires 
no prior knowledge of the structure (or in some cases sequence) 
of the enzyme since the variants are selected simply on their 
ability to carry out a specific transformation, without regard to 
prior assumptions as to which particular amino acids might be 
important. The real challenge in this area is to devise high-
throughput screens that are able to handle sufficiently large 
libraries (ca. 10-10) such that significant improvements over 
the activity of the wild-type enzyme can be achieved. Such 
levels of throughput (i.e. >10 5 samples per day) have been 
achieved using in vivo 'life or death' selection and in vitro detec-
tion (e.g colorimetric/fluorescence detection, capillary array 
electrophoresis) but new methods are required to expand the 
range of enzyme activities that can be detected.' 
The aim of this article is to provide an insight into the field of 
'directed evolution' and to consider how this technology can 
best be employed to develop new enzyme-catalysed reactions 
and processes for the future. To assist in this objective, the 
authors have provided a personal case study from their own 
laboratory in which many of the current themes surrounding 
directed evolution have been encountered. 
Deracemisation reactions: the development of a platform 
technology 
Inspired by the early work of Hafner et al.,7 and Soda et aL, 8 
we set out to develop general and practical methods for the 
cyclic deracemisation of chiral compounds via an oxid-
ation—reduction sequence (Fig. 2). In this catalytic cycle the 
combination of an enantioselective oxidase, together with a 
non-selective chemical reducing agent, results in the conversion 
of a racemic mixture to a single enantiomer. Provided that the 
oxidase enzyme is highly enantioselective, only 7 cycles are 
required to achieve an ee of >99%. We have successfully 
applied this method to the deracemisation of a variety of 
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Fig. 2 Deracemisation of 0-amino acids using an enantioselective 
amino acid oxidase in combination with a non-selective chemical 
reducing agent. 
a-amino acids in high yield (70-85%) and ee (>98%) using 
both D- and L-amino acid oxidases together with a variety of 
reducing agents (NaCNBH 3; NaBH4; amine—boranes: Pd! 
C—ammonium formate) .'°" Because the reaction is in essence 
a stereoinversion process, we have also shown that it can be 
used to interconvert diastereomeric amino acids bearing more 
than one stereogenic centre.' 2 Encouraged by this success with 
a-amino acids, we sought to broaden the range of substrates 
amenable to deracemisation and considered amines in view of 
their increasing value as chiral intermediates for pharma-
ceutical drugs and also ligands for asymmetric catalysis' 3 The 
key issue at the outset was the availability of enantioselective 
amine oxidases that could be applied to deracemisation reac-
tions. Unfortunately, we could not find any convincing liter-
ature precedent for the presence of enantioselective Type II 
amine oxidases in microbial sources (some Type I enzymes were 
known to be enantioselective but these amine oxidases generate 
an enzyme-bound imine and hence were unsuitable for use 
in deracemisation reactions). Thus we decided to undertake a 
directed evolution approach to evolve enzymes that had the 
characteristics required for our deracemisation reactions. 
Directed evolution of an amine oxidase 
The starting point for any successful directed evolution project 
is a reliable and robust high-throughput screen. In vitro screens, 
based upon the production of a coloured or fluorescent prod-
uct, have the advantage that they can be used to screen colonies 
directly on an agar plate thus enabling 105_106  clones to be 
assayed in a short period of time. We developed a colorimetric 
screen, based upon capture of the hydrogen peroxide generated 
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Fig. 3 Range of amines that are substrates for the Asn336Ser variant of the amine oxidase from Aspergillus niger.. The numbers in italics below the 
structures indicate the activity relative to a -methylbenzyl amine, 
by the oxidase enzyme, and demonstrated that it could be used 
to detect colonies expressing amino acid or amine oxidases. The 
next decision concerned the starting gene to be used for 
generation of the library of variants. It was known that the 
monoamine oxidase (MAO-N) from Aspergil/us niger catalysed 
the oxidation of simple alkyl amines including benzylamine 
although no data was reported for any chiral amines.' 4 A 
plasmid harbouring the MAO-N gene was obtained, subcloned 
into Escherichia coli, and used to express the wild-type enzyme 
which was found to have very low, but detectable activity 
towards u-methylbenzylamine, the amine chosen for our model 
studies. Interestingly there was also evidence that the wild-type 
enzyme was enantioselective although the intrinsic rates were 
very low. Next the MAO-N gene was randomly mutated, using 
the E. co/i XL I-Red mutator strain,' 5 and the library of vari-
ants (Ca. 150000) screened against (S)-a-methylbenzylamine as 
a substrate using the agar-plate colorimetric assay. The fre-
quency of mutation was adjusted such that individual clones 
possessed Ca. 1-2 nucleotide mutations per gene. Approx-
imately 30 clones were selected at this stage, on the basis of their 
activity in the screen, and amongst these one clone in particular 
was found to have very high (S)-selectivity. Small scale growth 
of this clone and partial purification of the amine oxidase 
revealed that this variant possessed approximately 47 fold 
greater activity, and 6 fold greater enantioselectivity towards 
a-methylbenzylamine compared with the wild-type enzyme, a 
substantial improvement from a single round of directed evolu-
tion. This variant was sufficiently catalytically active to be used 
in combination with ammonia—borane to deracemise ct-methyl-
benzylamine yielding the (R)-enantiomer in 771/o yield and 93% 
ee.' 6 
Sequencing of this variant revealed that it possessed a single 
mutation (Asn336Ser). The variant amine oxidase was sub-
sequently purified to homogeneity, by Ni affinity chromato-
graphy, and examined for its reactivity towards a panel of Ca. 50 
different chiral amines. Interestingly, more than 60/ of these 
structurally different amines were found to be substrates. 
some with greater activity than a-methylbenzylamine itself 
(Fig. 3). For those substrates where the individual enantio-
mers were available we determined the enantioselectivity and 
found that in all cases the enzyme was highly (S)-selective 
(E >10). By contrast, the wild-type enzyme was active towards 
only ca. 15% of the substrates, confirming that the Asn336Ser 
variant possessed a substantially different substrate specificity.' 7 
Analysis of the relationship between structure and reactivity 
led us to propose a simple model to summarise the effect of 
directed evolution of the wild-type amine oxidase (Fig. 4). 
Overall, this first round of directed evolution had resulted 
in the identification of a variant with substantially improved 
catalytic activity and enantioselectivity together with signifi-
cantly broadened substrate specificity. 
Further rounds of 'real time' directed evolution 
An attractive aspect of directed evolution is that variants 
selected from the first round of evolution can form the starting 
Org. BIomol. Chem., 2003,1,4133-4137 	4135 
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Fig. 4 Schematic illustration of the change in substrate of specificity of the Asn336Ser mutant relative to the wild-type enzyme. 
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Fig. 5 Strategy for Iterative evolution of enzymes in 'real time by employing hierarchical screening protocols; Step ]: Library of variants generated 
from parent gene using E. coil, XLI -Red mutator strain. Step 2: DNA library transformed into E. co/i, expression strain and colonies streaked and 
grown on nitrocellulose membrane on agar plate. Step 3: Membrane lifted, colonies partially lysed (freeze-thaw) and then screened for activity using 
colorimetric assay containing specific amine substrate. Step 4: 'Hits' picked and replated to give single colonies. Active colonies checked for 
enantioselectivity towards individual (R)- and (S)-enantiomers of amine substrate. Step 5: Variants that are both highly active and enantioselective 
grown on small scale (100 ml) and screened against range of chiral amines (Ca., 32) in 96-well microtitre plate using liquid-phase colorimetric assay. 
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point for further rounds of mutagenesislselection in the anti-
cipation than additional mutations might lead to further 
changes in an additive manner. These further cycles can be 
carried out rapidly (3-4 weeks), in a highly automated fashion, 
in order to fine tune the enzyme towards substrates of 
specific interest. Fig.5 illustrates the approach we have recently 
developed involving initial passage through the mutator strain, 
to generate new libraries (ca. 10 000-300 000 clones) which are 
then screened for specific characteristics including substrate 
specificity, thermal stability, enantioselectivity etc. Libraries 
can also be generated at this stage using error-prone PCR or 
combinatorial mutagenesis in which several amino acids are 
simultaneously randomised. Any identified 'hits', which typi-
cally arise with a frequency of ca. I in 10000 using the mutator 
strain, are rapidly checked against a panel of substrates (ca. 32 
structurally different compounds) in order to roughly define the 
substrate range and enantioselectivity. At this stage we are also 
able to identify 'expression mutants' i.e. those variants in which 
the protein expression levels have been enhanced without any 
change in specific activity or substrate specificity. Variants of 
4136 1 Org. Blomel. Chem,, 2003,1.4133-4137 
particular interest are subsequently purified to homogeneity, via 
Ni-chelation chromatography, and then fully characterised 
against specific chiral amines of interest including determin-
ation of k., and KM values. Further rounds of evolution can 
then be carried out until an enzyme possessing suitable charac-
teristics is obtained. In this way we have been able to evolve new 
types of amine and amino acid oxidases, i.e. enzymes that pos-
sess greater activity towards secondary, rather than primary, 
amines or variants that are able to oxidise sterically demanding 
substrates. The goal is to rapidly generate a family of (S)- and 
(R)-selective amine and amino acid oxidases that possess com-
plementary substrate specificities allow us to deracemise a wide 
range of chiral amines and amino acids respectively. 
Future directions 
Directed evolution represents a powerful strategy for altering 
the properties of an enzyme in a rapid and targeted manner. 
However, the challenge now for applying this technology to 
biocatalysis is to identify the best strategy for evolving enzymes 
such that they ultimately possess all of the characteristics 
required for ultimate use in a large scale bioprocess.' 8 The ideal 
biocatalyst should possess most, if not all of the following 
properties; high k, K M in the millimolar range, high enantio-
selectivity (E> 50), broad substrate specificity, high tolerance 
towards organic solvents and stability at elevated temperatures. 
Each of these characteristics can probably be screened for by 
adjusting the assay conditions and in principle it may be pos-
sible to select for more than one property in a single step.' 9 For 
example in our experience, based upon the directed evolution of 
amine and amino acid oxidases, variants selected primarily for 
their activity in the solid-phase assay against a single enantio-
mer substrate, often turn out to be also highly enantioselective. 
Since high catalytic activity is a fundamental prerequisite for 
any biocatalyst, this observation is guiding our thinking in 
terms of the way forward for the directed evolution of enzymes. 
Perhaps the most exciting aspect of this area is that directed 
evolution can now be carried out in 'real time', at a rate that is 
commensurate with the expectations of those wishing to 
develop and optimise enzymes for applications in the com-
mercial synthesis of fine chemicals and chiral intermediates. 20 
Undoubtedly, as we learn more about the best strategies for 
evolving an enzyme in a particular direction, this process of 
optimisation will become faster, more automated, and hence 
increasingly attractive to synthetic organic chemists. 
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COMMUNICATIONS 
Directed Evolution of an Amine 
Oxidase for the Preparative 
Deracemisation of Cyclic Secondary 
Amines 
Reuben Carr, Marina Alexeeva, 
Michael J. Dawson,' Vicente GotorFernández , tai 
Cara E. Humphrey, and Nicholas J. Turner*I 
Enantiomerically pure primary and secondary amines are 
widely used as chiral auxiliaries and resolving agents and are 
also valuable intermediates for the synthesis of pharmaceuti-
cals and agrochemicals.' 1 ' Although enantiomerically pure 
amines are traditionally prepared by classical resolution of the 
corresponding racemate, alternative approaches have been de-
veloped based upon i) asymmetric reduction of imines,' 2 ' ii) hy-
droamination of alkenes' 3 ' and iii) lipase-catalysed kinetic reso-
lution of racemic amines.''' However, secondary amines, many 
of which have pronounced biological activity, 15 ' are poor sub-
strates for lipases compared to the corresponding primary 
amines, with only a few documented examples in the litera-
ture. 161  Hence the use of lipase resolution does not offer a gen-
eral route to this class of chiral molecule. Moreover, to date it 
has generally not been possible to achieve the in situ racemi-
sation of amines to effect a dynamic kinetic resolution process 
due to the relatively harsh conditions required to racemise 
amines. [71 
Against this backdrop, we sought to extend our chemo-en-
zymatic deracemisation method to encompass chiral secondary 
amines. Based upon our earlier work with a-amino acids, 181 we 
recently reported the deracemisation of a-methylbenzyl amine 
(a-MBA, 1) in a one-pot procedure by the combined use of an 
enantioselective amine oxidase and ammonia borane as the re-
ducing agent (Scheme 1).'' 
In order to identify an enzyme with appropriate activity and 
enantioselectivity towards a-methylbenzyla mine, the amine ox-
idase from Aspergillus niger (MAO-N) was subjected to directed 
evolution,' 10' with (5)-i as the probe substrate, by random mu-
tagenesis and selection employing a high-throughput agar-
plate-based colorimetric screen. This approach led to the iden-
tification of an important amino acid substitution (Asn336Ser) 
that resulted in a variant enzyme possessing significantly en-
hanced activity (ca. 50-fold) and greater enantioselectivity to-
wards 1 than the wild-type enzyme)"' Subsequently, we 
[a] R. Cart, Dr. M. Alexeeva, Dr. V. Gotor-FernOnde.z, Dr. C. E. Humphrey, 
Prof. N. J. Turner 
School of Chemistry, The University of Edinburgh 
King's Buildings, West Mains Road, Edinburgh EH9 3JJ (UK) 
Fax: (+44)131-650-4717 
E-mail: n.j.turner@ed.ac.uk  
(b) Dr. M. J. Dawson 
Novacta Biosystems Ltd, UH Innovation Centre 
University of Hertfordshire, College Lane 
Hatfield, Herts AL 10 9AB (UK) 
Supporting information for this article is available on the WWW under 













Scheme 1. Deracemisation of a-methylbenzylamine (1) with an amine oxidase 
in combination with ammonia borane. 
showed that this variant was also characterised by broad sub-
strate specificity, being able to oxidize a wide range of chiral 
primary amines with high enantiosel ectivity. IhhJ However, al-
though this variant showed some activity towards chiral secon-
dary amines (relative activity of 1-methyltetrahydroisoquinoline 
(MTQ, 2) 15% of a-MBA), the rates of oxidation were too 
low to permit efficient preparative deracemisation reactions. 
Our goal therefore was to evolve a "secondary amine oxidase" 
for preparative-scale deracemisation reactions to complement 
the existing "primary amine oxidase". 
The MAO-N gene used as the starting point for further di-
rected evolution contained four amino acid substitutions com-
pared to the wild-type. In addition to the Asn336Ser mutation, 
which is important for catalytic activity/enantioselectivity, mu-
tations were Arg259Lys and Arg260Lys (improved expression) 
and Met348Lys (improved activity). This gene was subjected to 
random mutagenesis, by using the E. coli XL1-Red mutator 
strain (mutation frequency ca. 1-2 base changes per gene), fol-
lowed by transformation and screening of the library (ca. 
20000 clones) against (R/S)-2 as the substrate, as previously 
described. 19' A number of clones (Ca. 10) showed greater activi-
ty than the parent, with one in particular appearing to be sig-
nificantly more active. Purification of this variant amine oxidase 
showed that it possessed a kcat value about 5.5-fold higher 
than the parent towards (S)-2 (Table 1) and also a higher KM 
value (0.31 vs. 0.06 mm). The new variant displayed very high 
(5)-selectivity (E> 100; calculated from ratio of kCaJKM for (5) vs. 
(R) enantiomer) towards MTQ and, upon sequencing, was 
found to possess an additional point mutation (lle246Met) 
compared to the parent. 
Interestingly, this new variant was found to have kcat values 
towards a-MBA and amylamine (3) comparable to those of the 
parent. However, the new variant showed evidence for en- 
Table 1. Kinetic parameters of Asn336Ser and Asn336Ser/11e246Met variants 
towards selected amines. 
Asn336Ser 	 Asn3365er/11e246 Met 
Amine 	k 	KM 	kC JKM k, 	KM 	k,/KM 
[min - '] [mM] [minmM'] [min - 1 [mm] [minmM] 
(S)-2 1.10 0.06 18.33 6.00 0.31 19.35 
(R)-2 0.06 0.70 0.09 0.08 3.58 0.02 
(R/S)-1 6.01 1.11 5.41 7.00 2.88 2.43 
(R/S)-4 150.07 0.38 394.92 128.20 0.72 178.06 
amylamine (3) 72.10 0.54 133.52 72.49 2.46 29.47 
ChemBioChem 2005, 6, 1-3 DOl: 10.1002/cbic.200400329 © 2005 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 	 1 
hariced activity towards chiral secondary amines (i.e., 2, 5, 6, 7 
and 9) as shown in Scheme 2, with 2-phenylpyrrolidine (4) 
showing the highest k., (Table 1). Although in some cases the 
activity was reduced (8 and 10), in general, the initial aim of 
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using a model secondary amine substrate (2) to select for a 
variant enzyme with improved activity towards a wider range 
of chiral secondary amines had been realised. 
To further probe the importance of lle246 as a key residue in 
controlling substrate specificity, we screened a second library 
in which position 246 was fully randomized. By using the Quik-
change kit (Stratagene), a library of 220 colonies was screened, 
with (R/S)-2 as substrate, to ensure a 99% probability of all 
possible 32 NNS codons being represented (p=1—e'where 
p=% probability, N=sample size required, V= total number of 
combinations). Eight colonies showed distinctly greater activity 
than the rest and, when picked and sequenced, to our surprise 
all contained methionine at position 246 (statistically expected 
6.9 clones). Thus although the use of the mutator 
strain places constraints on the range of amino acids 
that can be introduced at specific sites, in the present 
example the optimal amino acid was indeed found 
by this approach. 
Prior to assessing the suitability of the Asn336Ser/ 
lle246Met variant for preparative-scale deracemisation 
reactions of secondary amines, we screened a variety 
of reducing agents for their ability to reduce 1- 
 100 
methyl-3,4-di hydroisoquinoline (M DQ) to MTQ. 
(Figure 1). Amine boranes were generally found to be 	80 
highly reactive under aqueous conditions with the fol- 60 
lowing order of activity: 4-dimethylaminopyridine g 
borane (DMAP borane)>2-(methylamino)pyridine 	40 
borane > ammonia borane. Catalytic transfer hydroge- 20 
nation (Pd/C ammonium formate) was also found to 	
0 
be effective. By using ammonia borane, it was found 
that as little as 1.0 equivalent (0.5 equiv for DMAP 
borane), relative to the substrate, could be used for 
complete reduction of MDQ to MTQ. For ease of use, Figure 1. Ic 
ammonia borane was chosen for all subsequent preparative-
scale reactions. 
Initial small-scale deracemisation reactions of (R/S)-MTQ 
were carried out at 10 mm substrate concentration with 
loequiv of ammonia borane 
and washed whole cells (E. coil) 
expressing the Asn336Ser/ 
I NH lle246Met variant amine oxidase. 
Complete deracemisation (ee= 
99%) was achieved within 8 h. 
2053 	 At 20 mm MTQ, on a preparative 
3252 
scale, the reaction was complete 
after 48 h and yielded (R)-MTQ in 
71% isolated yield lee =99%). To 
NHMe 	 complement the whole-cell ap- 
proach, we also developed an 
immobilised form of the amine 
oxidase. The soluble fraction 
from the cell-free extract was 
subjected to purification by Ni- 
affinity chromatography to give 
the amine oxidase in >80% 
purity. Treatment with Eupergit C 
resulted in immobilisation onto 
the resin. By using the immobilised amine oxidase with 20 mm 
MTQ, the deracemisation process was found to be slower (ca. 
96 h) than with the whole-cell approach, but the isolated yield 
was considerably higher (yield =95%; ee=99%). Finally to 
demonstrate the generality of the approach and explore the 
effect of working at higher substrate concentration, we exam-
ined the preparative deracemisation of (R/S)-2-phenylpyrrol-
dine, analogues of which are potent ligands for the nicotinic 
acetylcholine receptor.  1121  With the immobilized enzyme, a sub-
strate concentration of 100 mm (14.7 gL 1 ) and ammonia 
borane (2.5 equiv), the deracemisation was complete within 
48 h and, after work-up, yielded (R)-2-phenylpyrrolidine in 80% 
yield and 98% ee. 
Scheme 2. Relative activities of various amines towards Asn336Ser and Asn336Ser11/e246Met variants. 
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In order to gain insights into the possible significance of the 
mutation at 1le246, we generated an homology model of the 
active site. Although there is no X-ray structure available for 
monoamine oxidase N (MAO-N) from A. niger, the related 
enzyme monoamine oxidase B (MAO-B) from human liver has 
been crystallized, and the structure has been solved to a reso-
lution of 2.5 A.' 13 ' Figure 2 shows a picture of the suicide inhibi- 
By using a representative secondary amine as the substrate for 
screening the library, we were able to identify a variant 
enzyme that possessed general activity towards a range of 
structurally related, but different, secondary amines. Further-
more the key mutation lle246Met appears to be important in 
terms of controlling substrate specificity, and therefore consti-
tutes a "hot spot" that can be explored for altering specificity 
towards other amine substrates of interest. 
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Figure 2. Model of the active site of MAO-B showing the residues that make 
contact with the inhibitor. The corresponding residues of MAO-N are shown 
alongside. 
tor pargyline covalently bound at the active site of MAO-B, to-
gether with the key amino acid residues that line the active 
site (black). We carried out a WU-Blast2 sequence alignment 
(EMBL-EBI) between MAO-N and MAO-B which revealed 24% 
sequence identity and 43% sequence similarity between the 
two proteins. The corresponding residues from MAO-N are 
shown in grey, and it is interesting to note that the active 
sites of both enzymes contain a high proportion of aromatic 
residues and iD there is considerable homology, and often iden-
tity, between the two enzymes (e.g. Tyr60/Trp94, Tyr435/ 
Phe466, Tyrl 88/Trp230, Phel 68/Phe2 10, Tyr365/Tyr326, 
Leu 171 /Leu2 13, Cysi 72/Cys2 14, Tyr3981rrp430). 1le246 (MAO-
N) maps onto Gln206 (MAO-B), the latter appearing to make 
intimate contact with the substrate. It is also perhaps signifi-
cant that these two amino acids are quite different in nature 
and steric demand, and might therefore represent important 
residues in the respective proteins for controlling substrate 
specificity. 
In summary we have developed a practical procedure for 
deracemisation of cyclic secondary amines by a further round 
of directed evolution of the monoamine oxidase from A. niger. 
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